Document:

Exhibit 10.3

 

EMPLOYEE MATTERS AGREEMENT

 

BY AND BETWEEN

 

AGILENT TECHNOLOGIES, INC.

 

AND

 

KEYSIGHT TECHNOLOGIES, INC.

 

AUGUST 1, 2014

 

 

TABLE OF CONTENTS

 

	
 
    	
 
    	
Page
    
	
 
    	
 
    
	
ARTICLE I   DEFINITIONS
    	
1
    
	
 
    	
 
    
	
Section 1.01.
    	
Definitions
    	
1
    
	
 
    	
 
    
	
ARTICLE II   GENERAL PRINCIPLES FOR ALLOCATION OF LIABILITIES
    	
12
    
	
 
    	
 
    
	
Section 2.01.
    	
General Principles
    	
12
    
	
Section 2.02.
    	
Plan Authority
    	
14
    
	
Section 2.03.
    	
Service Credit
    	
14
    
	
Section 2.04.
    	
Benefit Plans
    	
15
    
	
Section 2.05.
    	
Individual Agreements
    	
17
    
	
Section 2.06.
    	
Collective Bargaining
    	
18
    
	
Section 2.07.
    	
Non-U.S. Regulatory Compliance
    	
18
    
	
 
    	
 
    
	
ARTICLE III   ASSIGNMENT OF EMPLOYEES
    	
18
    
	
 
    	
 
    
	
Section 3.01.
    	
Employee List
    	
18
    
	
Section 3.02.
    	
Pre-Distribution Transfers
    	
18
    
	
 
    	
 
    
	
ARTICLE IV   EQUITY AND OTHER COMPENSATION
    	
20
    
	
 
    	
 
    
	
Section 4.01.
    	
Equity Incentive Awards
    	
20
    
	
Section 4.02.
    	
Employee Stock Purchase Plans
    	
24
    
	
Section 4.03.
    	
Variable Pay Plans
    	
24
    
	
 
    	
 
    
	
ARTICLE V   U.S. QUALIFIED RETIREE PLANS
    	
25
    
	
 
    	
 
    
	
Section 5.01.
    	
Keysight U.S. Retirement Plan
    	
25
    
	
Section 5.02.
    	
Keysight DPSP
    	
28
    
	
Section 5.03.
    	
Keysight 401(k) Plan
    	
30
    
	
 
    	
 
    
	
ARTICLE VI   NON-U.S. RETIREMENT PLANS
    	
31
    
	
 
    	
 
    
	
Section 6.01.
    	
Establishment of Non-U.S.   Retirement Plans and Transfers of Assets and Liabilities
    	
31
    
	
Section 6.02.
    	
Shared Plan Model
    	
33
    
	
 
    	
 
    
	
ARTICLE VII   NONQUALIFIED DEFERRED COMPENSATION
    	
34
    
	
 
    	
 
    
	
Section 7.01.
    	
Keysight Nonqualified Plans
    	
34
    
	
Section 7.02.
    	
Rabbi Trust
    	
35
    
	
Section 7.03.
    	
Participant Elections
    	
35
    
	
Section 7.04.
    	
Participation; Distributions
    	
36
    

 

i

 

	
Section 7.05.
    	
Top Hat Filings
    	
36
    
	
 
    	
 
    
	
ARTICLE VIII   HEALTH AND WELFARE BENEFIT PLANS
    	
36
    
	
 
    	
 
    
	
Section 8.01.
    	
Welfare Plans
    	
36
    
	
Section 8.02.
    	
COBRA and HIPAA
    	
38
    
	
Section 8.03.
    	
Vacation, Holidays and Leaves of   Absence
    	
38
    
	
Section 8.04.
    	
Severance and Unemployment   Compensation
    	
38
    
	
Section 8.05.
    	
Insurance Contracts
    	
39
    
	
Section 8.06.
    	
Third-Party Vendors
    	
39
    
	
Section 8.07.
    	
California Disability Benefits
    	
39
    
	
Section 8.08.
    	
Retiree Medical Trust Account
    	
39
    
	
Section 8.09.
    	
Fringe Benefits
    	
39
    
	
Section 8.10.
    	
Workers’ Compensation
    	
39
    
	
 
    	
 
    
	
ARTICLE IX   MISCELLANEOUS
    	
40
    
	
 
    	
 
    
	
Section 9.01.
    	
Information Sharing and Access
    	
40
    
	
Section 9.02.
    	
Consistency of Tax Positions;   Duplication
    	
41
    
	
Section 9.03.
    	
Employment and ERISA Litigation
    	
41
    
	
Section 9.04.
    	
Costs
    	
41
    
	
Section 9.05.
    	
Employee Notices and Governmental   Filings
    	
41
    
	
Section 9.06.
    	
Preservation of Rights to Amend
    	
41
    
	
Section 9.07.
    	
Fiduciary Matters
    	
41
    
	
Section 9.08.
    	
Section 409A of the Code
    	
42
    
	
Section 9.09.
    	
Further Assurances
    	
42
    
	
Section 9.10.
    	
Dispute Resolution
    	
42
    
	
Section 9.11.
    	
Governing Law
    	
42
    
	
Section 9.12.
    	
Survival of Covenants
    	
42
    
	
Section 9.13.
    	
Force Majeure
    	
43
    
	
Section 9.14.
    	
Notices
    	
43
    
	
Section 9.15.
    	
Termination
    	
44
    
	
Section 9.16.
    	
Severability
    	
44
    
	
Section 9.17.
    	
Entire Agreement
    	
44
    
	
Section 9.18.
    	
Assignment
    	
44
    
	
Section 9.19.
    	
Third-Party Beneficiaries
    	
44
    
	
Section 9.20.
    	
Specific Performance
    	
45
    
	
Section 9.21.
    	
Amendments
    	
45
    
	
Section 9.22.
    	
Rules of Construction
    	
45
    
	
Section 9.23.
    	
Counterparts
    	
46
    

 

ii

 

EMPLOYEE MATTERS AGREEMENT

 

This EMPLOYEE MATTERS AGREEMENT, dated as of August 1, 2014 (this “Agreement”), is by and between Agilent Technologies, Inc., a Delaware corporation (“Agilent”), and Keysight Technologies, Inc., a Delaware corporation (“Keysight”).

 

R E C I T A L S:

 

WHEREAS, the board of directors of Agilent (the “Agilent Board”) has determined that it is in the best interests of Agilent and its shareholders to create a new publicly traded company that shall operate the Keysight Business;

 

WHEREAS, in furtherance of the foregoing, the Agilent Board has determined that it is appropriate and desirable to separate the Keysight Business from the Agilent Business (the “Separation”) and, following the Separation, make a distribution, on a pro rata basis, to holders of Agilent Shares on the Record Date of all the outstanding Keysight Shares owned by Agilent (the “Distribution”);

 

WHEREAS, in order to effectuate the Separation and Distribution, Agilent and Keysight have entered into a Separation and Distribution Agreement, dated as of August 1, 2014 (the “Separation Agreement”); and

 

WHEREAS, in addition to the matters addressed by the Separation Agreement, the parties desire to enter into this Agreement to set forth the agreement between the parties relating to the transfer of employees between the companies and their respective compensation and benefit plans and programs, the division of assets and liabilities associated with certain employment, compensation and benefit matters, and other matters associated with the replication of certain employee benefits plans and programs.

 

NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, hereby agree as follows:

 

ARTICLE I
 DEFINITIONS

 

Section 1.01.                          Definitions.  For purposes of this Agreement, the following terms shall have the meanings set forth below.  Capitalized terms used in this Agreement but not otherwise defined herein shall have the meanings ascribed to them in the Separation Agreement.

 

“Action” shall mean any demand, action, claim, dispute, charge of discrimination, suit, countersuit, arbitration, inquiry, subpoena, proceeding or investigation of any nature (whether criminal, civil, legislative, administrative, regulatory, prosecutorial or otherwise) by or before any federal, state, local, foreign or international Governmental Authority or any arbitration or mediation tribunal.

 

 

“Affiliate” (including, with a correlative meaning, “affiliated”) shall mean, when used with respect to a specified Person, a Person that directly or indirectly, through one (1) or more intermediaries, controls, is controlled by or is under common control with such specified Person.  For the purpose of this definition, “control” (including with correlative meanings, “controlled by” and “under common control with”), when used with respect to any specified Person shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by Contract or otherwise.  It is expressly agreed that, from and after the Effective Time and for purposes of this Agreement and the other Transaction Documents, no member of the Keysight Group shall be deemed to be an Affiliate of any member of the Agilent Group, and no member of the Agilent Group shall be deemed to be an Affiliate of any member of the Keysight Group; provided, that for purposes of this Agreement such rule shall also be applicable from and after the Operational Separation Date as the context requires.

 

“Agilent” shall have the meaning set forth in the preamble to this Agreement.

 

“Agilent 401(k) Plan” shall mean the Agilent Technologies, Inc. 401(k) Plan, as amended and restated January 1, 2014.

 

“Agilent 401(k) Trust” shall have the meaning set forth in Section 5.03(b).

 

“Agilent 1999 Non-Employee Director Stock Plan” means the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan (amended and restated 2007).

 

“Agilent 1999 Stock Plan” shall mean the Agilent Technologies, Inc. 1999 Stock Option Plan (amended and restated 2006).

 

“Agilent 2009 Stock Plan” shall mean the Agilent Technologies, Inc. 2009 Stock Plan.

 

“Agilent Benefit Plan” shall mean any Benefit Plan established, sponsored or maintained by Agilent or any of its Subsidiaries immediately prior to the Separation Date, excluding any Keysight Benefit Plan.

 

“Agilent Board” shall have the meaning set forth in the recitals to this Agreement.

 

“Agilent Business” shall have the meaning set forth in the Separation Agreement.

 

“Agilent California Voluntary Plan Fund” shall mean the bank account established by Agilent to hold California employee contributions for the Agilent Technologies, Inc. Disability Plan.

 

“Agilent Compensation Committee” shall mean the Compensation Committee of the Agilent Board.

 

“Agilent Deferred Compensation Plans” shall mean the Agilent Technologies, Inc. 2005 Deferred Compensation Plan (DCP), the Agilent Technologies, Inc. Deferred Compensation Plan (Frozen), the Agilent Technologies, Inc. 2005 Deferred Compensation Plan for

 

2

 

Non-Employee Directors, and the Agilent Technologies, Inc. Deferred Compensation Plan for Non-Employee Directors (Frozen).

 

“Agilent DPSP” shall mean Agilent Technologies, Inc. Deferred Profit Sharing Plan, as amended and restated November 1, 2013.

 

“Agilent Equity Awards” shall mean, collectively, Agilent Options, Agilent RSU Awards, and Agilent Performance Share Awards.

 

“Agilent Equity Plan” shall mean any equity compensation plan sponsored or maintained by Agilent immediately prior to the Effective Time (other than the Agilent ESPP), including the Agilent 2009 Stock Plan, the Agilent 1999 Stock Plan, and the Agilent 1999 Non-Employee Director Stock Plan.

 

“Agilent ESPP” shall mean the Agilent Technologies, Inc. Employee Stock Purchase Plan (amended and restated effective November 1, 2008).

 

“Agilent Group” shall mean Agilent and each Person that is or becomes a Subsidiary of Agilent; provided that, on and following the Operational Separation Date, “Agilent Group” shall exclude members of the Keysight Group and, for clarity, immediately following the Operational Separation Date, shall include those entities set forth on Schedule 2.2(b)(ii)(B) to the Separation Agreement.

 

“Agilent Group Employee” shall mean an individual who, as of the Operational Separation Date is, (i) employed by, or, on an approved leave of absence from, any member of the Agilent Group, or (ii) a Former Agilent Group Employee.  Subject to applicable Law, such term shall also include any individual who otherwise would be a Keysight Group Employee but who fails to execute a Keysight ARCIPD as described in Section 2.05(c).

 

“Agilent Long-Term Performance Program” shall mean the Agilent Technologies Long-Term Performance Program (as amended and restated November 1, 2005).

 

“Agilent Master Trust” shall mean the Agilent Technologies, Inc. Master Trust, effective as of November 1, 2003.

 

“Agilent Nonqualified Plans” shall mean the Agilent Technologies, Inc. Supplemental Benefit Retirement Plan, the Agilent Technologies, Inc. International Relocation Benefit Plan, the Agilent Technologies, Inc. Excess Benefit Retirement Plan, the Agilent Technologies, Inc. Global Relocation Supplement Plan, and the Agilent Deferred Compensation Plans.

 

“Agilent Option” shall mean a stock option to purchase Agilent Shares, granted pursuant to an Agilent Equity Plan, that is outstanding as of immediately prior to the Effective Time.

 

“Agilent Performance Share Award” shall mean a performance share award, granted pursuant to the Agilent 2009 Stock Plan, including Agilent Long-Term Performance

 

3

 

Program, which award includes a “new executive stock award” (as defined in the Agilent 2009 Stock Plan as a performance-based stock award granted to a newly hired executive).

 

“Agilent Rabbi Trust” shall mean the Agilent Technologies, Inc. 2005 Deferred Compensation Plan and the Agilent Technologies, Inc. 2005 Non-Employee Directors Deferred Compensation Plan Trust established pursuant to the trust agreement between Agilent Technologies, Inc. and Fidelity Management Trust Company dated October 28, 2009, as amended.

 

“Agilent Ratio” shall mean the quotient obtained by dividing (i) the Pre-Distribution Agilent Stock Value, by (ii) the Post-Distribution Agilent Stock Value.

 

“Agilent Retiree Medical Trust Agreement” shall mean the Trust Agreement by and between Agilent Technologies, Inc., as Plan Sponsor and as Named Fiduciary, and The Bank of New York Mellon, dated December 31, 2010.

 

“Agilent Retirement Plan” shall mean the Agilent Technologies, Inc. Retirement Plan, as amended and restated November 1, 2013.

 

“Agilent RSU Award” shall mean a restricted stock unit award, granted pursuant to an Agilent 2009 Stock Plan, that is outstanding as of immediately prior to the Effective Time, which is not otherwise accelerated solely by virtue of the Distribution.

 

“Agilent Share” shall mean a share of Agilent common stock, par value $0.01 per share.

 

“Agilent Variable Pay Plans”  Any annual variable incentive plan, program or arrangement sponsored by a member of the Agilent Group pursuant to which an Employee or non-employee director is eligible to receive a cash award, subject in whole or in part to the achievement of performance goals over a period of no more than one (1) year, including without limitation the Agilent Technologies, Inc. Variable Pay Plan, Agilent Technologies, Inc. 2010 Performance-Based Compensation Plan for Covered Employees, and Agilent Technologies, Inc. 2009 Performance-Based Compensation Plan for Non-Covered Employees.

 

“Agilent Welfare Plan” shall mean any Welfare Plan established, sponsored, maintained or contributed to by Agilent or any of its Subsidiaries for the benefit of Employees, including each Welfare Plan listed on Schedule 2.04(a)(i).

 

“Agreement” shall have the meaning set forth in the preamble to this Agreement and shall include all Schedules hereto and all amendments, modifications, and changes hereto entered into pursuant to Section 9.20.

 

“ARCIPD” shall mean an Agreement Regarding Confidential Information and Proprietary Developments between Agilent or any of its subsidiaries, or Keysight, or any of its subsidiaries, as applicable, and any Employee.

 

“Assets” shall have the meaning set forth in the Separation Agreement.

 

4

 

“Automatic Transfer Employees” shall mean those Keysight Group Employees or Agilent Group Employees, as applicable, where local employment Laws, including but not limited to the Transfer Regulations, require an automatic transfer of employees upon the transfer of a business as a going concern and such business transfer occurs by operation of Law.

 

“Benefit Plan” shall mean any contract, agreement, policy, practice, program, plan, trust, commitment or arrangement providing for benefits, perquisites or compensation of any nature from an employer to any Employee, or to any family member, dependent, or beneficiary of any such Employee, including cash or deferred arrangement plans, profit sharing plans, post-employment programs, pension plans, thrift plans, supplemental pension plans, welfare plans, stock option, stock purchase, stock appreciation rights, restricted stock, other equity-based compensation and contracts, agreements, policies, practices, programs, plans, trusts, commitments and arrangements providing for terms of employment, fringe benefits, severance benefits, change in control protections or benefits, travel and accident, life, accidental death and dismemberment, disability and accident insurance, tuition reimbursement, adoption assistance, travel reimbursement, vacation, sick, personal or bereavement days, leaves of absences and holidays; provided, however, that the term “Benefit Plan” does not include any government-sponsored benefits, such as workers’ compensation, unemployment or any similar plans, programs or policies or Individual Agreements.

 

“COBRA” shall mean the U.S. Consolidated Omnibus Budget Reconciliation Act of 1985, as codified at Section 601 et seq. of ERISA and at Section 4980B of the Code.

 

“Code” shall mean the Internal Revenue Code of 1986, as amended.

 

“Contract” shall mean any agreement, contract, obligation, indenture, instrument, lease, promise, arrangement, commitment or undertaking (whether written or oral and whether express or implied).

 

“Distribution” shall have the meaning set forth in the recitals to this Agreement.

 

“Distribution Date” shall mean the date on which Agilent commences distribution of the issued and outstanding Keysight Shares to the holders of Agilent Shares.

 

“Effective Time” shall mean the time at which the Distribution occurs on the Distribution Date, which shall be deemed to be 12:01 a.m., New York City time, on the Distribution Date.

 

“Employee” shall mean any Agilent Group Employee or Keysight Group Employee.

 

“ERISA” shall mean the U.S. Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated thereunder.

 

“Force Majeure” shall mean, with respect to a party, an event beyond the control of such party (or any Person acting on its behalf), which by its nature could not reasonably have been foreseen by such party (or such Person), or, if it could have reasonably been foreseen, was unavoidable, and includes acts of God, storms, floods, riots, fires, sabotage, civil commotion or

 

5

 

civil unrest, interference by civil or military authorities, acts of war (declared or undeclared) or armed hostilities or other national or international calamity or one (1) or more acts of terrorism or failure of energy sources or distribution facilities.

 

“Former Agilent Group Employee” shall mean any individual who, as of the Operational Separation Date, is a former employee of the Agilent Group (other than any Former Keysight Group Employee).

 

“Former Keysight Group Employee” shall mean any individual who, as of the Operational Separation Date is, (i) a former employee of the Agilent Group whose most recent employment with the Agilent Group was in the Keysight Business, (ii) a former employee of the Keysight Group, or (iii) an individual identified as a Former Keysight Employee on the list previously prepared by Agilent and supplied to Keysight, and approved by Agilent in its sole discretion, not later than the Operational Separation Date.

 

“Governmental Authority” shall mean any nation or government, any state, municipality or other political subdivision thereof, and any entity, body, agency, commission, department, board, bureau, court, tribunal or other instrumentality, whether federal, state, local, domestic, foreign, transnational or multinational, exercising executive, legislative, judicial, regulatory, administrative or other similar functions of, or pertaining to, government and any executive official thereof.

 

“HIPAA” shall mean the U.S. Health Insurance Portability and Accountability Act of 1996, as amended, and the regulations promulgated thereunder.

 

“Individual Agreement” shall mean any individual (i) employment contract, (ii) retention, severance or change of control agreement, (iii) expatriate (including any international assignee) contract or agreement (including agreements and obligations regarding repatriation, relocation, equalization of taxes and living standards in the host country), or (iv) other agreement containing restrictive covenants (including confidentiality, non-competition and non-solicitation provisions) between a member of the Agilent Group and a Keysight Group Employee, as in effect immediately prior to the Operational Separation Date.

 

“IRS” shall mean the United States Internal Revenue Service.

 

“Keysight” shall have the meaning set forth in the preamble to this Agreement.

 

“Keysight 401(k) Plan” shall mean the Keysight Technologies, Inc. 401(k) Plan, to be adopted by Keysight prior to or on the Operational Separation Date as described in Section 5.03(a).

 

“Keysight 401(k) Trust” shall have the meaning set forth in Section 5.03(a).

 

“Keysight Equity Awards” shall mean, collectively, Keysight Stock Options, Keysight RSU Awards, and Keysight Performance Share Awards.

 

6

 

“Keysight Benefit Plan” shall mean any Benefit Plan established, sponsored, maintained or contributed to by a member of the Keysight Group prior to, on or after the Operational Separation Date.

 

“Keysight Board” shall mean the Board of Directors of Keysight.

 

“Keysight Business” shall have the meaning set forth in the Separation Agreement.

 

“Keysight California Voluntary Plan Fund” shall mean the bank account to be established by Keysight to hold California employee contributions for the Keysight Technologies, Inc. Disability Plan.

 

“Keysight Deferred Compensation Plans” shall mean the Keysight Technologies, Inc. 2014 Deferred Compensation Plan (DCP), the Keysight Technologies, Inc. 2014 Deferred Compensation Plan for Non-Employee Directors, and the Keysight Technologies, Inc.  Deferred Compensation Plan (Frozen) with such plans to be adopted as described in Section 7.01(a) by Keysight prior to or on the Operational Separation Date or Distribution Date, as applicable.

 

“Keysight DPSP” shall mean the Keysight Technologies, Inc. Deferred Profit Sharing Plan, to be adopted by Keysight prior to or on the Operational Separation Date as described in Section 5.02(a).

 

“Keysight Equity Plan” shall mean the Keysight Technologies, Inc. 2014 Equity and Incentive Compensation Plan to be adopted by Keysight on or prior to the Distribution Date.

 

“Keysight ESPP” shall mean the Keysight Technologies, Inc. Employee Stock Purchase Plan, to be adopted by Keysight prior to or on the Distribution Date as described in Section 4.02(b), and which shall be intended to meet the requirements of Section 423(b) of the Code.

 

“Keysight Group” shall mean Keysight and each Person that is or becomes a Subsidiary of Keysight on and following the Operational Separation Date including, for clarity, those entities set forth on Schedule 2.2(a)(ii)(B) to the Separation Agreement.

 

“Keysight Group Employee” shall mean an individual who, as of the Operational Separation Date is, (i) employed by, or on an approved leave of absence from, Keysight or any of its Affiliates (other than an individual who otherwise would be a Keysight Group Employee but who fails to execute a Keysight ARCIPD as described in Section 2.05(c) subject to applicable Law) or (ii) a Former Keysight Group Employee.

 

“Keysight Master Trust” shall mean the trust established by Keysight prior to or on the Operational Separation Date, which is intended to hold the assets of the Keysight Retirement Plan and the Keysight DPSP.

 

“Keysight Nonqualified Plans” shall mean (i) the Keysight Deferred Compensation Plans and (ii) the Keysight Technologies, Inc. Supplemental Benefit Retirement Plan, the Keysight Technologies, Inc. International Relocation Benefit Plan, and the Keysight  Technologies, Inc.

 

7

 

Excess Benefit Retirement Plan, with such plans described in (ii) to be adopted by Keysight prior to or on the Operational Separation Date, as described in Section 7.01(a).

 

“Keysight Option” shall mean an option to purchase Keysight Stock granted by Keysight pursuant to the Keysight Equity Plan in accordance with Section 4.01(c).

 

“Keysight Performance Share Award” shall mean a performance share award granted pursuant to the Keysight Equity Plan in accordance with Section 4.01(d), including any new executive stock awards granted to newly hired executives.

 

“Keysight Rabbi Trust” shall mean the trust to be established by Keysight prior to or on the Operational Separation Date as described in Section 7.02.

 

“Keysight Retiree Medical Trust” shall mean the trust agreement by and between Keysight and the trustee thereof, to be adopted by Keysight prior to or on the Operational Separation Date as described in Section 8.08.

 

“Keysight Retirement Plan” shall mean the Keysight Technologies, Inc. Retirement Plan, to be adopted by Keysight prior to or on the Operational Separation Date as described in Section 5.01(a).

 

“Keysight RSU Award” shall mean a restricted stock unit award granted pursuant to the Keysight Equity Plan in accordance with Section 4.01(b).

 

“Keysight Share” shall mean a share of Keysight common stock, par value $0.01 per share.

 

“Keysight Stock Ratio” shall mean the quotient obtained by dividing (i) the Pre-Distribution Agilent Stock Value, by (ii) the Keysight Stock Value.

 

“Keysight Stock Value” shall mean the VWAP of a Keysight Share.

 

“Keysight Variable Pay Plans” shall mean variable pay plans, programs or arrangements established by Keysight on or prior to the Distribution Date in accordance with Section 4.03(b).

 

“Keysight Welfare Plans” shall mean any Welfare Plan established, sponsored, maintained or contributed to by any member of the Keysight Group for the benefit of Keysight Group Employees.

 

“Law” shall mean any national, supranational, foreign, international, multinational, federal, state, provincial, local or similar law (including common law), statute, code, order, ordinance, rule, regulation, treaty (including any income tax treaty), license, permit, authorization, approval, consent, decree, injunction, binding judicial or administrative interpretation or other requirement, in each case, enacted, promulgated, issued or entered by a Governmental Authority.

 

“Liabilities” shall mean any and all debts, guarantees, liabilities, costs, expenses, interest and obligations, whether accrued or fixed, absolute or contingent, matured or unmatured,

 

8

 

reserved or unreserved, or determined or determinable, including those arising under any Law, claim (including any claim arising in connection with a Benefit Plan), demand, Action, whether asserted or unasserted, or order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority and those arising under any Contract, release, warranty, or any fines, damages or equitable relief that is imposed, in each case, including all costs and expenses relating thereto.

 

“Material Feature” shall mean any feature of a Benefit Plan that could reasonably be expected to be of material importance to the sponsoring employer or the participants (or their dependents or beneficiaries) (in the aggregate) of that Benefit Plan, which could include, depending on the type and purpose of the particular Benefit Plan, the class or classes of employees eligible to participate in such plan, the nature, type, form, source, and level of benefits provided under such plan and the amount or level of contributions, if any, required to be made by participants (or their dependents or beneficiaries) to such plan.

 

“Non-Automatic Transfer Employees” shall mean those Keysight Group Employees or Agilent Group Employees, as applicable, who are employed by a non-U.S. Subsidiary of Agilent or Keysight and not Automatic Transfer Employees.

 

“Non-U.S. Agilent Benefit Plan” shall mean an Agilent Benefit Plan (excluding Agilent Nonqualified Plans) established, maintained, or contributed to by a member of Agilent Group that is primarily for the benefit of Agilent Group Employees who are or were employed by a non-U.S. Subsidiary of Agilent.

 

“Non-U.S. Keysight Benefit Plan” shall mean a Keysight Benefit Plan (excluding Keysight Nonqualified Plans) established, maintained, or contributed to by a member of the Keysight Group that is primarily for the benefit of Keysight Group Employees who are or were employed by a non-U.S. Subsidiary of Keysight.

 

“Non-U.S. Retirement Plan” means an Agilent Benefit Plan or Keysight Benefit Plan, the primary purpose of which is to provide retirement benefits to Agilent Group Employees and/or Former Agilent Group Employees who are or were employed by a non-U.S. Subsidiary of Agilent, or to Keysight Group Employees and/or Former Keysight Group Employees who are or were employed by a non-U.S. Subsidiary of Agilent or Keysight, respectively.

 

“NYSE” shall mean the New York Stock Exchange.

 

“Offering Period” shall have the meaning set forth in the Agilent ESPP or the Keysight ESPP, as the context requires.

 

“Operational Separation Date” shall mean August 1, 2014, being the date the Keysight Business is segregated operationally from the Agilent Business.

 

“Option Exercise Price Ratio” shall mean, with respect to an Agilent Option, the quotient obtained by dividing (i) the per share exercise price of such Agilent Option immediately prior to the Effective Time, by (ii) the Pre-Distribution Agilent Stock Value.

 

9

 

“Person” shall mean any individual, corporation, partnership, firm, joint venture, association, joint-stock company, trust, unincorporated organization, limited liability company, Governmental Authority or other entity.

 

“Post-Distribution” shall refer to any period of time as of or after the Effective Time.

 

“Post-Distribution Agilent Awards” shall mean, collectively, Post-Distribution Agilent Options, Post-Distribution Agilent RSU Awards and Post-Distribution Agilent Performance Share Awards.

 

“Post-Distribution Agilent Option” shall mean an Agilent Option as adjusted as of the Effective Time in accordance with Section 4.01(c).

 

“Post-Distribution Agilent Performance Share Award” shall mean an Agilent Performance Share Award as adjusted as of the Effective Time in accordance with Section 4.01(d).

 

“Post-Distribution Agilent RSU Award” shall mean an Agilent RSU Award as adjusted as of the Effective Time in accordance with Section 4.01(b).

 

“Post-Distribution Agilent Stock Value” shall mean the VWAP of Agilent Shares.

 

“Pre-Distribution Agilent Stock Value” shall mean the closing price of Agilent Shares trading “regular way with due bills” on the NYSE during the Trading Session immediately prior to the Distribution Date.

 

“Purchase Date” shall have the meaning set forth in the Agilent ESPP.

 

“Purchase Period” shall have the meaning set forth in the Agilent ESPP or the Keysight ESPP, as the context requires.

 

“QDRO” shall mean a qualified domestic relations order within the meaning of ERISA Section 206(d) and Section 414(p) of the Code.

 

“Qualification Requirements” shall mean, in the aggregate, the tax qualification requirements of Section 401(a) of the Code, the tax exemption requirements of Section 501(a) of the Code, and the requirements described in Sections 401(k) and 401(m) of the Code in respect of a plan intended to meet such requirements.

 

“Record Date” shall mean the date determined by the Agilent Board as the record date for the Distribution.

 

“Returning Agilent Employee” shall have the meaning set forth in Section 3.02(e).

 

“Securities Act” shall mean the U.S. Securities Act of 1933, as amended, together with the rules and regulations promulgated thereunder.

 

10

 

“Separation Agreement” shall have the meaning set forth in the recitals to this Agreement.

 

“Services Agreement” shall mean the Services Agreement in substantially the form attached to the Separation Agreement as Exhibit A, to be entered into by and between Agilent and Keysight on or prior to the Distribution Date.

 

“Subsequently Transferred Keysight Employees” shall have the meaning set forth in Section 3.02(d).

 

“Subsidiary” or “subsidiary” shall mean, with respect to any Person, any corporation, limited liability company, joint venture or partnership of which such Person (i) beneficially owns, either directly or indirectly, more than fifty percent (50%) of (A) the total combined voting power of all classes of voting securities of such Person, (B) the total combined equity interests or (C) the capital or profit interests, in the case of a partnership, or (ii) otherwise has the power to vote, either directly or indirectly, sufficient securities to elect a majority of the board of directors or similar governing body.

 

“Third Party” shall mean a Person that is not a member of the Agilent Group or the Keysight Group.

 

“Trading Session” shall mean the period of time during any given calendar day, commencing with the determination of the opening price on the NYSE and ending with the determination of the closing price on the NYSE, in which trading in Agilent Shares or Keysight Stock (as applicable) is permitted on the NYSE.

 

“Transaction Documents” shall mean, collectively, this Agreement, the Separation Agreement, the Services Agreement, the Tax Matters Agreement, the Intellectual Property and License Agreement, the Manufacturing Trademark License Agreement, the Intercompany Agreements, the Real Estate Agreement, and the Transfer Documents.

 

“Transfer Date” shall mean (i) the date a Returning Agilent Employee transfers employment from the Keysight Group to the Agilent Group and/or (ii) the date a Subsequently Transferred Keysight Employee transfers employment from the Agilent Group to the Keysight Group.

 

“Transferred Account Balances” shall have the meaning set forth in Section 8.01(c).

 

“Transfer Regulations” shall mean the Council Directive 77/187/EEC of 14 February 1977 on the approximation of the laws of the Member States relating to the safeguarding of employees’ rights in the event of transfers of undertakings, businesses or parts of businesses (and its amendments) (collectively, the “Acquired Rights Directive”) and the legislation and regulations of any EU Member State implementing such Acquired Rights Directive.

 

11

 

“Transferred Non-U.S. Employee” shall mean a Keysight Group Employee or Agilent Group Employee, as applicable, who is or was employed by a non-U.S. Subsidiary of Agilent or Keysight who is an Automatic Transfer Employee or a Non-Automatic Transfer Employee.

 

“U.S.” shall mean the United States of America.

 

“VWAP” shall mean the volume-weighted average trading price of Agilent Shares or Keysight Shares, as applicable, over the first two (2) Trading Sessions immediately after the Distribution Date, computed by dividing (i) the aggregate sales price of all shares sold over the NYSE during such two (2) Trading Sessions, by (ii) the number of such sold shares.

 

“Welfare Plan” shall mean any “welfare plan” (as defined in Section 3(1) of ERISA) or a “cafeteria plan” under Section 125 of the Code, and any benefits offered thereunder, and any other plan offering health benefits (including medical, prescription drug, dental, vision, wellness, mental health, substance abuse and retiree health), disability benefits, or life, accidental death and dismemberment, and business travel insurance, pre-tax premium conversion benefits, dependent care assistance programs, employee assistance programs, flexible spending accounts, or severance.

 

ARTICLE II
 GENERAL PRINCIPLES FOR ALLOCATION OF LIABILITIES

 

Section 2.01.                          General Principles.

 

(a)                                 Acceptance and Assumption of Liabilities.  At or prior to the Operational Separation Date, except as provided in this Agreement, Keysight and/or one (1) or more of its Subsidiaries designated by Keysight shall retain or accept, and assume, and agree faithfully to perform, discharge and fulfill the following Liabilities in accordance with their respective terms.  Keysight and such Subsidiaries shall be responsible for all such Liabilities, regardless of when or where such Liabilities arose or arise, or whether the facts on which they are based occurred prior to, on or subsequent to the Operational Separation Date, regardless of where or against whom such Liabilities are asserted or determined or whether asserted or determined prior to the date of this Agreement, and regardless of whether arising from or alleged to arise from negligence, recklessness, violation of Law, fraud or misrepresentation by any member of the Agilent Group or the Keysight Group, or any of their respective directors, officers, employees, agents, Subsidiaries or Affiliates:

 

(i)                         any and all wages, salaries, incentive compensation, commissions, bonuses, variable pay, severance and any other employee compensation or benefits payable to or on behalf of any Keysight Group Employees after the Operational Separation Date, without regard to when such wages, salaries, incentive compensation, commissions, bonuses, variable pay, severance or other employee compensation or benefits are or may have been earned, other than claims for benefits with respect to which a lawsuit has not been filed, made by or with respect to any Keysight Group Employees in connection with any Benefit Plan retained or, if any, assumed by any member of the Agilent Group pursuant to this Agreement, the Separation Agreement or any other Transaction Document;

 

12

 

(ii)                      any and all Liabilities whatsoever with respect to claims made by or with respect to any Keysight Group Employees in connection with any Benefit Plan other than claims for benefits with respect to which a lawsuit has not been filed, made by or with respect to any Keysight Group Employee in connection with any Benefit Plan retained or, if any, assumed by any member of the Agilent Group pursuant to this Agreement, the Separation Agreement or any other Transaction Document;

 

(iii)                   any and all Liabilities with respect to any Keysight Group Employees as required under applicable Law;

 

(iv)                  any and all Liabilities with respect to the Philips Lumileds Lighting Company employees who are referenced by name in certain Agilent Benefit Plans, including the obligation to recognize credit for service or compensation with the Philips Lumileds Lighting Company under certain Agilent Benefit Plans including the Agilent Technologies, Inc. Health Plan for Retirees and Agilent Retirement Plan, as such plans are in effect immediately prior to the Operational Separation Date; and

 

(v)                     any and all Liabilities expressly assumed by any member of the Keysight Group pursuant to this Agreement.

 

For purposes of this Section 2.01(a), as of the relevant Transfer Date, the term “Keysight Group Employees” shall also include any Subsequently Transferred Keysight Employees and exclude any Returning Agilent Employees.

 

(b)                                 Acceptance and Assumption of Agilent Liabilities.  At or prior to the Operational Separation Date, except as otherwise provided in this Agreement Agilent and/or one (1) or more of its Subsidiaries designated by Agilent (other than any member of the Keysight Group) shall retain or accept and assume from one (1) or more of its Subsidiaries designated by Agilent and agree faithfully to perform, discharge and fulfill the following Liabilities in accordance with their respective terms (each of which shall be considered an Agilent Liability).  Agilent and such Subsidiaries shall be responsible for all such Liabilities, regardless of when or where such Liabilities arose or arise, or whether the facts on which they are based occurred prior to or subsequent to the Operational Separation Date, regardless of where or against whom such Liabilities are asserted or determined or whether asserted or determined prior to the date of this Agreement, and regardless of whether arising from or alleged to arise from negligence, recklessness, violation of Law, fraud or misrepresentation by any member of the Agilent Group or the Keysight Group, or any of their respective directors, officers, employees, agents, Subsidiaries or Affiliates:

 

(i)                         any and all wages, salaries, incentive compensation, commissions, bonuses, and any other employee compensation or benefits payable to or on behalf of any Agilent Group Employees after the Operational Separation Date, without regard to when such wages, salaries, incentive compensation, commissions, bonuses, or other employee compensation or benefits are or may have been earned, other than claims for benefits with respect to which a lawsuit has not been filed, made by or with respect to any Agilent Group Employees in connection with any Benefit Plan, if any, retained, assumed or adopted by any members of the  Keysight Group pursuant to this Agreement, the Separation Agreement or any Transaction Document;

 

13

 

(ii)                      any and all Liabilities whatsoever with respect to claims made by or with respect to any Agilent Group Employees in connection with any Benefit Plan other than claims for benefits with respect to which a lawsuit has not been filed made by or with respect to any Agilent Group Employee in connection with any Benefit Plan, if any, retained, assumed or adopted by any members of the Keysight Group pursuant to this Agreement, the Separation Agreement or any Transaction Document;

 

(iii)                   any and all Liabilities with respect to any Agilent Group Employees as required under applicable Law; and

 

(iv)                  any and all Liabilities expressly assumed or retained by any member of the Agilent Group pursuant to this Agreement.

 

For purposes of this Section 2.01(b), as of the relevant Transfer Date, the term “Agilent Group Employees” shall also include any Returning Agilent Employees and exclude any Subsequently Transferred Keysight Employees.

 

(c)                                  Other Allocation of Liabilities.  To the extent that this Agreement does not address particular Liabilities under any Benefit Plan and the parties later determine that they should be allocated in connection with the Distribution (whether on the Distribution Date or the Operational Separation Date), the parties shall agree in good faith on the allocation, taking into account the handling of comparable Liabilities under this Agreement.

 

Section 2.02.                          Plan Authority.  Prior to the Operational Separation Date, actions required under this Agreement by any member of the Keysight Group or, where applicable, any member of the Agilent Group, shall be authorized and taken where applicable (i) by Agilent in its capacity as the direct or indirect sole shareholder of Keysight, whether by shareholder consent, action by the Agilent Board or a committee thereof or its delegate as well as by any officer or employee of any member of the Agilent Group or (ii) by the member of the Keysight Group whether by shareholder consent, action by the board of directors of the applicable Keysight Group member or a committee thereof.  On or after the Operational Separation Date, actions required under this Agreement by any member of the Keysight Group, or, where applicable, the Agilent Group, shall be taken by such member whether by shareholder consent, action by the Keysight Board, or, where applicable, the Agilent Board, or the board of directors of the applicable Keysight Group member, or, where applicable, the Agilent Group member, or a committee thereof or its delegate, as well as by any officer or employee of any member of the Keysight Group, or, where applicable, the Agilent Group.  On or after the Operational Separation Date, actions consisting of fiduciary duties under ERISA with respect to a Keysight Benefit Plan shall be taken by the applicable named fiduciary under such plan.

 

Section 2.03.                          Service Credit.

 

(a)                                 Service for Eligibility, Vesting, and Benefit Purposes.

 

The Keysight Benefit Plans shall, and Keysight shall cause each member of the Keysight Group to, recognize each Keysight Group Employee’s and Subsequently Transferred Keysight Employee’s recognized service with Agilent or any of its Subsidiaries or predecessor entities at or before the Operational Separation Date or Transfer Date, as applicable, with respect

 

14

 

to those Keysight Benefit Plans adopted or maintained by the Keysight Group on or as of the Operational Separation Date or as otherwise required by applicable Law, to the same extent that such service was recognized by Agilent for similar purposes prior to the Operational Separation Date or the Transfer Date, as applicable. Notwithstanding the foregoing, Keysight shall cause each member of the Keysight Group, and Agilent shall cause each member of the Agilent Group, to recognize service with either the Keysight Group or the Agilent Group that is recognized as of the Distribution Date. The service crediting provisions shall be subject to any respectively applicable “service bridging,” “break in service,” “employment date” or “eligibility date” rules under the Agilent Benefit Plans or Keysight Benefit Plans.  Except as required by applicable law, the Keysight Benefit Plans shall not recognize service with the Agilent Group for periods on or after the Distribution Date.

 

(i)                         The Agilent Benefit Plans shall, and Agilent shall cause each member of the Agilent Group to, recognize each Agilent Group Employee’s and Returning Agilent Employee’s recognized service with Keysight or any of its Subsidiaries, or where applicable, Agilent or any of its Subsidiaries, at or before the Operational Separation Date or Transfer Date, as applicable, with respect to those Agilent Benefit Plans adopted or maintained by the Agilent Group on or as of the Operational Separation Date or as otherwise required by applicable Law to the same extent that such service was recognized by Agilent or any of its Subsidiaries for similar purposes prior to the Operational Separation Date or Transfer Date, as applicable.

 

(ii)                      Except as required by applicable law, the Agilent Group Plans shall not recognize service with the Keysight Group for periods on or after the Distribution Date.

 

Section 2.04.                          Benefit Plans.

 

(a)                                 Establishment of Plans.  Except as otherwise provided and subject to Section 9.06, Keysight shall, or shall cause an applicable member of the Keysight Group to, adopt Benefit Plans (and related trusts, if applicable), that are substantially similar in all Material Features (or such other standard as is specified in this Agreement with respect to any particular Benefit Plan) to those of the corresponding Agilent Benefit Plans (without derogating from Keysight’s ability to replicate the Material Features of certain Agilent Benefit Plans in a single Keysight Benefit Plan), effective as of the Operational Separation Date with respect to those plans listed on Schedule 2.04(a)(i), effective as of the Distribution Date with respect to those listed on Schedule 2.04(a)(ii) and effective as soon as practical after the Distribution Date with respect to those listed on Schedule 2.04(a)(iii); provided, however, that Keysight may limit participation in any such Keysight Benefit Plan to Keysight Group Employees and Subsequently Transferred Keysight Employees who participated in the corresponding Agilent  Benefit Plan immediately prior to the Operational Separation Date, Transfer Date or the Effective Time, as applicable.

 

(b)                                 Plans Not Required to Be Adopted by Keysight.  Notwithstanding Section 2.04(a) above, Keysight shall not be required to adopt any Benefit Plan (or related trust, if applicable) (i) to the extent that such adoption would not be permitted under applicable Law, regulation, practice, or vendor limitations (ii) if the parties agree that such Benefit Plan should not be so adopted by Keysight, or (iii) if such Benefit Plan is listed on Schedule 2.04(b).  With respect to any Agilent Benefit Plan not listed on Schedules 2.04(a)(i) through (iii) and Schedule 2.04(b),

 

15

 

the parties shall agree in good faith on the treatment of such plan taking into account the handling of any comparable plan under this Agreement.

 

(c)                                  Employee Elections and Information.  Subject to applicable law, Agilent shall provide Keysight with information describing each Agilent Benefit Plan election, beneficiary designations and employee declarations (including, any QDROs, domestic relations orders, qualified medical child support orders and, to the extent applicable, elections made with respect to non-U.S. Agilent Benefit Plans) made by a Keysight Group Employee or a Subsequently Transferred Keysight Employee that may have application to Keysight Benefit Plans from and after the Operational Separation Date, and Keysight shall use its commercially reasonable efforts to administer the Keysight Benefit Plans using those elections.  Keysight shall provide Agilent with comparable information with respect to any Returning Agilent Employee. Each party shall, upon reasonable request, provide the other party and the other party’s respective Affiliates, agents, and vendors all other information reasonably necessary to the other party’s operation or administration of its Benefit Plans.

 

(d)                                 No Acceleration or Duplication of Benefits.  Notwithstanding anything to the contrary in this Agreement, the Separation Agreement or any other Transaction Document, (i) no participant in any Keysight Benefit Plan shall receive service credit or benefits to the extent that receipt of such service credit or benefits would result in duplication of benefits provided to such participant by the corresponding Agilent Benefit Plan or any other plan, program or arrangement sponsored or maintained by a member of the Agilent Group and (ii) no participant in any Agilent Benefit Plan shall receive service credit or benefits to the extent that receipt of such service credit or benefits would result in duplication of benefits provided to such participant by the corresponding Keysight Benefit Plan or any other plan, program or arrangement sponsored or maintained by a member of the Keysight Group .  Furthermore, unless expressly provided for in this Agreement, the Separation Agreement or in any other Transaction Document or required by applicable Law, no provision in this Agreement shall be construed to create any right to accelerate vesting, distributions or entitlements under any compensation or Benefit Plan, program or arrangement sponsored or maintained by a member of the Agilent Group or member of the Keysight Group on the part of any Employee.

 

(e)                                  Transition Services.  The parties acknowledge that the Agilent Group or the Keysight Group may provide administrative services for certain of the other party’s compensation and benefit programs for the period stated under the terms of the Services Agreement.  The parties agree to enter into a business associate agreement (if required by  HIPAA or other applicable health information privacy Laws) in connection with the Services Agreement.

 

(f)                                   Beneficiaries.  Except as otherwise provided in this Agreement, references to Agilent Group Employees, Keysight Group Employees, Returning Agilent Employees, Subsequently Transferred Keysight Employees, and non-employee directors of either Agilent or Keysight, shall be deemed to refer to their eligible beneficiaries, dependents, survivors, spouses and alternate payees, as applicable.

 

(g)                                  Non-U.S. Plans.  Prior to the Operational Separation Date, the Keysight Group shall, except as otherwise mutually agreed upon by the parties, adopt Non-U.S. Keysight

 

16

 

Benefit Plans, with terms comparable to those of the corresponding Non-U.S. Agilent Benefit Plans; provided, however, that Keysight may limit participation in any Non-U.S. Keysight Benefit Plan to Transferred Non-U.S. Employees who participated in the corresponding Non-U.S. Agilent Benefit Plan immediately prior to the Operational Separation Date.

 

(h)                                 Keysight as a Participating Affiliate.  With respect to each Agilent Benefit Plan in which any Keysight Group Employee will continue to participate or no longer participate following the Operational Separate Date pursuant to the terms of this Agreement, Agilent and Keysight shall, prior to the Operational Separation Date, take the necessary actions, if any, so that Keysight, and any applicable Keysight Subsidiary, becomes or is no longer a participating employer in such plan, as applicable, to the extent required by the terms of such plan, including, without limitation, obtaining such Governmental Authority approvals, as may be required with respect to the participation by Keysight or an applicable Keysight Subsidiary.

 

Section 2.05.                          Individual Agreements.

 

(a)                                 Assignment by Agilent.  To the extent necessary and subject to applicable Law, Agilent shall assign, or cause an applicable member of the Agilent Group to assign, to Keysight or another member of the Keysight Group, as designated by Keysight, all Individual Agreements, with such assignment to be effective as of the Operational Separation Date or Transfer Date (except as mutually agreed by the parties in writing or with respect to any Individual Agreement that is a change in control severance agreement); provided, however, that to the extent that assignment of any such Individual Agreement is not permitted by the terms of such agreement, effective as of the Operational Separation Date or Transfer Date, as applicable (or such other date as mutually agreed by the parties in writing), each member of the Keysight Group shall be considered to be a successor to each member of the Agilent Group for purposes of, and a third-party beneficiary with respect to, such Individual Agreement, such that each member of the Keysight Group shall enjoy all of the rights and benefits under such agreement (including rights and benefits as a third-party beneficiary), with respect to the business operations of the Keysight Group; provided, further, that, following the Effective Time, only Keysight or another member of the Keysight Group, and not Agilent, shall be permitted to enforce any Individual Agreement (including any agreement containing non-competition or non-solicitation covenants) against a Keysight Group Employee or a Subsequently Transferred Keysight Employee for action taken in such individual’s capacity as an employee of the Keysight Group.

 

(b)                                 Assumption by Keysight.  Effective as of the Operational Separation Date or Transfer Date, as applicable (or such other date as mutually agreed by the parties in writing), Keysight will assume and honor, or will cause a member of the Keysight Group to assume and honor, any Individual Agreement assigned to Keysight or a member of the Keysight Group pursuant to Section 2.05(a).

 

(c)                                  ARCIPDs.  Prior to the Operational Separation Date or Transfer Date, as applicable, the parties shall use their reasonable best efforts to cooperate to cause each employee who is intended to be a Keysight Group Employee or Subsequently Transferred Keysight Employee (other than any Former Keysight Group Employee) who is party to an ARCIPD with Agilent or any of its Subsidiaries to enter into an ARCIPD with Keysight or one of its Subsidiaries with terms substantially comparable to the terms of each such employee’s ARCIPD with Agilent

 

17

 

or its applicable Subsidiary unless otherwise required by applicable Law.  Subject to applicable Law, any such employee who does not enter into an ARCIPD with Keysight or one of its Subsidiaries shall not become a Keysight Group Employee.

 

(d)                                 Change in Control Severance Agreements.  Keysight shall use its reasonable best efforts to cause each Keysight Group Employee with an Individual Agreement that is a change in control severance agreement with Agilent, to enter into a change in control severance agreement with Keysight effective as of the Distribution Date.

 

Section 2.06.                          Collective Bargaining.  Agilent and Keysight and their respective Subsidiaries shall comply with all obligations under applicable Law to notify and/or consult with Employees or employee representatives, unions, works councils or other employee representative bodies, if any, in respect of the operational segregation of the Keysight Business on the Operational Separation Date and shall provide such information to the other party as is reasonably required by that party to comply with its notification and/or consultation obligations.  Any Liabilities resulting from the failure by one party to comply with such obligations shall be borne by such party.

 

Section 2.07.                          Non-U.S. Regulatory Compliance.  Agilent shall have the authority to adjust the treatment described in this Agreement with respect to Keysight Group Employees who are located outside of the United States in order to ensure compliance with the applicable Laws or regulations of countries outside of the United States or to preserve the tax benefits provided under local tax law or regulation before the Distribution.

 

ARTICLE III
 ASSIGNMENT OF EMPLOYEES

 

Section 3.01.                          Employee List.  Prior to the Operational Separation Date, Agilent shall provide Keysight with a list of all Employees by name, title and location who should be Keysight Group Employees as of the Operational Separation Date.

 

Section 3.02.                          Pre-Distribution Transfers.

 

(a)                                 Assignment and Transfer of Employees.  Effective on the Operational Separation Date and except as otherwise agreed by the parties and subject to Section 3.02(b), (i) the applicable member of the Agilent Group shall have taken such actions as are necessary to  ensure that each Keysight Group Employee (other than any Former Keysight Group Employee) is employed by a member of the Keysight Group, and (ii) the applicable member of the Agilent Group shall have taken such actions as are necessary to ensure that each Agilent Group Employee (other than any Former Agilent Group Employee) is employed by a member of the Agilent Group.

 

(b)                                 Transfer of Non-U.S. Agilent Group Employees (other than any Former Agilent Group Employee).

 

(i)                         Automatic Transfer Employees shall not be terminated upon the Operational Separation Date, but rather the rights, powers, duties, liabilities and obligations of Agilent (or the relevant Subsidiary of Agilent) to such Employees in respect of the material terms of employment with the Employees in force immediately before the Operational Separation Date

 

18

 

shall be transferred to Keysight or its relevant Subsidiary, but only to the extent required by, and only then in accordance with, applicable Law.

 

(ii)                      For Non-Automatic Transfer Employees, except in Argentina, Brazil, and Mexico (collectively, the “Latin American Countries”), where the transfer of employment is by way of employer substitution, Keysight or its relevant Subsidiary shall offer employment to each such Employee effective on the Operational Separation Date, or as otherwise agreed between Agilent and Keysight, each such offer to be at the Employee’s same general location and same base salary as is in effect immediately prior to the Operational Separation Date and otherwise on substantially the same terms and conditions of employment in the aggregate as was provided by Agilent or its relevant Subsidiary immediately prior to the Operational Separation Date.

 

(iii)                   For Non-Automatic Transfer Employees in the Latin American Countries, Keysight shall, and shall cause its relevant Subsidiaries to, effectuate an employer substitution on the Operational Separation Date with respect to the Keysight Group Employees, in accordance with applicable Laws in each country, pursuant to which each relevant Keysight subsidiary will employ the Keysight Group Employees, and will acknowledge and accept all rights, obligations, duties, and responsibilities with respect to such employees as of the Operational Separation Date.

 

(c)                                  Transfer of Keysight Group Employees in Malaysia, Israel and the United Kingdom (other than any Former Keysight Group Employee).  With respect to Keysight Group Employees in Malaysia, Israel and the United Kingdom (other than any Former Keysight Group Employee), all of the provisions of Section 3.02(b)(i)-(ii) shall apply except that references to Agilent shall be references to Keysight and vice versa.

 

(d)                                 Subsequently Transferred Keysight Employees.  Subject to Section 3.02(f), from time to time following the Operational Separation Date and ending on the Distribution Date, any individual who is actively employed by, or on a leave of absence from, the Agilent Group may move to the employ of the Keysight Group from the Agilent Group (“Subsequently Transferred Keysight Employees”).

 

(e)                                  Returning Agilent Employee.  Subject to Section 3.02(f), from time to time following the Operational Separation Date and ending on the Distribution Date, any individual (i) who immediately prior to the Operational Separation Date was an employee of Agilent or one of its affiliates and (ii) who is actively employed by, or on a leave of absence from, the Keysight Group may move to the employ of the Agilent Group from the Keysight Group (“Returning Agilent Employee”).

 

(f)                                   Transfers of Employment.  Any transfers of employment between the Keysight Group and the Agilent Group after the Operational Separation Date and before the Distribution Date shall be through an external opening process. The parties agree that with respect to any transfers of employment they will cooperate for the transfer of benefits under principles consistent with this Agreement to the extent possible; provided, that where vendor or legal issues exist, neither party shall be liable for the failure to replicate in such circumstances.

 

19

 

(g)                                  Documentation.  Each of the parties agrees to execute, and to seek to have the applicable Employees execute, such documentation, if any, as may be necessary to reflect the transfers of employment described in this Section 3.02

 

(h)                                 At-Will Status.  Nothing in this Agreement shall create any obligation on the part of any member of the Agilent Group or any member of the Keysight Group to (i) continue the employment of any Employee or permit the return from a leave of absence for any period after the date of this Agreement (except as required by applicable Law) or (ii) change the employment status of any Employee from “at-will,” to the extent that such Employee is an “at-will” employee under applicable Law.

 

(i)                                     No Termination of Employment.  In no event shall any administrative action taken by either party and/or their third party record-keeper, payroll agent, and/or plan trustee or administrator, to effectuate the transfer of employment pursuant to this Section 3.02, including the identification of Keysight Group Employees as “terminated” in Agilent’s electronic systems, or the electronic systems of any third party record-keeper, payroll agent, and/or plan trustee or administrator, be deemed to be a termination of any Keysight Group Employee’s employment for any purpose unless otherwise required by applicable Law.  The parties acknowledge and agree that the Separation and the Distribution and the assignment, transfer or continuation of the employment of Employees as contemplated by this Section 3.02 shall not entitle any Keysight Group Employee or Agilent Group Employee to separation payments, benefits or rights of any kind unless otherwise required by applicable Law.

 

(j)                                    Not a Change of Control/Change in Control.  The parties acknowledge and agree that neither the consummation of the Distribution nor any transaction contemplated by this Agreement, the Separation Agreement or any other Transaction Document shall be deemed to be a “change of control,” “change in control,” or term of similar import for purposes of any Benefit Plan or Individual Agreement sponsored or maintained by any member of the Agilent Group or member of the Keysight Group.

 

ARTICLE IV
 EQUITY AND OTHER COMPENSATION

 

Section 4.01.                          Equity Incentive Awards.

 

(a)                                 Generally.  Each Agilent Award granted that is outstanding as of immediately prior to the Effective Time shall be adjusted as described below; provided, however, that the Agilent Compensation Committee may provide for different adjustments with respect to some or all Agilent Equity Awards to the extent that the Agilent Compensation Committee deems such adjustments to be necessary and appropriate.  Any adjustments made by the Agilent Compensation Committee pursuant to the foregoing sentence shall be deemed to have been incorporated by reference herein as if fully set forth below and shall be binding on the parties and their respective Affiliates.

 

(b)                                 Restricted Stock Units.  Each Agilent RSU Award that is outstanding immediately prior to the Effective Time shall be converted as of the Effective Time into either a Post-Distribution Agilent RSU Award or a Keysight RSU Award as described below:

 

20

 

(i)                         Each Agilent RSU Award held by an Agilent Group Employee and a Returning Agilent Employee, but not including any Subsequently Transferred Keysight Employee, shall be converted as of the Effective Time, through an adjustment thereto, into a Post-Distribution Agilent RSU Award and shall, except as otherwise provided in this Section 4.01, be subject to the same terms and conditions (including with respect to vesting) after the Effective Time as applicable to such Agilent RSU Award immediately prior to the Effective Time.  The number of Agilent Shares subject to each Post-Distribution Agilent RSU Award, rounded to the nearest one-thousandth (1/1,000) of a share, shall be equal to the product obtained by multiplying (1) the number of Agilent Shares subject to the corresponding Agilent RSU Award immediately prior to the Effective Time, by (2) the Agilent Ratio.

 

(ii)                      Each Agilent RSU Award held by a Keysight Group Employee and any Subsequently Transferred Keysight Employee, but not including any Returning Agilent Employee, shall be converted as of the Effective Time into a Keysight RSU Award outstanding under the Keysight Equity Plan and shall, except as otherwise provided in this Section 4.01, be subject to the same terms and conditions (including with respect to vesting) after the Effective Time as applicable to such Agilent RSU Award immediately prior to the Effective Time.  The number of Keysight Shares subject to such Keysight RSU Award, rounded to the nearest one-thousandth (1/1,000) share, shall be equal to the product obtained by multiplying (1) the number of Agilent Shares subject to the corresponding Agilent RSU Award immediately prior to the Effective Time, by (2) the Keysight Stock Ratio.

 

(c)                                  Stock Options.  Each Agilent Option that is outstanding immediately prior to the Effective Time shall be converted as of the Effective Time into either a Post-Distribution Agilent Option or a Keysight Option as described below:

 

(i)                                     Each Agilent Option held by an Agilent Group Employee and any Returning Agilent Employee, but not including any Subsequently Transferred Keysight Employee, shall be converted as of the Effective Time, through an adjustment thereto, into a  Post-Distribution Agilent Option and shall, except as otherwise provided in this Section 4.01, be subject to the same terms and conditions (including with respect to vesting and expiration) after the Effective Time as applicable to such Agilent Option immediately prior to the Effective Time.  From and after the Effective Time:

 

(A)                               the number of Agilent Shares subject to such Post-Distribution Agilent Option, rounded down to the nearest whole share, shall be equal to the product obtained by multiplying (1) the number of Agilent Shares subject to the corresponding Agilent Option immediately prior to the Effective Time, by (2) the Agilent Ratio; and

 

(B)                               the per share exercise price of such Post-Distribution Agilent Option, rounded up to the nearest cent, shall be equal to the product obtained by multiplying (1) the Post-Distribution Agilent Stock Value, by (2) the Option Exercise Price Ratio.

 

(ii)                                  Each Agilent Option held by a Keysight Group Employee and any Subsequently Transferred Keysight Employee, but not including any Returning Agilent Employee, shall be converted as of the Effective Time into a Keysight Option outstanding under the Keysight Equity Plan and shall, except as otherwise provided in this Section 4.01(c), be subject

 

21

 

to the same terms and conditions (including with respect to vesting and expiration) after the Effective Time as applicable to such Agilent Option immediately prior to the Effective Time.  From and after the Effective Time:

 

(A)                               the number of Keysight Shares subject to such Keysight Option, rounded down to the nearest whole share, shall be equal to the product obtained by multiplying (1) the number of Agilent Shares subject to the corresponding Agilent Option immediately prior to the Effective Time, by (2) the Keysight Stock Ratio; and

 

(B)                               the per share exercise price of such Keysight Option, rounded up to the nearest cent, shall be equal to the product obtained by multiplying (1) the Keysight Stock Value, by (2) the Option Exercise Price Ratio of the corresponding Agilent Option.

 

Notwithstanding anything to the contrary in this Section 4.01(c), the exercise price, the number of Agilent Shares and Keysight Shares subject to each Post-Distribution Agilent Option and Keysight Option, and the terms and conditions of exercise of such options, shall be determined in a manner consistent with the requirements of Section 409A of the Code provided, further, that, in the case of any Agilent Option to which Section 421 of the Code applies by reason of its qualification under Section 422 of the Code as of immediately prior to the Effective Time, the exercise price, the number of Agilent Shares and Keysight Shares subject to such option, and the terms and conditions of exercise of such option shall be determined in a manner consistent with the requirements of Section 424(a) of the Code.

 

(d)                                 Performance Share Awards.

 

(i)                         As of the Effective Time, each outstanding Agilent Performance Share Award with a fiscal year 2012-2014 performance period, a fiscal year 2013-2015 performance period or a fiscal year 2014-2016 performance period that is outstanding  immediately prior to the Effective Time shall be converted as of the Effective Time into either a Post-Distribution Agilent Performance Award or a Keysight Performance Share Award as described below:

 

(ii)                      Each Agilent Performance Share Award held by an Agilent Group Employee and any Returning Agilent Employee, but not including any Subsequently Transferred Keysight Employee, shall be converted as of the Effective Time, through an adjustment thereto, into a Post-Distribution Agilent Performance Share Award and shall, except as otherwise provided in this Section 4.01, be subject to the same terms and conditions (including with respect to vesting and performance conditions) after the Effective Time as applicable to such Agilent Performance Share Award immediately prior to the Effective Time; provided, that from and after the Effective Time, the target number of Agilent Shares subject to such Post-Distribution Agilent Performance Share Award, rounded to the nearest one-thousandth (1/1,000) of a share, shall be equal to the product obtained by multiplying (1) the number of Agilent Shares subject to the corresponding Agilent Performance Share Award immediately prior to the Effective Time, by (2) the Agilent Ratio.

 

(iii)                   Each Agilent Performance Award held by a Keysight Group Employee and any Subsequently Transferred Keysight Employee, but not including any Returning

 

22

 

Agilent Employee, shall be converted as of the Effective Time into a Keysight Performance Share Award outstanding under the Keysight Equity Plan and shall, except as otherwise provided in this Section 4.01, be subject to the same terms and conditions (including with respect to vesting and performance conditions (which, for purposes of clarity, shall continue to relate to Agilent)) after the Effective Time as applicable to such Agilent Performance Share Award immediately prior to the Effective Time; provided that, from and after the Effective Time, the target number of Keysight Shares subject to such Keysight Performance Share Award, rounded to the nearest one-thousandth (1/1,000) of a share, shall be equal to the product obtained by multiplying (1) the number of Agilent Shares subject to the corresponding Agilent Performance Share Award immediately prior to the Effective Time, by (2) the Keysight Stock Ratio. Notwithstanding the above, if a Subsequently Transferred Keysight Employee who is not a Returning Agilent Employee has an outstanding Agilent Performance Share Award with a fiscal year 2014-2016 performance period, Agilent and Keysight agree to attempt to substitute such Agilent Performance Share Award with an equitable Keysight RSU Award.

 

(e)                                  Tax Reporting and Withholding.  Unless prohibited by applicable Law, following the Effective Time, (i) Keysight shall be solely responsible for all income, payroll and other tax remittance and reporting related to income recognized by holders of Keysight Awards in respect of their Keysight Awards; and (ii) Agilent shall be solely responsible for all income, payroll and other tax remittance and reporting related to income recognized by holders of Post-Distribution Agilent Equity Awards in respect of their Post-Distribution Agilent Equity Awards.  Agilent and Keysight agree to enter into any necessary agreements regarding the subject matter of this Section 4.01(e) to enable Agilent and Keysight to fulfill their respective obligations hereunder, including but not limited to compliance with all applicable Laws regarding the reporting, withholding or remitting of income and/or taxes.

 

(f)                                   Establishment of Keysight Equity Plan.  Subject to Section 9.06 and effective as of or prior to the Effective Time, Keysight shall adopt the Keysight Equity Plan  under which the Keysight RSUs, Keysight Options and Keysight Performance Award Units shall be issued, and Keysight shall issue all such awards under the Keysight Equity Plan.  To the extent necessary for any such awards to qualify for transitional relief under Treasury Regulation Section 1.162-27(f)(4)(iii), the Compensation Committee of the Agilent Board shall take the necessary action to grant or approve the Keysight Awards.  The Keysight Equity Plan shall be substantially similar in all Material Features to the Agilent Equity Plans under which the corresponding Agilent Equity Awards were governed prior to the Distribution with such changes as are necessary and appropriate to reflect the Separation but result in terms and conditions that are substantially similar, as of the Operational Separation Date, to those applicable under the Agilent Equity Plans immediately prior to the Distribution Date.

 

(g)                                  Registration and Other Regulatory Requirements.  Keysight agrees to file Forms S-1, S-3 and/or S-8 registration statements with respect to, and to cause to be registered pursuant to the Securities Act, the Keysight Shares authorized for issuance under the Keysight Equity Plan, as required pursuant to the Securities Act, before the date of issuance of any Keysight Shares pursuant to the Keysight Equity Plan.  The parties shall take such additional actions as are deemed necessary or advisable to effectuate the foregoing provisions of this Section 4.01(g), including compliance with securities Laws and other legal requirements associated with equity compensation awards in affected non-U.S. jurisdictions.

 

23

 

Section 4.02.                          Employee Stock Purchase Plans.

 

(a)                                 Agilent ESPP.  The administrator of the Agilent ESPP shall take all actions necessary and appropriate to provide that:  (i) Agilent Group Employees and Keysight Group Employees, where the Agilent ESPP is offered, may participate in the Offering Period beginning May 1, 2014 and with a Purchase Date of September 30, 2014; (ii) all participant payroll deductions and other contributions under the Agilent ESPP shall cease on or before the Purchase Date described in clause (i) of this paragraph; (iii) Keysight Group Employees and Subsequently Transferred Keysight Employees will not be eligible to participate in any Purchase Periods and Offering Periods under the Agilent ESPP after the Distribution Date; and (iv) the Purchase Periods and Offering Periods under the Agilent ESPP which commences on or following the Distribution Date shall be established by the administrator of the Agilent ESPP in its sole discretion.

 

(b)                                 Establishment of Keysight ESPP.  Subject to Section 9.06 and prior to the Distribution Date, Keysight shall adopt the Keysight ESPP, which shall be substantially similar in all Material Features to the Agilent ESPP; provided, that the administrator of the Keysight ESPP, in its sole discretion, shall determine the jurisdictions offered and the timing of the Purchase Period and Offering Periods.  The Keysight ESPP will include authority to grant options which do not meet the requirements of Section 423(b) of the Code (as well as options which meet such requirements).

 

Section 4.03.                          Variable Pay Plans.

 

(a)                                 Agilent Variable Pay Plans.  Keysight Group Employees and Subsequently Transferred Keysight Employees covered by the Agilent Variable Pay Plans as of the Operational Separation Date shall continue to be eligible to participate in such plans until  immediately prior to the Effective Time.  Agilent shall determine the amount of the awards payable to such persons under the Agilent Variable Pay Plans for the fiscal year ending October 31, 2014.  At the option of Agilent, payment of awards may be made in one (1) of the following methods: (i) Agilent shall pay to such persons the entire amount of the awards under the Agilent Variable Pay Plans in respect of such performance period, and Keysight shall reimburse Agilent for Keysight’s pro rata portion, (ii) Keysight shall pay to such persons the entire amount of the awards under the Agilent Variable Pay Plans in respect of such performance period, and Agilent shall reimburse Keysight for Agilent’s pro rata portion, such reimbursement to be made no more than twenty (20) business days following Agilent’s notification of the amount of the awards made to such persons, or (iii) Agilent and Keysight shall each pay a pro rata portion of such awards to such persons.  For these purposes, pro rata portion shall be based on the number of days in such performance period from the first (1st) day of such performance period through the Operational Separation Date or Transfer Date, as applicable (as to Agilent), and based on the number of days in such performance period from the Operational Separation Date or Transfer Date, as applicable, through the end of such performance period fiscal year (as to Keysight).

 

(b)                                 Keysight Variable Pay Plans.  Subject to Section 9.06 and not later than the Distribution Date, Keysight shall establish Keysight Variable Pay Plans, which shall be substantially similar in all Material Features to the Agilent Variable Pay Plans as of immediately prior to the Distribution Date.  If the terms of the Keysight Variable Pay Plans provide for eligibility, Keysight Group Employees and Subsequently Transferred Employees shall be eligible

 

24

 

to participate in the Keysight Variable Pay Plans immediately following the Effective Time.  The Keysight Group shall be solely responsible for establishing performance metrics, funding, paying, and discharging all obligations relating to any variable pay awards under the Keysight Variable Pay Plans, and no member of the Agilent Group shall have any obligations with respect thereto.

 

ARTICLE V
 U.S. QUALIFIED RETIREE PLANS

 

Section 5.01.                          Keysight U.S. Retirement Plan.

 

(a)                                 Establishment of Keysight U.S. Retirement Plan.  Subject to Section 9.06 and effective as of the Operational Separation Date, Keysight shall establish the Keysight Retirement Plan and Keysight Master Trust, which shall be intended to meet the Qualification Requirements, and the Keysight Retirement Plan shall be substantially similar in all Material Features as of immediately prior to the Operational Separation Date to the Agilent Retirement Plan. At least thirty (30) days prior to the Operational Separation Date, Agilent shall have filed the notice required under Section 6058(b) of the Code.  On or, as soon as practicable after, the Operational Separation Date and after receipt by Agilent of (i) a copy of the Keysight Retirement Plan and (ii) a copy of certified resolutions of the Keysight Board (or its authorized committee or other delegate) evidencing adoption of the Keysight Retirement Plan and the Keysight Master Trust, Agilent shall direct the trustee of the Agilent Master Trust to transfer assets of the Agilent Master Trust to the Keysight Master Trust in the amounts described in Section 5.01(b).

 

(b)                                 Liability Assumption and ERISA Section 4044 Transfer.  As of the Operational Separation Date, Keysight shall cause the Keysight Retirement Plan to assume all  Liabilities under the Agilent Retirement Plan for Keysight Group Employees and the Keysight Master Trust to accept Assets with respect to such assumed Liabilities and the Agilent Master Trust shall transfer such Assets to the Keysight Master Trust and the Agilent Retirement Plan shall be relieved of such Liabilities.  The amount of Assets shall be transferred in-kind, pro rata, unless otherwise agreed by the parties in writing, from the Agilent Master Trust to the Keysight Master Trust and such transfer (or transfers) shall be determined as of the Operational Separation Date in accordance with, and shall comply with Sections 414(l) and 411(d)(6) of the Code and, to the extent deemed applicable by the parties, ERISA Section 4044 and shall be calculated as follows: Agilent shall engage actuaries and cause to be determined for the Agilent Retirement Plan:  (A) the present value of all Liabilities determined under ERISA Section 4044  as of the Operational Separation Date (without regard to any benefit Liabilities funded through the Code Section 401(h) account) in the Agilent Retirement Plan for all participants in the Agilent Retirement Plan with such Liabilities calculated using plan termination assumptions and methodology such that participants in pay status and those who are early retirement eligible are given priority over other plan participants in the division of the assets as these priority categories are “funded” based on liability measurements used for plan terminations, as stipulated under ERISA Section 4044, rather than ongoing plan operation and (B) the present value of all of the retiree health benefit Liabilities that are funded in part through the Code Section 401(h) account portion of the Agilent Retirement Plan as of the Operational Separation Date, calculated on an accumulated post-retirement benefit obligation basis in accordance with ASC 715-60.  The particular actuarial assumptions that will be used to value the benefit Liabilities described in the preceding sentence shall be generally consistent with the actuarial assumptions used by Agilent in prior valuations for purposes of

 

25

 

satisfying, respectively, its ASC 715-30 and ASC 715-60 reporting obligations, as determined by Agilent’s actuary.

 

(i)                         The Keysight Retirement Plan’s share of the Agilent Retirement Plan assets (other than those Agilent Retirement Plan assets attributable to the Code Section 401(h) account in the Agilent Retirement Plan) shall be equal to the percentage that the benefit Liabilities for the Keysight Group Employees bears to the total benefit Liabilities determined under Section 5.01(b) above.

 

(ii)                      The Keysight Retirement Plan’s share of the Agilent Retirement Plan assets in the Code Section 401(h) account portion of the Agilent Retirement Plan shall be equal to the percentage that the retiree health benefit Liabilities for the Keysight Group Employees funded through Section 401(h) account under the Agilent Retirement Plan bears to the total retiree health benefit Liabilities determined under Section 5.01(b) above.

 

The amount of Assets to be transferred shall equal the sum of (i) and (ii)  which amount shall be credited or debited, as applicable, with a pro rata share of the actual investment earnings or losses allocable to the transfer amount for the period between the Operational Separation Date and an assessment date set by Agilent that is as close as practicable, taking into account the timing and reporting of valuation of Assets in the Agilent Master Trust, to the date upon which Assets equal in value to the transfer amount are actually transferred from the Agilent Master Trust to the Keysight Master Trust.  During this period, each plan will be responsible for a portionate share of third party fees, costs and expenses including trustee, investment management, administration and other similar fees incurred by or in respect of the plans, with such proportion based on the relative liabilities of the plans as of the Operational Separation  Date.  The parties agree that to the extent necessary to effectuate the provisions of this Section 5.01, there may be additional transfers of assets between the Agilent Master Trust and Keysight Master Trust on such dates as agreed to by the parties.

 

(c)                                  Adjustment for Subsequently Transferred Keysight Employees and Returning Agilent Employees.  As of the Effective Time (or such other times as agreed to by the parties), with respect to any Subsequently Transferred Keysight Employees or Returning Agilent Employees, there shall be an adjustment in the transfer of Assets and assumption of Liabilities as described in Section 5.01(b), in accordance with such Section 5.01(b) as modified by this Section 5.01(c).  As of the Distribution Date, Keysight shall cause the Keysight Retirement Plan to assume Liabilities under the Agilent Retirement Plan for Keysight Subsequently Transferred Employees and the Keysight Master Trust to accept Assets with respect to such assumed Liabilities and the Agilent Master Trust shall transfer such Assets to the Keysight Master Trust and the Agilent Retirement Plan shall be relieved of such Liabilities.  As of the Distribution Date (or such other times as agreed to by the parties), Agilent shall cause the Agilent Retirement Plan to assume Liabilities under the Keysight Retirement Plan for Returning Agilent Employees and the Agilent Master Trust to accept Assets with respect to such assumed Liabilities and the Keysight Master Trust shall transfer such Assets to the Agilent Master Trust and the Keysight Retirement Plan shall be relieved of such Liabilities.  The Assets and Liabilities described in the preceding two (2) sentences with respect to Subsequently Transferred Keysight Employees and Returning Agilent Employees shall be determined based on the procedures set forth in Section 5.01(b) using the Distribution Date (or such other date as agreed to by the parties) instead of the Operational

 

26

 

Separation Date and with respect to the calculation for any Returning Agilent Employees, replacing the reference to Keysight with Agilent and Agilent with Keysight.  If the actual transfer of Assets has not yet occurred under Section 5.01(b), the amount of Assets, if any, to be transferred as a result of the application of this Section 5.01(c) shall either be added to, or subtracted from, the Assets to be transferred under Section 5.01(b), as applicable.

 

(d)                                 Keysight Retirement Plan Provisions.  The Keysight Retirement Plan shall provide that:

 

(i)                         (A) Keysight Group Employees and Subsequently Transferred Keysight Employees shall be eligible to participate in the Keysight Retirement Plan as of the Operational Separation Date (or the Transfer Date with respect to any Subsequently Transferred Employees) to the extent that they were eligible to participate in the Agilent Retirement Plan as of immediately prior to the Operational Separation Date (or the Transfer Date with respect to any Subsequently Transferred Employees), and (B) service for a Keysight Group Employee or a Subsequently Transferred Keysight Employee that is recognized under the Agilent Retirement Plan as of immediately prior to the Operation Separation Date (or the Transfer Date with respect to any Subsequently Transferred Keysight Employee) shall be credited and recognized for all applicable purposes under the Keysight Retirement Plan as though it were service from the Keysight Group;

 

(ii)                      compensation paid by the Agilent Group to a Keysight Group Employee or a Subsequently Transferred Keysight Employee that is recognized under the Agilent Retirement Plan as of immediately prior to the Operational Separation Date (or the Transfer Date with respect to a Subsequently Transferred Keysight Employee) shall be credited  and recognized for all applicable purposes under the Keysight Retirement Plan as though it were compensation from the Keysight Group;

 

(iii)                   the accrued benefit of each Keysight Group Employee under the Agilent Retirement Plan as of the Operational Separation Date (or the Transfer Date with respect to a Subsequently Transferred Keysight Employee) shall be payable under the Keysight Retirement Plan at the time and in a form that would have been permitted under the Agilent Retirement Plan as in effect as of immediately prior to the Operational Separation Date (or the Transfer Date with respect to any Subsequently Transferred Employees) to the extent required under Section 411(d)(6) of the Code, with employment by the Agilent Group before the Operational Separation Date (or the Transfer Date with respect to a Subsequently Transferred Keysight Employee) treated as employment by the Keysight Group under the Keysight Retirement Plan for purposes of determining eligibility for optional forms of benefit, early retirement benefits, or other benefit forms; and

 

(iv)                  the Keysight Retirement Plan shall assume and honor the terms of all QDROs in effect under the Agilent Retirement Plan in respect of Keysight Group Employees and Subsequently Transferred Keysight Employees as of immediately prior to the Operational Separation Date (for Keysight Group Employees) or as of immediately prior to the Transfer Date (with respect to Subsequently Transferred Employees).

 

(e)                                  Determination Letter Request.  Keysight shall submit an application to the IRS as soon as practicable after the Operational Separation Date (but no later than the last day of

 

27

 

the applicable remedial amendment period as described in Section 401(b) of the Code and the regulations and IRS pronouncements thereunder) requesting a determination letter that the Keysight Retirement Plan and Keysight Master Trust meet the Qualification Requirements, and shall make any amendments reasonably requested by the IRS to receive such a favorable determination letter.

 

(f)                                   Agilent Retirement Plan After Operational Separation Date.  With respect to any Returning Agilent Employee, to the extent applicable, the Agilent Retirement Plan shall assume and honor QDROs and recognize compensation paid and service with the Keysight Group under comparable terms to those that apply to Keysight Group Employees and Subsequently Transferred Keysight Employees under the Keysight Retirement Plan.

 

(g)                                  Plan Fiduciaries.  For all periods after the Operational Separation Date, the parties agree that the applicable fiduciaries of each of the Agilent Retirement Plan and the Keysight Retirement Plan, respectively, shall have the authority with respect to the Agilent Retirement Plan and the Keysight Retirement Plan, respectively, to determine the plan investments and such other matters as are within the scope of their duties under ERISA, and the terms of the applicable plan documents.

 

(h)                                 No Distributions.  No Keysight Group Employee or Subsequently Transferred Keysight Employee shall be entitled to a right to a distribution of his or her benefit under the Agilent Retirement Plan as a result of the transfer of employment to the Keysight Group and no Returning Agilent Employee shall be entitled to a right to a distribution of his or  her benefit under the Keysight Retirement Plan as a result of the transfer of employment from the Keysight Group to the Agilent Group.

 

Section 5.02.                          Keysight DPSP.

 

(a)                                 Establishment of Plan.  Subject to Section 9.06 and effective as of the Operational Separation Date, Keysight shall establish the Keysight DPSP which shall be intended to meet the Qualification Requirements and which shall be substantially similar in all Material Features as of immediately prior to the Operational Separation Date to the Agilent DPSP.  Before the Operational Separation Date, Keysight shall provide Agilent with (i) a copy of the Keysight DPSP and (ii) a copy of certified resolutions of the Keysight Board (or its authorized committee or other delegate) evidencing adoption of the Keysight DPSP and the assumption by the Keysight DPSP of the Liabilities described in Section 5.02(b).

 

(b)                                 Transfer of Account Balances.  On the Operational Separation Date for Keysight Group Employees or the Distribution Date for any Subsequently Transferred Keysight Employees (or such other times as mutually agreed to by the parties), Agilent shall cause the trustee of the Agilent DPSP to transfer from the Agilent Master Trust to the Keysight Master Trust, the account balances of such persons under the Agilent DPSP, determined as of the date of the transfer.  On or following the Distribution Date for Returning Agilent Employees (or such times as mutually agreed to by the parties), Keysight shall cause the trustee of the Keysight DPSP to transfer from the Keysight Master Trust to the Agilent Master Trust, the account balances of such persons under the Keysight DPSP, determined as of the date of the transfer.  Such transfers shall be made in-kind pro rata, unless otherwise agreed by the parties.  Any Asset and Liability transfers

 

28

 

pursuant to this Section 5.02(b) shall comply in all respects with Sections 414(l) and 411(d)(6) of the Code and, if required, shall be made not less than thirty (30) days after Agilent shall have filed the notice under Section 6058(b) of the Code.

 

(c)                                  Keysight DPSP Provisions.  The Keysight DPSP shall provide that:

 

(i)                         Keysight Group Employees and Subsequently Transferred Keysight Employees shall receive credit for all service credited for the same purpose under the Agilent DPSP as of the Operational Separation Date (or Transfer Date with respect to any Subsequently Transferred Employee) as if that service had been rendered to Keysight;

 

(ii)                      the account balance of each Keysight Group Employee or Subsequently Transferred Keysight Employee under the Agilent DPSP as of the date of the transfer of Assets from the Agilent DPSP shall be credited to such individual’s account under the Keysight DPSP; and

 

(iii)                   the Keysight DPSP shall assume and honor the terms of all QDROs in effect under the Agilent DPSP in respect of Keysight Group Employees and Subsequently Transferred Keysight Employees as of immediately prior to the Operational Separation Date (for Keysight Group Employees) or as of immediately prior to the Transfer Date (with respect to Subsequently Transferred Employees).

 

(d)                                 Determination Letter Request.  Keysight shall submit an application to the IRS as soon as practicable after the Operational Separation Date (but no later than the last day of  the remedial amendment period as described in Section 401(b) of the Code and the regulations and IRS pronouncements thereunder) requesting a determination letter that the Keysight DPSP meets the Qualification Requirements, and shall make any amendments reasonably requested by the IRS to receive such a favorable determination letter.

 

(e)                                  Agilent DPSP After the Operational Separation Date.  With respect to any Returning Agilent Employee, to the extent applicable, the Agilent DPSP shall assume and honor QDROs in effect under the Keysight DPSP as of immediately prior to the Transfer Date.

 

(f)                                   No Distributions.  No Keysight Group Employee or Subsequently Transferred Keysight Employee shall be entitled to a right to a distribution of his or her benefit under the Agilent DPSP as a result of his or her transfer of employment from the Agilent Group to the Keysight Group.  No Returning Agilent Employee shall be entitled to a right to a distribution of his or her benefit under the Keysight DPSP as a result of his or her transfer of employment from the Keysight Group to the Agilent Group.

 

(g)                                  Plan Fiduciaries.  For all periods after the Operational Separation Date, the parties agree that the applicable fiduciaries of each of the Agilent DPSP and the Keysight DPSP, respectively, shall have the authority with respect to the Agilent DPSP and the Keysight DPSP, respectively, to determine the plan investments and such other matters as are within the scope of their duties under ERISA, and the terms of the applicable plan documents.

 

29

 

Section 5.03.                          Keysight 401(k) Plan.

 

(a)                                 Establishment of Plan.  Subject to Section 9.06 and effective as of the Operational Separation Date, Keysight shall establish the Keysight 401(k) Plan and a related trust (the “Keysight 401(k) Trust”) which shall be intended to meet the Qualification Requirements (including under Sections 401(k) and (m) of the Code) and which shall be substantially similar in all Material Features as of immediately prior to the Operational Separation Date to the Agilent 401(k) Plan, provided that both parties acknowledge that the Keysight 401(k) Plan shall not include an ESOP.  Before the Operational Separation Date, Keysight shall provide Agilent with (i) a copy of the Keysight 401(k) Plan and Keysight 401(k) Trust and (ii) a copy of certified resolutions of the Keysight Board (or its authorized committee or other delegate) evidencing adoption of the Keysight 401(k) Plan and Keysight 401(k) Trust and the assumption by the Keysight 401(k) Plan of the Liabilities described in Section 5.03(b).

 

(b)                                 Transfer of Account Balances.  Effective as of the Operational Separation Date for Keysight Group Employees or the Distribution Date for any Subsequently Transferred Keysight Employees (or such other times as mutually agreed to by the parties), Agilent shall cause the trustee of the Agilent 401(k) Plan to transfer from the trust which forms a part of the Agilent 401(k) Plan (the “Agilent 401(k) Trust”) to the Keysight 401(k) Trust, the account balances of such persons under the Agilent 401(k) Plan, determined as of the date of the transfer.  On or following the Distribution Date for Returning Agilent Employees (or such other times as mutually agreed to by the parties), Keysight shall cause the trustee of the Keysight 401(k) Plan to transfer from the Keysight 401(k) Trust to the Agilent 401(k) Trust, the account balances of such persons under the Keysight 401(k) Plan, determined as of the date of the transfer.  Unless otherwise agreed by the parties, such transfers shall be made in kind, including promissory notes  evidencing the transfer of outstanding loans.  Any Asset and Liability transfers pursuant to this Section 5.03 shall comply in all respects with Sections 414(l) and 411(d)(6) of the Code and if required, shall be made not less than thirty (30) days after Agilent shall have filed the notice under Section 6058(b) of the Code.  The parties agree that to the extent that any assets are not transferred in kind, the assets transferred will be mapped into an appropriate investment vehicle.

 

(c)                                  Keysight 401(k) Plan Provisions.  The Keysight 401(k) Plan shall provide that:

 

(i)                         Keysight Group Employees and Subsequently Transferred Keysight Employees shall be eligible to participate in the Keysight 401(k) Plan as of the Operational Separation Date (or Transfer Date with respect to any Subsequently Transferred Keysight Employees) to the extent that they were eligible to participate in the Agilent 401(k) Plan as of immediately prior to the Operational Separation Date (or Transfer Date with respect to any Subsequently Transferred Employees);

 

(ii)                      the account balance of each Keysight Group Employee or Subsequently Transferred Keysight Employee under the Agilent 401(k) Plan as of the date of the transfer of Assets from the Agilent 401(k) Plan (including any outstanding promissory notes relating to outstanding loans) shall be credited to such individual’s account under the Keysight 401(k) Plan; and

 

30

 

(iii)                   the Keysight 401(k) Plan shall assume and honor the terms of all QDROs in effect under the Agilent 401(k) Plan in respect of Keysight Group Employees and Subsequently Transferred Keysight Employees as of immediately prior to the Operational Separation Date (for Keysight Group Employees) or as of immediately prior to the Transfer Date (with respect to Subsequently Transferred Employees).

 

(d)                                 Determination Letter Request.  Keysight shall submit an application to the IRS as soon as practicable after the Operational Separation Date (but no later than the last day of the remedial amendment period as described in Section 401(b) of the Code and the regulations and IRS pronouncements thereunder) requesting a determination letter that the Keysight 401(k) Plan and Keysight 401(k) Trust meet the Qualification Requirements (including under Section 401(k) of the Code), and shall make any amendments reasonably requested by the IRS to receive such a favorable determination letter.

 

(e)                                  Agilent 401(k) Plan after the Operational Separation Date.  With respect to any Returning Agilent Employee, to the extent applicable, the Agilent 401(k) Plan shall assume and honor QDROs in effect under the Keysight 401(k) Plan as of immediately prior to the Transfer Date.

 

(f)                                   Plan Fiduciaries.  For all periods after the Operational Separation Date, the parties agree that the applicable fiduciaries of each of the Agilent 401(k) Plan and the Keysight 401(k) Plan, respectively, shall have the authority with respect to the Agilent 401(k) Plan and the Keysight 401(k) Plan, respectively, to determine the investment alternatives, the terms and conditions with respect to those investment alternatives and such other matters as are within the scope of their duties under ERISA and the terms of the applicable plan documents.

 

(g)                                  No Distributions.  No Keysight Group Employee or Subsequently Transferred Keysight Employee shall be entitled to a right to a distribution of his or her benefit under the Agilent 401(k) Plan as a result of his or her transfer of employment from the Agilent Group to the Keysight Group.  No Returning Agilent Employee shall be entitled to a right to a distribution of his or her benefit under the Keysight 401(k) Plan as a result of such transfer of employment from the Keysight Group to the Agilent Group.

 

ARTICLE VI
 NON-U.S. RETIREMENT PLANS

 

Section 6.01.                          Establishment of Non-U.S. Retirement Plans and Transfers of Assets and Liabilities.

 

(a)                                 Establishment of Keysight Non-U.S. Retirement Plans. Except as mutually agreed upon by the parties and set forth on Schedule 6.01(a) or required under this Article VI and before the Operational Separation Date, Keysight shall, or shall cause its relevant Subsidiary to, establish one (1) or more Non-U.S. Retirement Plans (whether one (1) or more defined contribution or defined benefit pension plans) with terms that are comparable to those of the corresponding Non-U.S. Agilent Benefit Plans which are Non-U.S. Retirement Plans.

 

(i)                         Transfer of Non-U.S. Retirement Plan Assets and Liabilities.  After a Keysight Non-U.S. Retirement Plan is established in accordance with Section 6.01(a), then, with

 

31

 

respect to each of the countries or entities listed in Schedule 6.01(a)(i)(A) except as otherwise provided in this Agreement, the Assets and Liabilities determined as of the Operational Separation Date under the corresponding Agilent Non-U.S. Retirement Plan attributable to Transferred Non-U.S. Employees and Former Keysight Group Employees) who are participants in that plan, along with any other Assets and Liabilities that Keysight agrees to assume with respect to such plan, shall be transferred to the applicable Keysight Non-U.S. Retirement Plan.  Each Agilent Non-U.S. Retirement Plan shall retain all Assets and Liabilities related to Agilent Group Employees, Former Agilent Group Employees, and, with respect to each of the countries or entities listed in Schedule 6.01(a)(i)(B), Former Keysight Group Employees.  Assets will be allocated between the plans based on the proportion of Liabilities borne by each plan.  Except as otherwise mutually agreed upon by the parties and set forth on Schedule 6.01(a)(i)(C), such Liabilities will be valued as of the Operational Separation Date using the projected benefit obligation based on the provisions of the applicable Agilent Non-U.S. Retirement Plan as in effect at the Operational Separation Date and applying demographic and other assumptions used in the most recently completed valuation of the applicable Agilent Non-U.S. Retirement Plan.  The parties agree to use commercially reasonable efforts to accomplish each transfer as soon as practicable following the Operational Separation Date and to cooperate with each other to make such filings and disclosures and obtain such approvals as may be deemed to be necessary or advisable in accordance with applicable Law.

 

(ii)                      Keysight Non-U.S. Retirement Plan Provisions.  Each Keysight Non-U.S. Retirement Plan shall provide, except as otherwise provided in this Agreement, the Separation Agreement or in any other Transaction Document that:

 

(A)                               Transferred Non-U.S. Employees and Former Keysight Group Employees shall (A) be eligible to participate in such Keysight Non-U.S. Retirement Plan to the extent that they were eligible to participate in the corresponding Agilent Non-U.S. Retirement Plan as of the Operational Separation Date, and (B) receive credit for vesting, eligibility and benefit service for all service credited for those purposes under the corresponding Agilent Non-U.S. Retirement Plan as if that service had been rendered to the Keysight Group;

 

(B)                               the compensation paid by the Agilent Group to a Transferred Non-U.S. Employee or an Former Keysight Group Employee that is recognized under the applicable Agilent Non-U.S. Retirement Plan shall be credited and recognized for all applicable purposes under the corresponding Keysight Non-U.S. Retirement Plan as though it were compensation from the Keysight Group; and

 

(C)                               the accrued benefit of each Transferred Non-U.S. Employee or Former Keysight Group Employee) under the applicable Agilent Non-U.S. Retirement Plan that is transferred to the corresponding Keysight Non-U.S. Retirement Plan pursuant to Section 6.01(a)(i) shall be paid under such Keysight Non-U.S. Retirement Plan in accordance with the terms of such Keysight Non-U.S. Retirement Plan and applicable Law, with employment by the Agilent Group treated as employment by the Keysight Group under the Keysight Non-U.S. Retirement Plan for purposes of determining eligibility for optional forms of benefit, early retirement benefits, or other benefit forms.

 

32

 

(b)                                 Establishment of Agilent Non-U.S. Retirement Plans.  Except as mutually agreed to by the parties and as set forth on Schedule 6.01(b)(i) or required under this Article VI and before the Operational Separation Date, Agilent shall, or shall cause its relevant Subsidiary to, establish one (1) or more Non-U.S. Retirement Plans (whether one (1) or more defined contribution or defined benefit pension plans) with terms that are comparable to those of the corresponding Non-U.S. Agilent Benefit Plans which are Non-U.S. Retirement Plans in such countries or with respect to such entities where Agilent shall be spun off and the existing Agilent entity shall be renamed Keysight.  Except as set forth on Schedule 6.01(b)(ii), with respect to such newly established Agilent non-U.S. Retirement Plans all of the provisions of Sections 6.01(a)(i)-(iii) shall apply except that references to Agilent shall be references to Keysight and vice versa.

 

Section 6.02.                          Shared Plan Model.

 

(a)                                 Keysight Participation in Agilent Non-U.S. Retirement Plans.

 

(i)                                     In each of the countries or entities listed in Schedule 6.02(a), Agilent shall, or shall cause its appropriate Affiliate to, permit Keysight or its relevant Subsidiary to continue to participate in the applicable Agilent Non-U.S. Retirement Plan providing retirement benefits in that country after the Distribution and where necessary, the parties agree to provide further details in the applicable local agreement.

 

(ii)                                  Except as mutually agreed to by the parties, at or before the end of the shared plan period, in each of the countries or entities listed in Schedule 6.02(a),  Keysight shall, or shall cause its relevant Subsidiary to, establish a Keysight Non-U.S. Retirement Plan or similar arrangement to deliver the benefits due to the Keysight Group Employees and Former Keysight Group Employees under the applicable Agilent Non-U.S. Retirement Plan or otherwise shall be responsible for all costs incurred by the parties in connection with winding up or terminating the participation of Keysight or its relevant subsidiary in such Agilent Non-U.S. Retirement Plan.  Following the establishment of each Keysight Non-U.S. Retirement Plan, the Assets and Liabilities of the corresponding Agilent Non-U.S. Retirement Plan attributable to the Keysight Group Employees and Former Keysight Group Employees who are participants in that plan shall be transferred to such Keysight Non-U.S. Retirement Plan.  Assets will be allocated between the plans based on the proportion of Liabilities borne by each plan.  Except as otherwise mutually agreed upon by the parties, such Liabilities will be valued as of the end of the shared plan period using the projected benefit obligation method based on the provisions of the applicable Agilent Non-U.S. Retirement Plan as in effect at the end of the shared plan period and applying the demographic and other assumptions used in the most recently completed valuation of the applicable Agilent Non-U.S. Retirement Plan.  The parties agree to use commercially reasonable efforts to accomplish each transfer as soon as practicable following the establishment of the applicable Keysight Non-U.S. Retirement Plan and to cooperate with each other to make such filings and disclosures, and obtain such approvals as may be deemed to be necessary or advisable in accordance with applicable Law.  Such transfers and any actuarial assumptions shall be subject to such minimum consents, approvals and other legal requirements as may apply under applicable Law, including, if required, the consent of any affected plan participant or any other third party.

 

33

 

(b)                                 Non-U.S. Agilent Retirement Plan Provisions.  Each Agilent Non-U.S. Retirement Plan described in Section 6.02(a) shall provide, except as otherwise provided in this Agreement that:

 

(i)                                     The Keysight Group Employees shall (A) be eligible to participate in such Agilent Non-U.S. Retirement Plan to the extent that they were eligible to participate in such plan immediately prior to the Operational Separation Date, and (B) receive credit for vesting, eligibility and benefit service for all service with the Keysight Group during the shared plan period as if that service had been rendered to the Agilent Group;

 

(ii)                                  the compensation paid by the Keysight Group to a Keysight Group Employee during the shared plan period shall be credited and recognized for all applicable purposes under the corresponding Agilent Non-U.S. Retirement Plan as though it were compensation from the Agilent Group; and

 

(iii)                               the accrued benefit of each Keysight Group Employee under such Agilent Non-U.S. Retirement Plan shall be paid at the time and in a form provided under such plan, with employment by the Keysight Group during the shared plan period treated as employment by the Agilent Group under such Agilent Non-U.S. Retirement Plan for purposes of determining eligibility for optional forms of benefit, early retirement benefits, or other benefit forms.

 

ARTICLE VII
 NONQUALIFIED DEFERRED COMPENSATION

 

Section 7.01.                          Keysight Nonqualified Plans.

 

(a)                                 Establishment of Keysight Nonqualified Plans.  Subject to Section 9.06 and effective as of the Operational Separation Date, Keysight shall establish Keysight Nonqualified Plans, each of which shall be substantially similar in all Material Respects as of immediately prior to the Operational Separation Date to the analogous Agilent Nonqualified Plan.  As of the Operational Separation Date with respect to Keysight Group Employees and as of the Transfer Date with respect to any Subsequently Transferred Keysight Employees, Keysight shall, and shall cause each Keysight Nonqualified Plan to, assume all Liabilities under the analogous Agilent Nonqualified Plan for the account balances and accrued benefits of Keysight Group Employees and Subsequently Transferred Keysight Employees, as applicable, and Agilent and the Agilent Nonqualified Plans shall be relieved of all such Liabilities.  All Agilent Shares notionally credited to participants’ accounts under the Agilent Nonqualified Plans, the liability for which is transferred to Keysight and the Keysight Nonqualified Plans pursuant to the preceding sentence, shall be adjusted so that, from and after the Effective Time, such notionally credited shares represent a number of notionally credited Keysight Shares equal to the product obtained by multiplying (1) the number of such notionally credited Agilent Shares immediately prior to the Effective Time, by (2) the Keysight Stock Ratio, provided that with respect to any resulting fractional shares, the cash equivalent of such fractional shares shall be credited to the participants’ cash accounts.  Notwithstanding the foregoing, with respect to the Liabilities under the Agilent Technologies, Inc. International Relocation Benefit Plan, Keysight shall not assume the Liabilities

 

34

 

in respect of any Agilent Group Employee or Keysight Group Employee if such Liability is or was funded by or through Foundation Pour La Prevoyance Internationale de Agilent Technologies and the terms of the Keysight, Inc. International Relocation Benefit Plan shall reflect that Keysight is not assuming such Liabilities.

 

(b)                                 Agilent Nonqualified Plans.  From and after the Operational Separation Date for Keysight Group Employees or Transfer Date with respect to any Subsequently Transferred Keysight Employees, no Keysight Group Employee or Subsequently Transferred Keysight Employee shall participate in or accrue any benefits under any Agilent Nonqualified Plan.  As of the Transfer Date with respect to any Returning Agilent Employees, Agilent shall, and shall cause the appropriate Agilent Nonqualified Plan to, assume Liabilities under the analogous Keysight Nonqualified Plan for the benefits of any Returning Agilent Employees, and Keysight and the Keysight Nonqualified Plans shall be relieved of all such Liabilities.  Agilent shall continue to be responsible for Liabilities in respect of Agilent Group Employees (and after the Transfer Date, any Returning Agilent Employees but not any Subsequently Transferred Keysight Employees) under the Agilent Nonqualified Plans.  All Agilent Shares notionally credited to participants’ accounts under an Agilent Nonqualified Plan shall be adjusted so that, from and after the Effective Time, such notionally credited shares represent a number of Agilent Shares equal to the product obtained by multiplying (1) the number of such notionally credited Agilent Shares immediately prior to the Effective Time, by (2) the Agilent Ratio, provided that with respect to any resulting fractional shares, the cash equivalent of such fractional shares shall be credited to the participants’ cash accounts.

 

Section 7.02.                          Rabbi Trust.  Subject to Section 9.06  and effective as of the Operational Separation Date, Keysight shall, or shall cause another member of the Keysight Group to, adopt the Keysight Rabbi Trust, the terms of which shall be substantially similar to those of the Agilent Rabbi Trust.  In connection with the establishment by Keysight of the Keysight Deferred Compensation Plans and the assumption by Keysight and the Keysight Deferred Compensation Plans of the Liabilities under the Agilent Deferred Compensation Plans in respect of the Keysight Group Employees, on or as soon as reasonably practicable following the Operational Separation Date, Agilent shall, or shall cause the Agilent Rabbi Trust to, transfer in kind to the Keysight Rabbi Trust account balances of Keysight Group Employees covered by such plans as of the Operational Separation Date determined as of the date of the transfer.  With respect to any Subsequently Transferred Keysight Employees and Returning Agilent Employees, account balances shall be transferred in kind on or as soon as practical after the applicable Transfer Date and determined as of the date of transfer.  With respect to Returning Agilent Employees, Keysight shall or shall cause the Keysight Rabbi Trust to transfer in kind to the Agilent Rabbi Trust account balances of Returning Agilent Employees on or as soon as practical after the Transfer Date, determined as of the date of transfer.

 

Section 7.03.                          Participant Elections.  Any election made by a Keysight Group Employee and Subsequently Transferred Keysight Employee under an Agilent Nonqualified Plan, including without limitation those with respect to compensation deferral, investments, optional forms of benefit, benefit commencement and beneficiaries, shall be recognized for the same purposes under the analogous Keysight Nonqualified Plan.  Any comparable election made by a Returning Agilent Employee under a Keysight Nonqualified Plan shall be recognized for the same purpose under the analogous Agilent Nonqualified Plan.  No new elections shall be permitted under the Keysight

 

35

 

Nonqualified Plans as a result of the operational separation of the Keysight Business on the Operational Separation Date or the Distribution.

 

Section 7.04.                          Participation; Distributions.  The parties acknowledge that none of the transactions contemplated by this Agreement, the Separation Agreement or any Transaction Document will trigger a payment or distribution of compensation under any of the Agilent Nonqualified Plans or Keysight Nonqualified Plans.

 

Section 7.05.                          Top Hat Filings.  To the extent applicable, with respect to each Keysight Nonqualified Plan, Keysight shall make the filings described under Dept. of Labor Reg.  § 2520.104-23 within the time prescribed by such regulation.

 

ARTICLE VIII
 HEALTH AND WELFARE BENEFIT PLANS

 

Section 8.01.                          Welfare Plans.

 

(a)                                 Establishment of Keysight Welfare Plans.  Subject to Section 9.06 and effective as of the Operational Separation Date, Keysight shall, or shall cause the applicable member of the Keysight Group to, establish the Keysight Welfare Plans.

 

(b)                                 Waiver of Conditions; Benefit Maximums.

 

(i)                         Keysight shall use commercially reasonable efforts to cause the Keysight Welfare Plans to:

 

(A)                               with respect to initial enrollment made pursuant to Section 2.04(c) and coverage of the Keysight Group Employees as of the Operational Separation Date or the Subsequently Transferred Keysight Employees as of the Transfer Date, waive (i) all limitations as to preexisting conditions, exclusions, and service conditions with respect to participation and coverage requirements applicable to any such Keysight Group Employee or Subsequently Transferred Keysight Employee, other than limitations that were in effect with respect to such Keysight Group Employee or Subsequently Transferred Keysight Employee under the applicable Agilent Welfare Plan as of immediately prior to the Operational Separation Date or Transfer Date, as applicable, and (ii) any waiting period limitation or evidence of insurability requirement applicable to such Keysight Group Employee or Subsequently Transferred Keysight Employee other than limitations or requirements that were in effect with respect to such Keysight Group Employee or Subsequently Transferred Keysight Employee under the applicable Agilent Welfare Plans as of immediately prior to the Operational Separation Date or Transfer Date, as applicable; and

 

(B)                               for any Keysight Group Employee or Subsequently Transferred Keysight Employee, take into account, (i) with respect to monthly, annual, lifetime, or similar maximum benefits available under the Keysight Welfare Plans, such employee’s prior claim experience under the Agilent Welfare; and (ii) any eligible expenses incurred by such employee and his or her covered dependents during the portion of the plan year of the applicable Agilent Welfare Plan ending as of the Operational Separation Date or Transfer

 

36

 

Date, as applicable, to be taken into account under such Keysight Welfare Plan for purposes of satisfying all deductible, coinsurance, and maximum out-of-pocket requirements applicable to such employee and his or her covered dependents for the applicable plan year to the same extent as such expenses were taken into account by Agilent for similar purposes prior to the Operational Separation Date or Transfer Date, as applicable, as if such amounts had been paid in accordance with such Keysight Welfare Plan.

 

(ii)                      Agilent shall use commercially reasonable efforts to cause the Agilent Welfare Plans to provide comparable rules as described in Section 8.01(b)(i) with respect to any Returning Agilent Employee.

 

(c)                                  Flexible Spending Accounts.  With respect to each Keysight Group Employee and Subsequently Transferred Keysight Employee, the parties shall use commercially reasonable efforts to ensure that as of the Operational Separation Date or the Transfer Date, as applicable, any health or dependent care flexible spending accounts of such Keysight Group Employee or Subsequently Transferred Keysight Employee (whether positive or negative) (the “Transferred Account Balances”) under Agilent Welfare Plans that are health or dependent care flexible spending account plans are transferred, as soon as practicable after the Operational Separation Date or the Transfer Date, as applicable, from the Agilent Welfare Plans to the  corresponding Keysight Welfare Plans.  Such Keysight Welfare Plans shall assume responsibility as of the Operational Separation Date or Transfer Date, as applicable, for all outstanding health or dependent care claims under the corresponding Agilent Welfare Plans of each Keysight Group Employee or Subsequently Transferred Keysight Employee for the calendar year in which the Operational Separation Date or Transfer Date, as applicable, occurs and shall assume and agree to perform the obligations of the corresponding Agilent Welfare Plans from and after the Operational Separation Date or Transfer Date, as applicable. The parties shall use commercially reasonable efforts to accord comparable treatment to a Returning Agilent Employee and make any adjustment necessary in calculating the Transferred Account Balances

 

(d)                                 Allocation of Welfare Liabilities.  (i) All outstanding Liabilities relating to, arising out of, or resulting from health and welfare claims incurred by or on behalf of any Keysight Group Employee or Subsequently Transferred Keysight Employee under the Agilent Benefit Plans specified on Schedule 8.01(d) or under the Agilent Technologies, Inc. Health Plan (Actives), Agilent Technologies, Inc. Health Plan for Retirees and Agilent Technologies, Inc. Global Medical Insurance Plan before the Operational Separation Date or Transfer Date, as applicable, including claims incurred but not reported, shall be retained by Agilent.

 

(ii)                      Effective as of the Operational Separation Date for each Keysight Group Employee and Transfer Date for each Subsequently Transferred Keysight Employee, Keysight shall assume all Liabilities relating to, arising out of or resulting from all other health and welfare coverage or claims incurred by or on behalf of such Keysight Group Employee or Subsequently Transferred Keysight Employee under the Agilent Welfare Plans or Keysight Welfare Plans before, at, or after the Operational Separation Date or Transfer Date, as applicable.

 

(iii)                   For these purposes, a claim or Liability is deemed to be incurred:  (a) with respect to medical, dental, vision and/or prescription drug benefits, upon the rendering of

 

37

 

health services giving rise to such claim or Liability; (b) with respect to life insurance, accidental death and dismemberment and business travel accident insurance, upon the occurrence of the event giving rise to such claim or Liability;  and (c) with respect to disability benefits, upon the date of an Employee’s disability, as determined by the disability benefit insurance carrier or claim administrator, giving rise to such claim or Liability.

 

Section 8.02.                          COBRA and HIPAA.  Agilent shall continue to be responsible for complying with, and providing coverage pursuant to, the health care continuation requirements of COBRA, the certificate of creditable coverage requirements of HIPAA, and the corresponding provisions of the Agilent Welfare Plans or Keysight Welfare Plans with respect to any Agilent Group Employee and Agilent Returning Employee who incur a qualifying event under COBRA before, as of, or after the Operational Separation Date.  Effective as of the Operational Separation Date with respect to any Keysight Group Employee or Transfer Date for any Subsequently Transferred Keysight Employee, Keysight shall assume responsibility for complying with, and providing coverage pursuant to, the health care continuation requirements of COBRA, the certificate of creditable coverage requirements of HIPAA, and the corresponding provisions of the Keysight Welfare Plans with respect to any such Keysight Group Employee or Subsequently Transferred Keysight Employee who incur a qualifying event or loss of coverage under the Agilent Welfare Plans and/or the Keysight Welfare Plans before, as of, or after the Operational Separation Date or Transfer Date, as applicable.  The parties agree that the  consummation of the transactions contemplated by the Separation Agreement shall not constitute a termination of employment for purposes of COBRA.

 

Section 8.03.                          Vacation, Holidays and Leaves of Absence.  Effective as of the Operational Separation Date, with respect to the Keysight Group Employees and effective as of the Transfer Date, with respect to any Subsequently Transferred Keysight Employees, Keysight shall assume, or cause its relevant Subsidiary to assume, all Liabilities of the Agilent Group with respect to earned vacation, holiday, annual leave or other leave of absence, and required payments related thereto, for each Keysight Group Employee and Subsequently Transferred Keysight Employee unless otherwise required by applicable Law.  Agilent or its relevant Subsidiary shall retain all Liabilities with respect to vacation, holiday, annual leave or other leave of absence, and required payments related thereto, for Agilent Group Employees and effective as of the Transfer Date, Returning Agilent Employees.

 

Section 8.04.                          Severance and Unemployment Compensation.  Effective as of the Operational Separation Date, with respect to Keysight Group Employees and effective as of the Transfer Date, with respect to any Subsequently Transferred Keysight Employees, Keysight shall assume, or cause its relevant Subsidiary to assume, any and all Liabilities to, or relating to, Keysight Group Employees or Subsequently Transferred Keysight Employees in respect of severance and unemployment compensation, regardless of whether the event giving rise to the Liability occurred before, at or after the Operational Separation Date or Transfer Date, as applicable unless otherwise required by applicable Law.  Agilent or its relevant Subsidiary shall be responsible for any and all Liabilities to, or relating to, Agilent Group Employees and effective as of the Transfer Date, Returning Agilent Employees in respect of severance and unemployment compensation, regardless of whether the event giving rise to the Liability occurred before, at or after the Operational Separation Date.

 

38

 

Section 8.05.                          Insurance Contracts.  To the extent that any Agilent Welfare Plan is funded through the purchase of an insurance contract or is subject to any stop loss contract, the parties will cooperate and use their commercially reasonable efforts to replicate such insurance contracts for Keysight (except to the extent that changes are required under applicable Laws or filings by the respective insurers) and to maintain any pricing discounts or other preferential terms for both Agilent and Keysight for a reasonable term.  Neither party shall be liable for failure to obtain such insurance contracts, pricing discounts, or other preferential terms for the other party.  Each party shall be responsible for any additional premiums, charges, or administrative fees that such party may incur pursuant to this Section 8.05.

 

Section 8.06.                          Third-Party Vendors.  Except as provided below, to the extent that any Agilent Welfare Plan is administered by a third-party vendor, the parties will cooperate and use their commercially reasonable efforts to replicate any contract with such third-party vendor for Keysight and to maintain any pricing discounts or other preferential terms for both Agilent and Keysight for a reasonable term.  Neither party shall be liable for failure to obtain such pricing discounts or other preferential terms for the other party.  Each party shall be responsible for any additional premiums, charges, or administrative fees that such party may incur pursuant to this Section 8.06.

 

Section 8.07.                          California Disability Benefits.  As of the Operational Separation Date, Keysight shall adopt a state voluntary disability plan for California.  Agilent shall assign and Keysight shall assume liability with respect to any Keysight Group Employee entitled to California voluntary disability benefits. As of the Operational Separation Date or as soon as practical thereafter, Keysight will establish the Keysight California Voluntary Plan Fund and on the Operational Separation Date or as soon as practical thereafter, Agilent shall cause the Agilent California Voluntary Plan Fund to transfer to the Keysight California Voluntary Plan Fund the account balances with respect to the Keysight Group Employees (or on the Transfer Date or such other date as agreed to by the parties with respect to Subsequently Transferred Keysight Employees).  With respect to any Returning Agilent Employees, on the Transfer Date or such other date as agreed to by the parties, the Keysight California Voluntary Plan Fund will transfer to Agilent California Voluntary Plan Fund the account balance of any such Returning Agilent Employee.

 

Section 8.08.                          Retiree Medical Trust Account.  Subject to Section 9.06, before the Operational Separation Date, Keysight shall establish the Keysight Retiree Medical Trust.  On or within 30 days following the Operational Separation Date, to the extent that there are assets attributable to premium payments made by the Keysight Group Employees in the Agilent Retiree Medical Trust, such assets will be transferred to the Keysight Retiree Medical Trust.  Any such transfer occurring after the Operational Separation Date will be adjusted by earnings and benefit payments, if any, made to Keysight Group Employees with respect to such premium payments.

 

Section 8.09.                          Fringe Benefits.  Effective as of the Operational Separation Date, Keysight shall adopt fringe benefit arrangements, if any, as it deems to be appropriate.

 

Section 8.10.                          Workers’ Compensation.  The treatment of workers’ compensation in connection with the operational separation of the Keysight Business and the Distribution shall be governed by the Separation Agreement.

 

39

 

ARTICLE IX
 MISCELLANEOUS

 

Section 9.01.                          Information Sharing and Access.

 

(a)                                 Sharing of Information.  Subject to any limitations imposed by applicable Law, Agilent and Keysight (acting directly or through members of the Agilent Group or the Keysight Group, respectively) shall provide to the other and their respective authorized agents and vendors all information necessary (including information for purposes of determining benefit eligibility, participation, vesting and calculation of benefits) on a timely basis under the circumstances for the parties to perform their respective duties under this Agreement.  To the extent that such information is maintained by a third party vendor, each party shall use its commercially reasonable best efforts to require the third party vendor to provide the necessary information and assist in resolving discrepancies or obtaining missing data.

 

(b)                                 Transfer of Personnel Records and Authorization.  Subject to any limitation imposed by applicable Law and to the extent that it has not done so before the Operational Separation Date, Agilent shall transfer to Keysight any and all employment records  (including any Form I-9, Form W-2 or other IRS forms) with respect to Keysight Group Employees (and Subsequently Transferred Keysight Employee) and other records reasonably required by Keysight to enable Keysight properly to carry out its obligations under this Agreement.  Such transfer of records generally shall occur as soon as administratively practicable at or after the Operational Separation Date.  Each party will permit the other party reasonable access to Employee records, to the extent reasonably necessary for such accessing party to carry out its obligations hereunder.

 

(c)                                  Access to Records.  To the extent not inconsistent with this Agreement, the Separation Agreement or any applicable privacy protection Laws or regulations, reasonable access to Employee-related and benefit plan related records after the Operational Separation Date will be provided to members of the Agilent Group and members of the Keysight Group pursuant to the terms and conditions set forth in Article IV of the Separation Agreement.

 

(d)                                 Maintenance of Records.  With respect to retaining, destroying, transferring, sharing, copying and permitting access to all Employee-related information, Agilent and Keysight shall comply with all applicable Laws, regulations and internal policies, including each party’s document retention policy; provided that the period for retention shall be the longest period required by any of the foregoing, as applicable, to such party.  Agilent and Keysight shall indemnify and hold harmless each other from and against any and all Liability, claims, actions, and damages that arise from a failure (by the indemnifying party or its Subsidiaries or their respective agents) to so comply with all applicable Laws, regulations and internal policies applicable to such information.

 

(e)                                  Cooperation.  Each party shall use commercially reasonable best efforts to cooperate and work together to unify, consolidate and share (to the extent permissible under applicable privacy/data protection laws) all relevant documents, resolutions, government filings, data, payroll, employment and benefit plan information on regular timetables and cooperate as needed with respect to (i) any claims under or audit of or litigation with respect to any employee benefit plan, policy or arrangement contemplated by this Agreement, (ii) efforts to seek a

 

40

 

determination letter, private letter ruling or advisory opinion from the IRS or U.S. Department of Labor on behalf of any employee benefit plan, policy or arrangement contemplated by this Agreement, (iii) any filings that are required to be made or supplemented to the IRS, U.S. Pension Benefit Guaranty Corporation, U.S. Department of Labor or any other Governmental Authority, and (iv) any audits by a Governmental Authority or corrective actions in either case, relating to any Benefit Plan, labor or payroll practices; provided, however, that requests for cooperation must be reasonable and not interfere with daily business operations.

 

(f)                                   Confidentiality.  Notwithstanding anything in this Agreement to the contrary, all confidential records and data relating to Employees to be shared or transferred pursuant to this Agreement shall be subject to Section 6.2 of the Separation Agreement and the requirements of applicable Law.

 

Section 9.02.                          Consistency of Tax Positions; Duplication.  Agilent and Keysight shall individually and collectively use commercially reasonable best efforts to avoid unnecessarily duplicated federal, state or local payroll taxes, insurance or workers’ compensation contributions, or unemployment contributions arising on or after the Operational Separation Date.  Agilent and  Keysight shall take consistent reporting and withholding positions with respect to any such taxes or contributions.

 

Section 9.03.                          Employment and ERISA Litigation.  All disputes involving an Agilent Benefit Plan or Keysight Benefit Plan (other than a claim where the participant has not exhausted the administrative claims procedure) and all employment related litigation shall be governed by the Separation Agreement.

 

Section 9.04.                          Costs.  Fees, costs and expenses relating to the establishment of Keysight Benefit Plans and the transfer of employment of Keysight Group Employees, and subsequently Transferred Employees and Returning Agilent Employees shall be borne by Agilent with respect to separation costs incurred or accrued prior to the Operational Separation Date.  Fees, costs and expenses incurred or accrued with respect to third party service providers relating to the establishment of Keysight Benefit Plans on or after the Operational Separation Date relating to such plans and employment transfers of Keysight Group Employees and Subsequently Transferred Employees shall be borne by Keysight.

 

Section 9.05.                          Employee Notices and Governmental Filings.  Effective as of the Operational Separation Date, except as otherwise provided by applicable law, Keysight shall be responsible for employee communications and legal filing including governmental filings with the Internal Revenue Service, Department of Labor and the Pension Benefit Guaranty Corporation with respect to Keysight Benefit Plans.

 

Section 9.06.                          Preservation of Rights to Amend.  The rights of each member of the Agilent Group and each member of the Keysight Group to amend, waive, or terminate any Benefit Plan, arrangement, agreement, program, or policy referred to herein shall not be limited in any way by this Agreement.

 

Section 9.07.                          Fiduciary Matters.  Agilent and Keysight acknowledge that actions required to be taken pursuant to this Agreement may be subject to fiduciary duties or standards of conduct

 

41

 

under ERISA or other applicable Law, and neither party shall be deemed to be in violation of this Agreement if it fails to comply with any provisions hereof based upon its good-faith determination (as supported by advice from counsel experienced in such matters) that to do so would violate such a fiduciary duty or standard.  Each party shall be responsible for taking such actions as are deemed to be necessary and appropriate to comply with its own fiduciary responsibilities and shall fully release and indemnify the other party for any Liabilities caused by the failure to satisfy any such responsibility.

 

Section 9.08.                          Section 409A of the Code.  The parties acknowledge that the provisions of the Agreement, the Separation Agreement or any Transaction Documents shall be interpreted and implemented in a manner to avoid the imposition on Employees of taxes under Section 409A of the Code.  If any of the provisions of this Agreement would result in imposition of taxes and/or penalties under Section 409A of the Code, the parties shall cooperate in good faith to modify the applicable provision in order to comply with the provisions of Section 409A of the Code, other applicable provisions of the Code and/or any rules, regulations or other regulatory guidance issued under such statutory provisions.  Notwithstanding the foregoing, neither the parties nor any of their Affiliates shall have any liability to any Employee in the event that  Section 409A applies to any payment in a manner that results in adverse tax consequences for an Employee.

 

Section 9.09.                          Further Assurances.  Each party hereto shall take, or cause to be taken, any and all reasonable actions, including the execution, acknowledgment, filing and delivery of any and all documents and instruments that any other party hereto may reasonably request to effect the intent and purpose of this Agreement and the transactions contemplated hereby.

 

(a)                                 Corporate Power.  Agilent represents on behalf of itself and on behalf of other members of the Agilent Group, and Keysight represents on behalf of itself and on behalf of other members of the Keysight Group, as follows:

 

(b)                                 each such Person has the requisite corporate power and authority and has taken all corporate action necessary in order to execute, deliver and perform this Agreement and each other Transaction Document to which it is a party and to consummate the transactions contemplated hereby and thereby; and

 

(c)                                  this Agreement to which it is a party has been duly executed and delivered by it and constitutes a valid and binding agreement of it enforceable in accordance with the terms thereof.

 

Section 9.10.                          Dispute Resolution.  The dispute resolution procedures set forth in Article VII of the Separation Agreement shall apply to any dispute, controversy or claim arising out of or relating to this Agreement.

 

Section 9.11.                          Governing Law.  This Agreement and, unless expressly provided therein, each other Transaction Document, shall be governed by and construed and interpreted in accordance with the Laws of Delaware without giving effect to the principles of conflicts of law thereof.

 

Section 9.12.                          Survival of Covenants.  The covenants and other agreements contained in this Agreement, and liability for the breach of any obligations contained herein, shall survive each

 

42

 

of the reorganization (as that term is defined in the Separation Agreement) and the Distribution and shall remain in full force and effect.

 

Section 9.13.                          Force Majeure.  No party shall be deemed to be in default of this Agreement for any delay or failure to fulfill any obligation hereunder or thereunder so long as and to the extent to which any delay or failure in the fulfillment of such obligations is prevented, frustrated, hindered or delayed as a consequence of circumstances of Force Majeure.  In the event of any such excused delay, the time for performance shall be extended for a period equal to the time lost by reason of the delay.  A party claiming the benefit of this provision shall, as soon as reasonably practicable after the occurrence of any such event, (a) provide written notice to the other party of the nature and extent of any such Force Majeure condition; and (b) use commercially reasonable efforts to remove any such causes and resume performance under this Agreement as soon as reasonably practicable.

 

Section 9.14.                          Notices.  All notices, requests, claims, demands or other communications under this Agreement shall be in writing and shall be given or made (and shall be deemed to  have been duly given or made upon receipt) by delivery in person, by overnight courier service, by facsimile with receipt confirmed (in the case of facsimile or electronic transmission, followed by delivery of an original via overnight courier service), or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 9.14):

 

	
If to Agilent, to:
    
	
 
    
	
 
    	
Agilent Technologies, Inc.
    
	
 
    	
5301 Stevens Creek Blvd.
    
	
 
    	
M/S 1A-PB
    
	
 
    	
Santa Clara, CA    95051
    
	
 
    	
Attention:
    	
General Counsel
    
	
 
    	
Facsimile:
    	
408-345-8958
    
	
 
    	
 
    
	
With a copy (until the   Effective Time) to:
    
	
 
    	
 
    
	
 
    	
Wachtell, Lipton, Rosen & Katz
    
	
 
    	
51 West 52nd Street
    
	
 
    	
New York, New York    10019
    
	
 
    	
Attention:
    	
Daniel A. Neff
    
	
 
    	
 
    	
Stephanie J. Seligman
    
	
 
    	
Facsimile:
    	
(212) 403-2000
    
	
 
    	
 
    
	
If to Keysight, to:
    
	
 
    	
 
    
	
 
    	
Keysight Technologies, Inc.
    
	
 
    	
1400 Fountaingrove Parkway
    
	
 
    	
Santa Rosa, CA    95403
    
	
 
    	
Attention:
    	
General Counsel
    
	
 
    	
Facsimile:
    	
707-540-6494
    

 

43

 

	
With a copy (until the Effective   Time) to:
    
	
 
    	
 
    
	
 
    	
Wachtell, Lipton,   Rosen & Katz
    
	
 
    	
51 West 52nd Street
    
	
 
    	
New York, New York  10019
    
	
 
    	
Attention:
    	
Daniel A. Neff
    
	
 
    	
 
    	
Stephanie J. Seligman
    
	
 
    	
Facsimile:
    	
(212) 403-2000
    

 

Any party may, by notice to the other party, change the address to which such notices are to be given.

 

Section 9.15.                          Termination.  Notwithstanding any provision to the contrary, this Agreement may be terminated and the Distribution abandoned at any time prior to the Effective Time by and in the sole discretion of Agilent without the prior approval of any Person, including  Keysight.  In the event of such termination, this Agreement shall become void and no party, or any of its officers and directors shall have any liability to any Person by reason of this Agreement.  After the Effective Time, this Agreement may not be terminated except by an agreement in writing signed by each of the parties to this Agreement.

 

Section 9.16.                          Severability.  If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced under any Law or as a matter of public policy, all other conditions and provisions of this Agreement shall remain in full force and effect.  Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties to this Agreement shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated as originally contemplated to the greatest extent possible.

 

Section 9.17.                          Entire Agreement.  Except as otherwise expressly provided in this Agreement, this Agreement (including any Schedules and Exhibits hereto) constitutes the entire agreement of the parties hereto with respect to the subject matter of this Agreement and supersedes all prior agreements and undertakings, both written and oral, between or on behalf of the parties hereto with respect to the subject matter of this Agreement.

 

Section 9.18.                          Assignment.  This Agreement shall not be assigned by any party without the prior written consent of the other parties hereto, except that a party may assign any or all of its rights and obligations under this Agreement in connection with a sale or disposition of any assets or entities or lines of business of such party or in connection with a merger transaction in which such party is not the surviving entity; provided, however, that, in each case, no such assignment shall release such party from any liability or obligation under this Agreement and the surviving entity of any merger or the transferee of such assets or businesses shall agree in writing to be bound by the terms of this Agreement as if named as a party hereto.

 

Section 9.19.                          Third-Party Beneficiaries.  The provisions of this Agreement are solely for the benefit of the parties and are not intended to confer upon any other Person except the parties

 

44

 

any rights or remedies hereunder.  There are no other third party beneficiaries of this Agreement and this Agreement shall not provide any other third party with any remedy, claim, Liability, reimbursement, claim of action or other right in excess of those existing without reference to this Agreement.  Nothing in this Agreement is intended to amend any employee benefit plan or affect the applicable plan sponsor’s right to amend or terminate any employee benefit plan pursuant to the terms of such plan.  The provisions of this Agreement are solely for the benefit of the parties, and no current or former Employee, officer, director, or independent contractor or any other individual associated therewith shall be regarded for any purpose as a third party beneficiary of this Agreement.  This Agreement may not be assigned by any party, except with the prior written consent of the other parties.

 

Section 9.20.                          Specific Performance.  Subject to Article VII of the Separation Agreement, in the event of any actual or threatened default in, or breach of, any of the terms, conditions and provisions of this Agreement, the party or parties who are, or are to be, thereby aggrieved shall have the right to specific performance and injunctive or other equitable relief (on an interim or permanent basis) in respect of its rights or their rights under this Agreement, in  addition to any and all other rights and remedies at Law or in equity, and all such rights and remedies shall be cumulative.  The parties agree that the remedies at Law for any breach or threatened breach, including monetary damages, may be inadequate compensation for any loss and that any defense in any Action for specific performance that a remedy at Law would be adequate is waived.  Any requirements for the securing or posting of any bond with such remedy are hereby waived by each of the parties.

 

Section 9.21.                          Amendments.  No provision of this Agreement may be amended or modified except by a written instrument signed by all the parties to this Agreement.  No waiver by any party of any provision of this Agreement shall be effective unless explicitly set forth in writing and executed by the party so waiving.  The waiver by any party of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any other subsequent breach.  The failure of any party to require strict performance by any other party of any provision in this Agreement will not waive or diminish that party’s right to demand strict performance thereafter of that or any other provision of this Agreement.

 

Section 9.22.                          Rules of Construction.  Interpretation of this Agreement shall be governed by the following rules of construction:  (i) words in the singular shall be held to include the plural and vice versa and words of one gender shall be held to include the other gender as the context requires, (ii) references to the terms Article, Section, paragraph, clause, Exhibit and Schedule are references to the Articles, Sections, paragraphs, clauses, Exhibits and Schedules of this Agreement unless otherwise specified, (iii) the terms “hereof,” “herein,” “hereby,” “hereto,” and derivative or similar words refer to this entire Agreement, including the Schedules and Exhibits hereto, (iv) references to “$” shall mean U.S. dollars, (v) the word “including” and words of similar import when used in this Agreement shall mean “including without limitation,” unless otherwise specified, (vi) the word “or” shall not be exclusive, (vii) references to “written” or “in writing” include in electronic form, (viii) unless the context requires otherwise, references to “party” shall mean Agilent or Keysight, as appropriate, and references to “parties” shall mean Agilent and Keysight, (ix) provisions shall apply, when appropriate, to successive events and transactions, (x) the table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement, (xi) Agilent and

 

45

 

Keysight have each participated in the negotiation and drafting of this Agreement and if an ambiguity or question of interpretation should arise, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or burdening either party by virtue of the authorship of any of the provisions in this Agreement or any interim drafts of this Agreement, and (xii) a reference to any Person includes such Person’s successors and permitted assigns.

 

Section 9.23.                          Counterparts.  This Agreement may be executed in one (1) or more counterparts, and by the different parties to each such agreement in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one (1) and the same agreement.  Delivery of an executed counterpart of a signature page to this Agreement by facsimile or portable document format (PDF) shall be as effective as delivery of a manually executed counterpart of any such Agreement.

 

[Remainder of page intentionally left blank]

 

46

 

IN WITNESS WHEREOF, the parties have caused this Employee Matters Agreement to be executed by their duly authorized representatives.

 

	
 
    	
AGILENT TECHNOLOGIES, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Shiela Barr Robertson
    
	
 
    	
 
    	
Name: Shiela Barr Robertson
    
	
 
    	
 
    	
Title: Senior Vice President, Corporate Development   and Strategy
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
KEYSIGHT TECHNOLOGIES, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Ronald S. Nersesian
    
	
 
    	
 
    	
Name: Ronald S. Nersesian
    
	
 
    	
 
    	
Title: President and Chief Executive Officer
    

 

 

Schedule 2.04(a)(i)

 

Material Agilent Benefit Plans to be adopted by Keysight as of Operational Separation Date

(subject to the terms of the Agreement)

 

List of Agilent Technologies, Inc. Employee Benefit Plans

 

Health and Welfare Plans

 

	
#
    	
Plan Name
    
	
1
    	
Agilent Technologies, Inc. Health Plan   (Actives)
    
	
2
    	
Agilent Technologies, Inc. Health Plan for   Retirees
    
	
3
    	
Agilent   Technologies, Inc. Reimbursement Arrangement (ARA) Plan
    
	
4
    	
Agilent Technologies, Inc. Retiree Medical   Account (RMA) Plan
    
	
5
    	
Agilent Technologies, Inc. Employee and Family   Assistance Plan (EFAP)
    
	
6
    	
Agilent Technologies, Inc. Global Medical   Insurance Plan
    
	
7
    	
Agilent Technologies, Inc. Business Travel   Health Plan (BTH)
    
	
8
    	
Agilent Technologies, Inc. Business Travel   Accident Plan (BTA)
    
	
9
    	
Agilent Technologies, Inc. Health Care Spending   Plan (HCSP)
    
	
10
    	
Agilent   Technologies, Inc. Cafeteria Plan
    
	
11
    	
Agilent Technologies, Inc. Dependent Care   Spending Plan (DCSP)
    
	
12
    	
Agilent Technologies, Inc. Disability Plan,   includes NY, NJ, CA, HI supplements
    
	
13
    	
Agilent   Technologies, Inc. Survivor Protection Plan (SPP)(1)
    
	
14
    	
Agilent Technologies, Inc. Workforce Management   Severance Benefit Plan (WFM)
    
	
15
    	
Agilent Technologies, Inc. Executive Physical   Program (a top hat plan)
    

 

Retirement Plans

 

	
#
    	
Plan Name
    
	
1
    	
Agilent   Technologies, Inc. 401(k) Plan (401(k))
    
	
2
    	
Agilent   Technologies, Inc. Retirement Plan (RP)
    
	
3
    	
Agilent Technologies, Inc. Deferred   Profit-Sharing Plan (frozen) (DPSP)
    

 

Executive Compensation and Other Nonqualified Plans

 

	
#
    	
Plan Name
    	
 
    
	
1
    	
Agilent Technologies, Inc. 2005 Deferred   Compensation Plan (DCP)
    	
 
    
	
2
    	
Agilent Technologies, Inc. Deferred   Compensation Plan (Frozen)
    	
 
    
	
3
    	
Agilent Technologies, Inc. Supplemental Benefit   Retirement Plan (SBRP)
    	
 
    
	
4
    	
Agilent Technologies, Inc. Excess Benefit   Retirement Plan (Frozen) (EBRP)
    	
 
    
	
5
    	
Agilent Technologies, Inc. International   Relocation Benefit Plan (Frozen) (IRBP)
    	
 
    

 

Non-U.S. Plan

 

	
1
    	
Those certain Non-US Agilent Benefit Plans as agreed   by the parties
    

 

(1)  Includes Group Universal Life Insurance (GUL)

 

 

Schedule 2.04(a)(ii)

 

Material Agilent Benefit Plans to be adopted by Keysight as of the Effective Time or Distribution Date (subject to terms of the Agreement)

 

Equity Plans

 

	
#
    	
Plan Name
    
	
1
    	
Agilent Technologies, Inc.   1999 Stock Option Plan (Amended & Restated 2006)
    
	
2
    	
Agilent   Technologies, Inc. 2009 Stock Plan
    
	
3
    	
Agilent Technologies, Inc. Employee Stock   Purchase Plan (Amended & Restated 2008)
    
	
4
    	
Agilent Technologies, Inc. Long-Term   Performance Program (Amended & Restated 2005)
    
	
5
    	
Agilent Technologies, Inc. 1999 Non-Employee   Director Stock Plan (Amended & Restated 2007)
    

 

Executive Compensation and other Nonqualified Plans

 

	
Agilent Technologies, Inc. Variable Pay   Plan, Inc.
    
	
Agilent Technologies, Inc., 2010 Performance-Based   Compensation Plan for Covered Employees
    
	
Agilent Technologies, Inc. 2010   Performance-Based Compensation Plan for Non-Covered Employees
    

 

	
Non-U.S. Plans
    
	
 
    
	
Those certain Non-US Agilent Benefit Plans as agreed   by the parties
    

 

 

Schedule 2.04(a)(iii)

 

Agilent Benefit Plans to be adopted by Keysight as soon as practical after the Distribution Date (subject to terms of the Agreement)

 

	
Executive Compensation and Other Nonqualified   Plans
    
	
 
    
	
Agilent Technologies, Inc. 2005 Deferred   Compensation Plan for Non-Employee Directors
    
	
 
    
	
Non-U.S. Plans
    
	
 
    
	
Those certain Non-US Agilent Benefit Plans as agreed   by the parties
    

 

 

Schedule 2.04(b)

 

Material Agilent Benefit Plans that Will Not Be Mirrored By Keysight

 

Agilent Technologies, Inc. Long-Term Care Insurance Plan

 

Agilent Technologies, Inc. Global Relocation Supplement Plan

 

Agilent Technologies, Inc. Voluntary Severance Incentive Plan

 

Agilent Technologies, Inc. Deferred Compensation Plan for Non-Employee Directors (Frozen)

 

Agilent Technologies, Inc. Change of Control Severance Plan

 

Those certain Non-US Agilent Benefit Plans as agreed by the parties

 

 

Schedule 6.01(a)

 

List of Countries where Defined Benefit Plans Will Not Be Replicated

 

Australia

China (one defined contribution plan cannot be replicated)

Denmark

France

Switzerland

 

 

Schedule 6.01(a)(i)(A)

List of Forward Spin Countries

 

Argentina

Austria

Belgium

Canada

China (two defined contribution plans replicated)

Finland

Germany

Hong Kong

India

Italy

Korea

Mexico

Netherlands

Puerto Rico

Russia

Singapore

Spain

Sweden

Taiwan

 

 

Schedule 6.01(a)(i)(B)

 

List of Countries where Former Keysight Employees do not transfer to the New Keysight Plan

 

Mexico

 

 

Schedule 6.01(a)(i)(C)

 

List of Countries Where Valuation other than PBO is used with respect to Defined Benefit Plans

 

Belgium

Finland

Netherlands

Sweden

 

 

Schedule 6.01(b)(i)

 

List of Reverse Spin Countries

 

Israel

Malaysia

United Kingdom

 

 

Schedule 6.01(b)(ii)

 

List of Reverse Spin Countries Where Former Agilent Employees do not transfer to New Agilent Plan and List of Reverse Spin Countries Where Valuation of other than PBO is used with respect to Defined Benefit Plans

 

A. Reverse Spin Countries Where Former Agilent Employees do not transfer to New

Agilent Plan

United Kingdom (two retirees/inactives)

 

B. Reverse Spin Countries Where Valuation of other than PBO is used with respect to Defined Benefit Plans

United Kingdom

 

 

Schedule 6.02(a)

 

List of Countries with Shared Plans

 

Brazil

Japan

 

 

Schedule 8.01(d)

 

Agilent Welfare Plans where Agilent will retain liabilities on a claims incurred basis

 

Agilent Technologies, Inc. Business Travel Health Plan (BTH)

 

Agilent Technologies, Inc. Business Travel Accident Plan (BTA)

 

Agilent Life insurance benefits as described under the Agilent Technologies, Inc. Survivor Protection Plan

 

Group Universal Life as described under the Agilent Technologies, Inc. Survivor Protection Plan

 

Agilent Technologies, Inc. Employee and Family Assistance PlanExhibit 10.4

 

INTELLECTUAL PROPERTY MATTERS AGREEMENT

 

between

 

AGILENT TECHNOLOGIES, INC.

 

and

 

KEYSIGHT TECHNOLOGIES, INC.

 

Dated as of August 1, 2014

 

 

TABLE OF CONTENTS

 

	
ARTICLE
    	
 
    	
DESCRIPTION
    	
 
    	
PAGE
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
I
    	
 
    	
DEFINITIONS AND RULES OF CONSTRUCTION
    	
 
    	
1
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
II
    	
 
    	
TRANSFERRED INTELLECTUAL PROPERTY RIGHTS AND TECHNOLOGY
    	
 
    	
2
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
III
    	
 
    	
LICENSES FROM AGILENT TO KEYSIGHT
    	
 
    	
4
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
IV
    	
 
    	
LICENSES FROM KEYSIGHT TO AGILENT
    	
 
    	
8
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
V
    	
 
    	
ADDITIONAL INTELLECTUAL PROPERTY RELATED MATTERS
    	
 
    	
11
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
VI
    	
 
    	
CONFIDENTIAL INFORMATION
    	
 
    	
13
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
VII
    	
 
    	
LIMITATION OF LIABILITY AND WARRANTY DISCLAIMER
    	
 
    	
15
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
VIII
    	
 
    	
TRANSFERABILITY AND ASSIGNMENT
    	
 
    	
15
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
IX
    	
 
    	
REVOCATION AND TERMINATION OF LICENSE RIGHTS
    	
 
    	
17
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
X
    	
 
    	
MISCELLANEOUS
    	
 
    	
18
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
EXHIBIT
    	
 
    	
DESCRIPTION
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
A
    	
 
    	
DEFINITIONS
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
B
    	
 
    	
COMPOSITE INTELLECTUAL PROPERTY ASSIGNMENT   AGREEMENTS
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
B1
    	
 
    	
PATENT ASSIGNMENT AGREEMENT
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
B2
    	
 
    	
TRADEMARK ASSIGNMENT AGREEMENT
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
B3
    	
 
    	
COPYRIGHT AND MASK WORK ASSIGNMENT AGREEMENT
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
B4
    	
 
    	
TRADE SECRET ASSIGNMENT AGREEMENT
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
C
    	
 
    	
SCHEDULE OF TRANSFERRED PATENTS
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
D
    	
 
    	
SCHEDULE OF TRANSFERRED INTELLECTUAL PROPERTY   RIGHTS
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
E
    	
 
    	
TRADEMARK LICENSE AGREEMENT
    	
 
    	
 
    

 

i

 

INTELLECTUAL PROPERTY MATTERS AGREEMENT

 

THIS INTELLECTUAL PROPERTY MATTERS AGREEMENT (this “Agreement”) is dated as of August 1, 2014 (“Effective Date”), by and between Agilent Technologies, Inc., a Delaware corporation (“Agilent”), and Keysight Technologies, Inc., a Delaware corporation (“Keysight”).  Agilent and Keysight are each a “Party” and collectively, the “Parties”.  Each reference to the words “Party” or “Parties” herein shall refer collectively to such Party or Parties on its or their own behalf and on behalf of each of its or their Affiliates.

 

W I T N E S S E T H:

 

WHEREAS, pursuant to the Separation and Distribution Agreement entered into by and between Keysight and Agilent (the “Separation Agreement”), the Parties have agreed to separate the Keysight Business from Agilent; and

 

WHEREAS, it is the intent of the Parties, in accordance with the Separation Agreement and the other agreements and instruments provided for therein, that Agilent convey, and cause its Affiliates to convey, to Keysight and its Affiliates substantially all of the business and assets of the Keysight Business and that Keysight and its Affiliates assume certain of the liabilities related to the Keysight Business; and

 

WHEREAS, it is the intent of the Parties that Agilent convey, and cause its Affiliates to convey, certain intellectual property rights and certain technology to Keysight, to license certain other intellectual property rights to Keysight, and for Keysight and its Affiliates to grant a license back to Agilent of the Transferred Intellectual Property Rights subject to the terms and conditions set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements set forth below, and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the Parties hereby agree as follows:

 

ARTICLE I

 

DEFINITIONS AND RULES OF CONSTRUCTION

 

1.1                               Definitions.  Unless otherwise defined in this Agreement, including Exhibit A hereto, capitalized terms used in this Agreement shall have the meanings ascribed to them in the Separation Agreement.  In the event of any conflict between the definitions in this Agreement and in the Separation Agreement, the terms of this Agreement shall control.

 

1.2                               Rules of Construction.

 

(a)                                 This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting or causing any instrument to be drafted.

 

(b)                                 The words “hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement will refer to this Agreement as a whole (including any

 

 

annexes, exhibits and schedules to this Agreement) and not to any particular provision of this Agreement, and section and subsection references are to this Agreement unless otherwise specified.  The words “include,” “including,” or “includes” when used herein shall be deemed in each case to be followed by the words “without limitation” or words having similar import.  The headings and table of contents in this Agreement are included for convenience of reference only and will not limit or otherwise affect the meaning or interpretation of this Agreement.  The meanings given to terms defined herein will be equally applicable to both the singular and plural forms of such terms.

 

ARTICLE II

 

TRANSFERRED INTELLECTUAL PROPERTY RIGHTS AND TECHNOLOGY

 

2.1                               Assignment of Intellectual Property Rights.  Agilent agrees to, and agrees to cause its Affiliates to, grant, assign and convey to Keysight all of Agilent’s and its Affiliates’ rights, title and interest in and to the Transferred Intellectual Property Rights and Transferred Trademarks.  For the avoidance of doubt, the Transferred Intellectual Property Rights are transferred subject to the licenses granted to Agilent in Article IV below and all other licenses granted under any such Intellectual Property Rights existing and in force as of the Effective Date (subject to the terms and conditions contained in each such license agreement).  The Transferred Intellectual Property Rights and Transferred Trademarks include all of Agilent’s and its Affiliates’ right, title, and interest in and to any and all proceeds, causes of action, and rights of recovery against Third Parties for past and future infringement, misappropriation, or other violation or impairment of any of the Transferred Intellectual Property Rights or Transferred Trademarks.  The Parties shall execute intellectual property assignments in a form substantially similar to that attached hereto as Exhibit B, Composite Intellectual Property Assignment Agreements (namely: B1 (patent) (the “Patent Assignment Agreement”); B2 (trademark) (the “Trademark Assignment Agreement”); B3 (copyright and mask works) (“The Copyright and Mask Work Assignment); and B4 (trade secret) (“ The Trade Secret Assignment”) as well as such additional case specific assignments as deemed appropriate to carry out the intent of the parties, (collectively the “Intellectual Property Assignment Agreements”).  Agilent shall cause its Affiliates to do so as appropriate, to document the transfer of the Transferred Intellectual Property Rights and Transferred Trademarks.

 

(a)                                 Recording Change of Ownership of the Transferred Intellectual Property Rights and Transferred Trademarks.  Keysight shall have the sole responsibility, at its sole cost and expense, to file the Intellectual Property Assignment Agreements and any other forms or documents as required to record the assignment of the Transferred Intellectual Property Rights and Transferred Trademarks from Agilent and its Affiliates to Keysight; provided, however, that, upon request, Agilent shall provide reasonable assistance to Keysight to record the assignment, at Keysight’s sole cost and expense.

 

(b)                                 Responsibility for Transferred Patents.  Agilent shall provide on or before the Effective Date a listing of all actions and fees due up to ninety (90) days after the Effective Date for the Transferred Patents in all relevant jurisdictions.  Agilent shall pay all fees incurred and respond to all office actions due up to and including the Effective Date.  Keysight shall, in its sole discretion, pay all fees incurred and respond to all office actions due

 

2

 

subsequent to the Effective Date.  Agilent shall forward to Keysight via electronic mail sent to notice.legal@Keysight.com and keydocketing@cpaglobal.com copies of all patent office correspondence received by Agilent and copies of all patent attorney and agent correspondence received by Agilent related to the Transferred Patents for ninety (90) days after the Distribution Date.  Agilent shall provide on or before the Effective Date a copy of all digitally stored files relating to the Transferred Patents, and shall retain in accordance with Agilent’s retention policy for Agilent patents, any hard-copy records related to the Transferred Patents (“Keysight Patent Records”) in Agilent’s possession as of the Effective Date, and Agilent shall provide Keysight with timely access to the Keysight Patent Records during normal business hours upon Keysight’s reasonable request.  The foregoing notwithstanding, in no case shall Agilent’s obligation to retain any Keysight Patent Records extend beyond ten (10) years from the Effective Date. The provisions in this Section 2.1(b) recite the only responsibilities of Agilent for the Transferred Patents after the Effective Date.

 

2.2                               Assignment of Intellectual Property Licenses.  Agilent agrees to, and agrees to cause its Affiliates to, assign and convey to Keysight, the Transferred Licenses, subject to the terms, conditions, and restrictions of each Transferred License.  Keysight acknowledges and agrees that it shall have sole responsibility to seek and obtain the consent of any Third Party necessary for the transfer of any of the Transferred Licenses, and shall bear sole responsibility for any consideration necessary for their transfer; provided, however, that upon request Agilent will provide reasonable assistance in obtaining such consent, at Keysight’s (or its Affiliates’) sole expense.  For the avoidance of doubt, and subject to the terms and conditions of the Transferred Licenses, upon the assignment and conveyance of the Transferred Licenses to Keysight, Keysight shall succeed to all of the rights, responsibilities, duties, obligations, and liabilities of Agilent and Agilent’s Affiliates under each such Transferred License, including, without limitation, any liabilities arising under such Transferred License prior to the date of such assignment and conveyance, which liabilities shall be the responsibility of Keysight.

 

2.3                               Transfer of Business Technology.  For the avoidance of doubt, the transfer of the Business Technology as set forth in the Separation Agreement does not include the transfer of any Intellectual Property Rights in or to the Business Technology; such Intellectual Property Rights are either transferred to Keysight as Transferred Intellectual Property Rights in Section 2.1 above or are licensed to Keysight in Section 3.1 below.

 

2.4                               Common Heritage Copyrights.  Common Heritage Copyrights (e.g., photos from the Agilent business archives) shall be deemed to be co-authored and co-owned by Agilent and Keysight.  Upon Keysight written request, Agilent and its Affiliates shall execute documents confirming the assignment of such co-ownership interest to Keysight.  Each co-owner shall be free to exercise full rights to the Common Heritage Copyrights without consent and without accounting to the other co-owner.

 

2.5                               Common Infrastructure Copyrights.  Common Infrastructure Copyrights shall be co-owned by Agilent and Keysight.   Upon Keysight written request, Agilent and its Affiliates shall execute documents confirming the assignment of such co-ownership interest to Keysight.  Subject to Article 6, below, each co-owner shall be free to exploit the Common Infrastructure Copyrights without further consent and without accounting to the other co-owner.

 

3

 

(a)                                 The parties acknowledge that some of the materials associated with Common Infrastructure Copyrights (e.g., documents, PowerPoint slides, photo libraries, etc.) may also contain Third Party-owned copyrighted material (“3POCM”) such as fonts, images and graphics, which are licensed to Agilent.  This provision therefore does not extend to such 3POCM, and Keysight is solely responsible for obtaining its own licenses to the 3POCM.   Keysight shall also indemnify and hold Agilent harmless from all claims by Third Parties arising out of or relating to Keysight’s unlicensed use of the 3POCM.

 

(b)                                 Notwithstanding the foregoing, the use of any Common Infrastructure Copyrights by or for Keysight, and any works related to, or based upon, any of the Common Infrastructure Copyrights, may not contain any references to Agilent (or any of Agilent’s marks, names, trade dress, logos or other source or business identifiers, including the Agilent Name and Agilent Marks), Agilent’s publications, Agilent’s personnel (including senior management), Agilent’s management structures or any other indication (other than the verbatim or paraphrased reproduction of the content) that such works are based upon any of Common Infrastructure Copyrights that originated with Agilent.

 

(c)                                  Neither Agilent nor Keysight shall have any obligation to the other to (i) notify of any changes or proposed changes to any of the Common Infrastructure Copyrights, (ii) include the other in any consideration of proposed changes to any of the Common Infrastructure Copyrights, (iii) provide draft changes of any of the Common Infrastructure Copyrights to the other for review and/or comment, or (iv) provide the other with any updated materials relating to any of the Common Infrastructure Copyrights.

 

2.6                               Common Infrastructure Trade Secrets.  Common Infrastructure Trade Secrets shall be co-owned by Agilent and Keysight.   Upon Keysight written request, Agilent and its Affiliates shall execute docments confirming the assignment of such co-ownership interest to Keysight.  Subject to Article 6, below, each co-owner shall be free to exploit the Common Infrastructure Trade Secrets without further consent and without accounting to the other co-owner.  Neither of the joint owners (Keysight, Agilent) shall make a Common Infrastructure Trade Secret public or otherwise destroy or impair the trade secret status of Common Infrastructure Trade Secret without the express, advance, written consent of the other joint owner.

 

ARTICLE III

 

LICENSES FROM AGILENT TO KEYSIGHT

 

3.1                               License Grants.  Agilent grants, agrees to grant, and agrees to cause its Affiliates to, grant to Keysight and its Affiliates the following personal, irrevocable (except as set forth in Article VIII and IX below), non-exclusive, worldwide, royalty-free and non-transferable (except as specified below in Article VIII below) licenses under Licensed Agilent IPR subject to the terms of this Agreement as follows:

 

(a)                                 Patents.  Under the patents included in Licensed Agilent IPR, to do the following with regard to Keysight Products solely within the Keysight Field:  (i) to make (including the right to practice methods, processes, and procedures), (ii) to have made (subject

 

4

 

to Section 3.2), and (iii) to use, lease, sell, offer for sale, and import.  The Agilent Patent licenses set forth in this Section 3.1(a) shall expire, with respect to each individual licensed Patent, upon the expiration of the term of each such Agilent Patent.

 

(b)                                 Trademarks.  As to certain Trademarks owned by Agilent or its Affiliates as of the Effective Date, Agilent agrees to grant Keysight a license as set forth in the Trademark License Agreement (TLA), a copy of which is attached hereto as Exhibit E.  To the extent there is a conflict between the terms of this Agreement and the TLA, the terms of the TLA shall control.

 

(c)                                  Copyrights.  Under the copyrights that are included in Licensed Agilent IPR, (i) to reproduce and have reproduced the works of authorship included therein and derivative works thereof prepared by or on behalf of Keysight, in whole or in part, solely as part of Keysight Products in the Keysight Field, (ii) to prepare derivative works or have derivative works prepared for it based upon such works of authorship solely to create Keysight Products in the Keysight Field, (iii) to distribute (by any means and using any technology, whether now known or unknown) copies of the works of authorship included therein (and derivative works thereof prepared by or on behalf of Keysight) to the public by sale or other transfer of ownership or by rental, lease or lending, solely as part of Keysight Products in the Keysight Field, (iv) to perform (by any means and using any technology, whether now known or unknown, including electronic transmission) and display the works of authorship included therein (and derivatives works thereof prepared by or on behalf of Keysight), in all cases solely as part of Keysight Products in the Keysight Field, and (v) to use such works of authorship (and derivative works thereof prepared by or on behalf of Keysight) to design, develop, manufacture and have manufactured (subject to Section 3.2), sell and support Keysight Products in the Keysight Field.

 

The parties acknowledge that some of the materials licensed under this provision (e.g., documents, PowerPoint slides, photo libraries, etc.) also contain 3POCM such as fonts, images and graphics, which are licensed to Agilent but that are not sub-licensable to Keysight.  The license granted under this provision, therefore, does not extend to the use of such 3POCM, and Keysight is solely responsible for obtaining its own licenses to the 3POCM.   Keysight shall also indemnify and hold Agilent harmless from all claims by Third Parties arising out of or relating to Keysight’s unlicensed use of the 3POCM.

 

(d)                                 Database Rights.  Under Database Rights included in Licensed Agilent IPR, to extract data from the databases included therein and to re-utilize such data (and Improvements thereof prepared by or on behalf of Keysight) solely to design, develop, manufacture and have manufactured (subject to Section 3.2), sell and support Keysight Products in the Keysight Field.

 

(e)                                  Mask Works Rights.  Under Mask Work Rights included in Licensed Agilent IPR, (i) to reproduce and have reproduced (subject to Section 3.2), by optical, electronic or any other means, mask works and semiconductor topologies included in the Business Technology and embodied in Keysight Products solely in the Keysight Field, (ii) to import or distribute a product in which any such mask work or semiconductor topology is embodied, and (iii) to permit Third Parties to do any of the foregoing.

 

5

 

(f)                                   Trade Secrets and Industrial Designs.  Under Agilent and its Affiliates Trade Secrets and Industrial Designs included in Licensed Agilent IPR, solely to design, develop, manufacture and have manufactured (subject to Section 3.2), sell and maintain Keysight Products in the Keysight Field.  Since laboratory notebooks being retained by Agilent may contain information about a mix of Agilent and Keysight IPR, Agilent shall retain such laboratory notebooks in accordance with Agilent’s current retention policy for Agilent laboratory notebooks, and Agilent shall provide Keysight with timely access to such laboratory notebooks during normal business hours upon reasonable request.

 

(g)                                  Third-Party Licenses.  With respect to Intellectual Property Rights licensed to Agilent or its Affiliates by a Third Party, the license grants set forth in this Article III shall be subject to all of the conditions set forth in the relevant license agreement between Agilent (or its Affiliate, as the case may be) and such Third Party, in addition to all of the terms, conditions, and restrictions set forth herein.  Licenses to Keysight under Intellectual Property Rights owned by a Third Party shall expire on the expiration of the term of the corresponding license agreement between such Third Party and Agilent (or its Affiliate, as the case may be).

 

(h)                                 Access Methods.  Keysight acknowledges and agrees that, subsequent to the Distribution Date, Keysight and its Affiliates may no longer use de-encryption algorithms or other access methods that were previously provided by Agilent to internal Agilent users to enable those internal Agilent users to use locked or encrypted copies of Agilent Commercial Software or other software, except to the extent necessary to continue using those copies rightfully in use before the Distribution Date.  Any access after the Distribution Date by Keysight, or a Keysight Affiliate, to additional copies of such Agilent Commercial Software beyond those copies rightfully in use before the Distribution Date, or to support, updates, revisions or service, shall be as separately agreed with Agilent or with an appropriate Third Party software vendor.

 

(i)                                     Software.  Without limiting the generality of the foregoing licenses granted in this Section 3.1, or transfer of rights with respect to software transferred to Keysight pursuant to Section 2.3 above, such licenses include the right to use, modify, and reproduce in source code and object code for such software (and Improvements thereof made by or on behalf of Keysight) solely to create Keysight Products in the Keysight Field, and to sell and maintain such software, in source code and object code form, as part of such Keysight Products; provided, however, that with respect to Agilent Commercial Software, Keysight shall be limited to using no more than ten percent (10%) of the lines of code of any Agilent Commercial Software in any Keysight Product sold or maintained by Keysight or its Affiliates to a Third Party after the Distribution Date (it being understood that such restriction shall not apply, however, to Keysight’s use of any software code contained in any Keysight Commercial Software to the extent that Keysight desires to continue to sell such Keysight Product in a form containing such software code or Improvements thereto).

 

(j)                                    Termination of Licenses to a Non-Affiliate.  Any and all licenses granted by Agilent to an Affiliate of Keysight hereunder shall terminate immediately at the time such entity is no longer an Affiliate of Keysight.

 

6

 

3.2                               Have Made Rights.  The licenses to Keysight and its Affiliates in Section 3.1 above shall include the right to have contract manufacturers and foundries manufacture Keysight Products for Keysight or its Affiliates (including private label or OEM versions of such products) solely within the Keysight Field, and are not intended to include foundry or contract manufacturing activities that Keysight or any of its Affiliates may undertake on behalf of Third Parties, whether directly or indirectly.

 

3.3                               Sublicenses.  The licenses granted to Keysight in Section 3.1 above shall not include any right to grant any sublicenses except as follows:

 

(a)                                 Affiliates.  Keysight may grant sublicenses to its Affiliates, even if they become Keysight Affiliates after the Distribution Date, within the scope of its licenses in Section 3.1 above with no right for such Affiliates to grant further sublicenses other than, (i) to another Affiliate of Keysight, even if it become an Affiliate of Keysight after the Distribution Date; provided, however, that sublicensing shall not be allowed to any entity which acquires Affiliate status as the result of a Change of Control, and any such sublicense shall only be effective for such time as such entity remains an Affiliate of Keysight, and (ii) as provided in Section 3.3(c), below.

 

(b)                                 Retroactivity.  Any sublicense granted pursuant to Section 3.3(a) above may be made effective retroactively, but shall not be effective for any time prior to the sublicensee’s becoming an Affiliate of Keysight, and shall only be effective for such times that such entity remains an Affiliate of Keysight.

 

(c)                                  For Resale and End Users.  Keysight and its Affiliates may grant sublicenses to its distributors, resellers, OEM customers, VAR customers, VAD customers, systems integrators and other channels of distribution and to its end user customers solely with respect to Keysight Products and solely within the scope of the licenses set forth in Section 3.1 above; provided, however, that any such sublicense by an Affiliate shall only be effective for such times that such sublicensing entity remains an Affiliate of Keysight.

 

3.4                               Improvements.  As between Agilent and its Affiliates on the one hand, and Keysight and its Affiliates on the other hand, Keysight hereby retains all right, title and interest, including all Intellectual Property Rights, in and to any Improvements made by or on behalf of Keysight from and after the Effective Date (a) to any of the Transferred Intellectual Property Rights or Business Technology, or (b) in the exercise of the licenses granted to it by Agilent and its Affiliates in this Article III, subject in each case only to the ownership interests of Agilent, its Affiliates, and Third Parties in the underlying Intellectual Property Rights that are improved.  Keysight shall not have any obligation under this Agreement to notify Agilent or its Affiliates of any such Improvements made by or on behalf of it or its Affiliates or to disclose or license any such Improvements to Agilent or its Affiliates.

 

3.5                               Agilent Restricted Patents.  Agilent hereby covenants on its own behalf and on behalf of its Affiliates that, unless obligated to do so by any Third Party agreement existing as of the Effective Date, it will not assert against Keysight or a Keysight Affiliate any Agilent Restricted Patent that would have been licensed hereunder but for the restriction against Agilent or its Affiliates licensing such Patent to Keysight contained in a Third Party agreement.

 

7

 

Such covenant shall be with respect to any conduct that would have otherwise been licensed hereunder.  Such covenant shall be effective to the extent permitted by the Third Party agreement.

 

ARTICLE IV

 

LICENSES FROM KEYSIGHT TO AGILENT

 

4.1                               License Grants.  Keysight grants, agrees to grant, and agrees to cause its Affiliates to grant, to Agilent and its Affiliates the following personal, irrevocable (except as set forth in Article VIII and IX below), non-exclusive, worldwide, royalty-free and non-transferable (except as set forth in Article VIII below) licenses under the Licensed Keysight IPR subject to the terms of this Agreement as follows:

 

(a)                                 Patents.  Under the patents included in Licensed Keysight IPR, to do the following with regard to Agilent Products in the Agilent Field: (i) to make (including the right to practice methods, processes and procedures), (ii) to have made (subject to Section 4.2), and (iii) to use, lease, sell, offer for sale and import.  The Keysight Patent licenses set forth in this Section 4.1(a) shall expire, with respect to each individual licensed Patent, upon the expiration of the term of each such Keysight Patent.

 

(b)                                 Copyrights.  Under the copyrights included in Licensed Keysight IPR, (i) to reproduce and have reproduced (subject to Section 4.2) the works of authorship included therein and derivative works thereof prepared by or on behalf of Agilent, in whole or in part, solely as part of Agilent Products in the Agilent Field, (ii) to prepare derivatives or have derivative works prepared for it based upon such works of authorship solely to create Agilent Products in the Agilent Field, (iii) to distribute (by any means and using any technology, whether now known or unknown) copies of the works of authorship included therein (and derivative works thereof prepared by or on behalf of Agilent) to the public by sale or other transfer of ownership or by rental, lease or lending, solely as part of Agilent Products in the Agilent Field, (iv) to perform (by any means and using any technology, whether now known or unknown, including, without limitation, electronic transmission) and display the works of authorship included therein (and derivative works thereof prepared by or on behalf of Agilent), in all cases solely as part of Agilent Products in the Agilent Field, and (v) to use such works of authorship (and derivative works thereof prepared by or on behalf of Agilent) solely to design, develop, manufacture and have manufactured (subject to Section 4.2), sell and support Agilent Products in the Agilent Field.

 

The parties acknowledge that some of the materials licensed under this provision (e.g. documents, PowerPoint slides, photo libraries, etc.) also contain 3POCM such as fonts, images and graphics, which are licensed to Keysight that are not sub-licensable to Agilent.  The license granted under this provision, therefore, does not extend to the use of such 3POCM, and Agilent is solely responsible for obtaining its own licenses to the 3POCM.  Agilent shall also indemnify and hold Keysight harmless from all claims by Third Parties arising out of or relating to Agilent’s unlicensed use of the 3POCM.

 

8

 

(c)                                  Database Rights.  Under the Database Rights included in Licensed Keysight IPR, to extract data from the databases included therein and to re-utilize such data (and Improvements thereof prepared by or on behalf of Agilent) solely to design, develop, manufacture and have manufactured (subject to Section 4.2), sell and support Agilent Products in the Agilent Field.

 

(d)                                 Mask Work Rights.  Under the Transferred Mask Work Rights included in Licensed Keysight IPR, (i) to reproduce and have reproduced (subject to Section 4.2), by optical, electronic or any other means, mask works and semiconductor topologies included in the Business Technology and embodied in Agilent Products solely in the Agilent Field, (ii) to import or distribute a product in which any such mask work or semiconductor topology is embodied, and (iii) to induce or knowingly to cause a Third Party to do any of the acts described in subclauses (i) and (ii) above.

 

(e)                                  Trade Secrets and Industrial Designs.  Under the Transferred Trade Secrets and Industrial Designs included in Licensed Keysight IPR solely to design, develop, manufacture and have manufactured (subject to Section 4.2), sell and maintain Agilent Products in the Agilent Field.

 

(f)                                   Third-Party Licenses.  With respect to Intellectual Property Rights licensed to Keysight or its Affiliates by a Third Party, the license grants set forth in this Article IV shall be subject to all of the conditions set forth in the relevant license agreement between Keysight or the Keysight Affiliate and such Third Party, in addition to all of the terms, conditions and restrictions set forth herein.  Licenses to Agilent under Intellectual Property Rights owned by a Third Party shall expire on the expiration of the term of the corresponding license agreement between such Third Party and Keysight or the Keysight Affiliate, as the case may be.

 

(g)                                  Termination of Licenses to a Non-Affiliate.  Any and all licenses granted by Keysight to an Affiliate of Agilent shall terminate immediately at the time such entity is no longer an Affiliate of Agilent.

 

(h)                                 Access Methods.  Agilent acknowledges and agrees that, subsequent to the Distribution Date, Agilent and its Affiliates may no longer use de-encryption algorithms or other access methods that were previously provided by the Keysight Business to internal Agilent users to enable those internal Agilent users to use locked or encrypted copies of Keysight Commercial Software, except to the extent necessary to continue using those copies rightfully in use before the Distribution Date.  Any access after the Distribution Date by Agilent, or an Agilent Affiliate, to additional copies of such Keysight Commercial Software beyond those copies rightfully in use before the Distribution Date, or to support, updates, revisions or service, shall be as separately agreed with Keysight or with an appropriate Third Party software vendor.

 

(i)                                     Software.  Without limiting the generality of the foregoing licenses granted in this Section 4.1, such licenses include the right to use, modify, and reproduce in source code and object code form such software (and Improvements thereof made by or on behalf of Agilent) solely to create Agilent Products in the Agilent Field, and to sell and

 

9

 

maintain such software, in source code and object code form, as part of such Agilent Products; provided, however, that with respect to Keysight Commercial Software, Agilent shall be limited to using no more than ten percent (10%) of the lines of code of any Keysight Commercial Software in any Agilent Product sold or maintained by Agilent or its Affiliates to a Third Party after the Distribution Date (it being understood that such restriction shall not apply, however, to Agilent’s use of any software code contained in any Agilent Commercial Software to the extent that Agilent desires to continue to sell such Agilent Product in a form containing such software code or Improvements thereto).

 

4.2                               Have Made Rights.  The licenses to Agilent and its Affiliates in Section 4.1 above shall include the right to have contract manufacturers and foundries manufacture Agilent Products for Agilent or its Affiliates (including private label or OEM versions of such products) and are not intended to include foundry or contract manufacturing activities that Agilent or any of its Affiliates may undertake on behalf of Third Parties, whether directly or indirectly.

 

4.3                               Sublicenses.  The licenses granted to Agilent in Section 4.1 above shall not include any right to grant any sublicenses except as follows:

 

(a)                                 Affiliates.  Agilent may grant sublicenses to its Affiliates, even if they become Affiliates after the Distribution Date, within the scope of its licenses in Section 4.1 above with no right for such Affiliates to grant further sublicenses other than, (i) to another Affiliate of Agilent, even if it becomes an Affiliate of Agilent after the Distribution Date; provided, however, that sublicensing shall not be allowed to any entity which acquires Affiliate status as the result of a Change of Control, and any such sublicense shall only be effective for such time as such entity remains an Affiliate of Agilent, and (ii) as provided in 4.3(c), below.

 

(b)                                 Retroactivity.  Any sublicense granted pursuant to Section 4.3(a) above may be made effective retroactively, but shall not be effective for any time prior to the sublicensee’s becoming an Affiliate of Agilent, and shall only be effective for such times that such entity remains an Affiliate of Agilent.

 

(c)                                  For Resale and End Users.  Agilent and its Affiliates may grant sublicenses to its distributors, resellers, OEM customers, VAR customers, VAD customers, systems integrators and other channels of distribution and to its end user customers solely with respect to Agilent Products and solely within the scope of the licenses set forth in Section 4.1 above, provided, however, that any such sublicense by an Affiliate shall only be effective for such times that such sublicensing entity remains an Affiliate of Agilent.

 

4.4                               Improvements.  As between Agilent and its Affiliates on the one hand, and Keysight and its Affiliates on the other hand, Agilent and its Affiliates hereby retain all right, title and interest, including all Intellectual Property Rights, in and to any Improvements made by or on behalf of Agilent or its Affiliates from and after the Effective Date in the exercise of the licenses granted to it by Keysight and Keysight’s Affiliates in this Article IV, subject only to the ownership of Keysight, Keysight Affiliates or any Third Parties in the underlying Intellectual Property Rights improved thereby.  Agilent shall not have any obligation under this

 

10

 

Agreement to notify Keysight of any such Improvements made by or on behalf of it or to disclose or license any such Improvements to Keysight or any Keysight Affiliates.

 

4.5                               Keysight Restricted Patents.  Keysight hereby covenants on its own behalf and on behalf of its Affiliates that, unless obligated to do so by any Third Party agreement existing as of the Effective Date, it will not assert against Agilent or an Agilent Affiliate any Keysight Restricted Patent that would have been licensed hereunder but for the restriction against Keysight or its Affiliate licensing such Patent to Agilent contained in a Third Party agreement.  Such covenant shall be with respect to any conduct that would have otherwise been licensed hereunder.  Such covenant shall be effective to the extent permitted by the Third Party agreement.

 

ARTICLE V

 

ADDITIONAL INTELLECTUAL PROPERTY RELATED MATTERS

 

5.1                               Assignments and Licenses.  No Party may assign or grant a license under any of such Party’s Intellectual Property Right which it has licensed to the other Party in Articles III or IV above, unless such assignment or grant is made subject to the licenses granted herein.   For the avoidance of any doubt, a non-exclusive license grant shall be deemed subject to the licenses granted herein.

 

5.2                               Assistance By Employees.  Each Party agrees that its employees and contractors have a continuing duty to assist the other Party with the prosecution of, and other patent or trademark office proceedings (e.g., reissue, reexamination, interference, inter partes review, post-grant review, etc.) regarding, the other Party’s Patent applications, Patents. Trademarks, and other Intellectual Property Rights (all of the foregoing, collectively, “Administrative IP Proceedings”). Accordingly, each Party agrees to reasonably make available to the other Party and its counsel (i) inventors and other reasonably necessary persons employed by it for the other Party’s reasonable needs regarding execution of documents, interviews, declarations, and testimony, and (ii) documents, materials, and information for the other Party’s reasonable good faith needs regarding such Administrative IP Proceedings.  Any actual and reasonable out-of-pocket expenses associated with such assistance shall be borne by the Party involved in the Administrative IP Proceeding, expressly excluding the value of the time of the other Party’s personnel (regarding which the Parties shall agree on a case by case basis with respect to reasonable compensation).

 

5.3                               Inventor Compensation.  Each Party will be responsible for providing inventor incentive compensation to its employees under its own internal policies.  To the extent that a Party bases an inventor’s incentive compensation on a Patent or a Patent application of the other Party, the Parties will reasonably cooperate by providing to each other relevant information about their Patents for which one or more inventors are employees of the other Party.  To the extent that inventor compensation is specified by local law, such as in Germany and Japan, the Parties will reasonably cooperate in providing information to each other in order to enable each Party to calculate inventor compensation.  No Party shall have any obligation to provide any inventor incentive compensation to an employee of the other Party except as required by law.  Any information provided under this Section 5.3 shall be subject to Section 6.1.

 

11

 

5.4                               No Implied Licenses.  Nothing contained in this Agreement shall be construed as conferring any rights by implication, estoppel or otherwise, under any Intellectual Property Rights, other than as expressly granted in this Agreement, and all other rights under any Intellectual Property Rights licensed to a Party or its Affiliates hereunder are expressly reserved by the Party granting the license.  The Party receiving the license hereunder acknowledges and agrees that the Party (or its applicable Affiliate) granting the license is the sole and exclusive owner of the Intellectual Property Rights so licensed.

 

5.5                               No Field Restrictions For Patent Licensing.  Except as expressly set forth elsewhere in this Agreement, including in the Exhibits, each Party shall be free to grant licenses of any sort under any of its owned Keysight Patents or Agilent Patents (as the case may be) to any Third Party without restriction as to field of use.

 

5.6                               No Obligation to Prosecute Patents.  Except as expressly set forth elsewhere in this Agreement, including in the Exhibits, no Party shall have any obligation to seek, perfect, or maintain any protection for any of its Intellectual Property Rights.  Without limiting the generality of the foregoing, except as expressly set forth elsewhere in this Agreement, including in the Exhibits, no Party shall have any obligation to file any Patent application, to prosecute any Patent, or secure any Patent rights or to maintain any Patent in force.

 

5.7                               Reconciliation.  The Parties acknowledge that, as part of the transfer of the Transferred Intellectual Property Rights, the Transferred Licenses and the Business Technology, Agilent or its Affiliates may inadvertently retain Technology or Intellectual Property Rights that should have been transferred to Keysight pursuant to Article II of this Agreement, and Keysight may inadvertently acquire Technology or Intellectual Property Rights that should not have been transferred.  Each Party agrees to resolve such errors using the procedures set forth in Section 5.12, Dispute Resolution.

 

5.8                               Technical Assistance.  Except as expressly set forth elsewhere in this Agreement (including in the Exhibits), in the Separation Agreement, or any other mutually executed agreement between the Parties, no Party shall be required to provide the other Party with any technical assistance or to furnish any other Party with, or obtain on their behalf, any documents, materials or other information or Technology.

 

5.9                               Third-Party Infringement.  No Party shall have any obligation hereunder to institute or maintain any action or suit against Third Parties for infringement or misappropriation of any Intellectual Property Rights in or to any Technology licensed to the other Party hereunder, or to defend any action or suit brought by a Third Party which challenges or concerns the validity of any of such Intellectual Property Rights or which claims that any Technology licensed to the other Party hereunder infringes or constitutes a misappropriation of any Intellectual Property Rights of any Third Party.  Each Party (the “Notifying Party”) has the continuing obligation to promptly notify the other Party in writing upon learning of a Third Party likely infringing, misappropriating, or other violating or impairing any Intellectual Property Rights of the other Party which are licensed to the Notifying Party under this Agreement.  Such notification shall set forth in reasonable specificity the identity of the suspected infringing Third Party and the nature of the suspected infringement.  The Party to whom the Intellectual Property

 

12

 

Right is licensed shall not take any steps to contact any such Third Party without the other Party’s prior written permission, and such other Party shall have the sole discretion to determine whether and in what manner to respond to any such unauthorized Third-Party use and shall be exclusively entitled to any remedies, including monetary damages, related thereto or resulting therefrom.  In the event that the Party granting the license hereunder decides to initiate any claim against any Third Party, the Party to whom the Intellectual Property Right is licensed shall cooperate fully with Licensor, subject to Section 5.4.

 

5.10                        Copyright Notices.  Notwithstanding anything to the contrary herein, as to works in which Keysight owns the copyright, to the extent any such works contain copyright notices which indicate Agilent as the copyright owner, Keysight may, but shall not be required, to change such notices.

 

5.11                        No Challenge to Title.  Each Party agrees that it shall not (and shall cause its Affiliates not to), for any reason, after the Effective Date (regardless of whether this Agreement is subsequently terminated), either itself do or authorize any Third Party to do any of the following anywhere in the world with respect to any Intellectual Property Rights licensed to such Party or its Affiliates hereunder:  (a) represent to any Third Party in any manner that it owns or has any ownership rights in such Intellectual Property Rights; (b) apply for any registration of such Intellectual Property Rights (including federal, state, and national registrations); or (c) impair, dispute or contest the validity or enforceability of the other Party’s (or any of such other Party’s Affiliates) right, title and interest in and to such Intellectual Property Rights.

 

5.12                        Dispute Resolution.  In the event of any controversy, dispute or claim (a “Dispute”) arising out of or relating to any Party’s rights or obligations under this Agreement (whether arising in contract, tort or otherwise) (including the interpretation or validity of this Agreement), such Dispute shall be resolved in accordance with the dispute resolution process referred to in Article VII of the Separation Agreement.

 

ARTICLE VI

 

CONFIDENTIAL INFORMATION

 

6.1                               Confidential Information.  Each Party shall (and shall cause its Affiliates to) hold all confidential or proprietary information licensed to it hereunder and any other confidential or proprietary information disclosed to it or any other member of its Affiliates hereunder in confidence in accordance with Section 6.2 of the Separation Agreement.

 

6.2                               Contract Manufacturing.  Notwithstanding anything to the contrary herein, each Party agrees that, in exercising its “Have-Made” rights (by Keysight, pursuant to Section 3.2, or by Agilent, pursuant to Section 4.2), each Party may only disclose Trade Secrets or Industrial Designs licensed from the other Party in Articles III and IV above if it has executed a written confidentiality agreement with the Third Party contract manufacturer with appropriate, industry standard terms, and in all cases containing terms and conditions pertaining to the

 

13

 

protection of proprietary and confidential information no less restrictive than those set forth in Section 6.1.

 

6.3                               Source Code.   In addition to the provisions of Section 6.2 of the Separation Agreement, Agilent shall maintain the confidentiality all information and documents related to all Licensed Keysight Source Code and Keysight shall maintain the confidentiality of all information and documents related to all Licensed Agilent Source Code until the expiration of any copyright therein.  Each Party shall use the same degree of care as it uses to protect its own proprietary source code, but in any case no less than a reasonable degree of care, to prevent unauthorized use, dissemination or publication of the source code.  Any Third Party disclosure necessary to make commercial use of the source code shall be made only under a confidentiality agreement with terms no less restrictive than those of this Article VI.   Source code shall cease to qualify as confidential information if it (a) becomes publicly available without breach of this Agreement, or (b) is obtained by the licensed party from a Third Party lawfully in possession of the source code and which provides the source code without breach of any duty of confidentiality owed directly or indirectly to the source code owner (either Agilent and/or Keysight, as may be applicable).  Notwithstanding the provisions of this Section 6.3, each Party may disclose the other Party’s source code if required by law, regulation, or court order provided that the Party seeking to disclose provides notice and a reasonable opportunity to object to, limit, or condition the disclosure (e.g., to limit the disclosure to the minimum necessary to comply with the law, regulation, or court order and for the disclosure to be made under protective order or other order of confidentiality).

 

6.4                               Trade Secrets.  In addition to the provisions of Section 6.2 of the Separation Agreement, Agilent shall maintain the confidentiality of the Transferred Trade Secrets and the Common Infrastructure Trade Secrets, and Keysight shall maintain the confidentiality of the Trade Secrets licensed under Section 3.1(f), above, and of the Common Infrastructure Trade Secrets.  Each Party shall use the same degree of care as it uses to protect its own trade secrets, but in any case no less than a reasonable degree of care, to prevent unauthorized use, dissemination or publication of the trade secrets.  Any Third Party disclosure necessary to exploit the trade secrets shall be made only under a confidentiality agreement with terms no less restrictive than those of this Article VI.  Trade secrets shall cease to qualify as confidential information if it (a) becomes publicly available without breach of this Agreement, or (b) is obtained from a Third Party lawfully in possession of the trade secret and which provides the trade secret without breach of any duty of confidentiality owed directly or indirectly to the trade secret owner (either Agilent and/or Keysight, as may be applicable).  Notwithstanding the provisions of this Section 6.4, each Party may disclose the other Party’s trade secret information if required by law, regulation, or court order provided that the Party seeking to disclose provides notice and a reasonable opportunity to object to, limit, or condition the disclosure (e.g., to limit the disclosure to the minimum necessary to comply with the law, regulation, or court order and for the disclosure to be made under protective order or other order of confidentiality).

 

14

 

ARTICLE VII

 

LIMITATION OF LIABILITY AND WARRANTY DISCLAIMER

 

7.1                               Limitation of Liability.  IN NO EVENT SHALL ANY PARTY BE LIABLE TO THE OTHER PARTY FOR ANY SPECIAL, CONSEQUENTIAL, INDIRECT, INCIDENTAL OR PUNITIVE DAMAGES OR LOST PROFITS, HOWEVER CAUSED AND BASED ON ANY THEORY OF LIABILITY (INCLUDING NEGLIGENCE) ARISING IN ANY WAY OUT OF THIS AGREEMENT, WHETHER OR NOT SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.  THE FOREGOING SHALL NOT, HOWEVER, LIMIT THE DAMAGES AVAILABLE TO A PARTY FOR (A) INFRINGEMENT OR MISAPPROPRIATION OF ITS INTELLECTUAL PROPERTY RIGHTS BY ANOTHER PARTY OR (B) BREACHES OF ARTICLE VI.

 

7.2                               Warranties Disclaimer.  Except as otherwise set forth herein, (a) EACH PARTY ACKNOWLEDGES AND AGREES THAT ALL INTELLECTUAL PROPERTY RIGHTS, TECHNOLOGY, INFORMATION, AND PROPRIETARY RIGHTS TRANSFERRED, ASSIGNED, LICENSED, OR GRANTED HEREUNDER ARE TRANSFERRED, ASSIGNED, LICENSED, AND GRANTED WITHOUT ANY WARRANTIES WHATSOEVER, WHETHER EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT THERETO, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, ENFORCEABILITY OR NON-INFRINGEMENT, (b) no Party makes any warranty or representation that any manufacture, use, importation, offer for sale or sale of any product or service will be free from infringement or misappropriation of any Patent or other Intellectual Property Right of any Third Party, (c) Agilent makes no warranty or representation as to the validity and/or scope of any Agilent Patent or any of the Transferred Patents, and (d) Keysight makes no warranty or representation as to the validity and/or scope of any Keysight Patent.

 

ARTICLE VIII

 

TRANSFERABILITY AND ASSIGNMENT

 

8.1                               No Assignment Or Transfer Without Consent.  Except as otherwise provided in this Article VIII, no Party may assign or transfer any of the Intellectual Property Rights licenses granted pursuant to this Agreement, nor this Agreement as a whole, whether by operation of law or otherwise, without the prior written consent of the non-transferring Party.  The non-transferring Party may, in its sole and absolute discretion, grant or withhold such consent.  Any purported assignment or transfer without such consent shall be void and of no effect.  Unless otherwise agreed in connection with consent to an assignment or transfer, no assignment or transfer made pursuant to this Section 8.1 shall release the transferring Party from any of its rights, responsibilities, duties, obligations, and liabilities under this Agreement.  For the avoidance of doubt, Section 8.2, rather than this Section 8.1, shall apply to any assignment, transfer or sublicensing of the Intellectual Property licenses granted pursuant to this Agreement, or this Agreement as a whole, in connection with a Change Of Control.

 

15

 

8.2                               Change Of Control. In the event of a Change of Control of a Party (or any of its respective Subsidiaries or Affiliates), neither this Agreement as a whole nor any of the Intellectual Property Rights or licenses or sublicenses granted pursuant to this Agreement may be assigned, transferred, licensed, or sublicensed, whether expressly, by operation of law, or otherwise, to a Third Party in connection with that Change of Control without first obtaining the prior written consent of the other (non-transferring) Party.  The non-transferring Party may not unreasonably withhold its consent.   Any purported assignment or transfer without such consent shall be void and of no effect.

 

8.3                               Sale of Part of the Business.

 

(a)                                 If any Party (the “Transferring Party”), after the Effective Date either (i) transfers, disposes of or otherwise divests a going business (but not all or substantially all of such Party’s business or assets) and such transfer includes at least one (1) marketable product and tangible assets having a net value of at least twenty-five million U.S. dollars ($25,000,000) to a Third Party and (ii) assigns, sublicenses or transfers any of the Intellectual Property Rights licenses granted pursuant to this Agreement to a Third Party, in any case other than in connection with a Change of Control (the Third Party in any of the foregoing transactions referred to as the “Transferee” and any such transaction referred to as the “Transfer”), then, upon the joint written request of the Transferring Party and the Transferee to the other Party (the “Non-Transferring Party”) not later than sixty (60) days following the closing of the Transfer, the Non-Transferring Party shall grant a royalty-free license to the Transferee under the same terms as the license granted to the Transferring Party under this Agreement subject to all of the following conditions and restrictions:

 

(i)                                     the effective date of such license shall be the closing date of the Transfer;

 

(ii)                                  the products, services and processes of the Transferee that are subject to such license shall be limited to the products, services and processes that are commercially released or for which substantial steps have been taken to commercialize as of the closing date of the Transfer by the Transferring Party, and for new extensions and versions of such products, services and processes;

 

(iii)                               the Intellectual Property Rights of the Non-Transferring Party that are subject to the license to be granted to the Transferee shall be limited to Intellectual Property Rights licensed to the Transferring Party pursuant to Articles III or IV above, as the case may be; and

 

(iv)                              the license to the Transferee shall terminate in the event that during the term of the license the Transferee (A) becomes engaged with the Non-Transferring Party in litigation, arbitration or other formal dispute resolution proceedings involving assertion of infringement, misappropriation, or other violation or impairment of Intellectual Property Rights (pending in any court, tribunal, or administrative agency or before any appointed or agreed upon arbitrator in any jurisdiction worldwide) (any of the foregoing proceedings referred to as “Formal IP Proceedings”) or (B)(1) makes a written allegation of infringement,

 

16

 

misappropriation, or other violation or impairment of Intellectual Property Rights against the Non-Transferring Party, (2) makes a written request that the Non-Transferring Party license or otherwise offer to the Non-Transferring Party a license to Intellectual Property Rights in connection with an allegation of infringement, misappropriation, or other violation or impairment of Intellectual Property Rights, or (3) engages in discussions or negotiations with the Non-Transferring Party for the settlement or compromise of any actual or alleged infringement, misappropriation, or other violation or impairment of Intellectual Property Rights (any of the foregoing in (1), (2) and (3) referred to as “Informal IP Discussions”), in each case involving Intellectual Property Rights under which the Transferee has ownership or control without any ongoing obligation to pay royalties or other consideration to Third Parties.

 

(b)                                 Notwithstanding anything to the contrary herein, the Non-Transferring Party, shall have no obligation to enter into a license with any Transferee under this Section 8.3 in the event that (i) at the time that the Transferring Party and Transferee make a joint request for a license from the Non-Transferring Party pursuant to this Section 8.3, the Non-Transferring Party and the Transferee are engaged in Formal IP Proceedings or (ii) at any time in the twelve (12) months prior to the date of the joint request that the Transferee has engaged in Informal IP Discussions with the Non-Transferring Party, in each case involving Intellectual Property Rights under which the Transferee has ownership or control without any ongoing obligation to pay royalties or other consideration to Third Parties.

 

(c)                                  There shall be no more than eight (8) license granted to a Transferee pursuant to this Section 8.3 as a result of a request by Seller and its Affiliates on the one hand, and Buyer and its Affiliates on the other hand, as the Transferring Party; provided, however, that if the Transferring Party elects to relinquish its license under this Agreement in the field of use covered by the license granted by a Non-Transferring Party to the Transferee under this Section 8.3, then the license to the Transferee shall not count toward the above limit.  In making such election, the Transferring Party shall promptly notify the Non-Transferring Party, and the Transferring Party and the Non-Transferring Party shall enter into a written amendment to this Agreement to reflect the relinquishment of its license in that field of use.

 

ARTICLE IX

 

REVOCATION AND TERMINATION OF LICENSE RIGHTS

 

9.1                               Revocation of License for Breach.  Either Party may revoke any licensed Intellectual Property Right, in the event of a material breach of this Agreement by the other Party (or any Affiliate of the other Party) with respect to such licensed Intellectual Property Right if such breach is not cured within ninety (90) days following the breaching Party’s receipt of written notice of such breach from the non-breaching Party.  Notwithstanding anything in this Agreement to the contrary, upon any revocation of a licensed Intellectual Property Right pursuant to this Section 9.1, all other rights and licenses granted under this Agreement that are in effect at the time of such revocation shall survive and remain in full force and effect.

 

17

 

9.2                               Termination by Licensee.  A Party may terminate any license granted to it (or any of its Affiliates) hereunder as to any Intellectual Property Right licensed to it (or any of its Affiliates) hereunder by written notice of such termination to the other Party.  Notwithstanding anything in this Agreement to the contrary, upon any termination of the license to any Intellectual Property Right pursuant to this Section 9.2, all other rights and licenses granted under this Agreement that are in effect at the time of such termination shall survive and remain in full force and effect.

 

9.3                               Effect of Revocation or Termination; Survival.  Upon the revocation or termination of a licensed Intellectual Property Right, the Party receiving the license hereunder shall not have any rights whatsoever to use such Intellectual Property Right subsequent to the date of such revocation or termination and shall (and shall cause each of its Affiliates to) immediately cease using such Intellectual Property Right.  Notwithstanding anything in this Agreement to the contrary, Section 5.5, Article VI, Article VII, this Section 9.3 and Article X shall survive any termination of this Agreement in whole or in part.

 

ARTICLE X

 

10.1 MISCELLANEOUS.   Article VIII of the Separation Agreement is hereby incorporated into this Agreement by this reference.

 

[SIGNATURE PAGES FOLLOW]

 

18

 

IN WITNESS WHEREOF, the Parties have caused this Intellectual Property Matters Agreement to be duly executed as of the Effective Date.

 

 

	
 
    	
AGILENT   TECHNOLOGIES, INC.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Sheila Barr Robertson
    
	
 
    	
 
    	
 
    	
Sheila   Barr Robertson
    
	
 
    	
 
    	
 
    	
Senior   Vice Presdient, Corporate Development and Strategy
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
KEYSIGHT   TECHNOLOGIES, INC.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Ronald S. Nersesian
    
	
 
    	
 
    	
 
    	
Ronald   S. Nersesian
    
	
 
    	
 
    	
 
    	
President   and Chief Executive Officer
    

 

[Signature Page to Intellectual Property Matters Agreement]

 

 

EXHIBIT A

 

Definitions

 

The following terms, as used in this Agreement, have the following meanings:

 

“Affiliate” means an entity that, as of the Distribution Date (except where expressly provided otherwise elsewhere in this Agreement), meets the definition of “Affiliate” set forth in the Separation Agreement.

 

“Agilent Commercial Software” means software products commercially released by Agilent or its Affiliates and listed on an Agilent CPL as of the Effective Date, or (if applicable) that has been released by Agilent or any of its Affiliates to Third Parties for beta testing as of the Effective Date.

 

“Agilent Field” means the design, development, research, manufacture, supply, distribution, sale (directly or through third parties), support (including consulting, repair, upgrade, calibration and other services), and maintenance (including the supply of components (including integrated circuits, subassemblies, accessories, parts, or software (including firmware, programs and applications)) of any products that are:  (a) within the Agilent Primary Field; or (b) within the Overlap Field; or (c) outside of the Keysight Primary Field.  For the avoidance of doubt, the Agilent Field excludes any products that are within the Keysight Primary Field unless those products are within the Agilent Primary Field or Overlap Field.

 

“Agilent Future Products and Services” mean new products and services that, as of the Effective Date, Agilent or an Agilent Affiliate has a business plan to bring to market before November 1, 2017, provided that such new products and services would not be a reasonable extension of 1) Agilent Products listed on Agilent’s published corporate price list as of the Effective Date; or of 2) Agilent Legacy Products.

 

“Agilent Labs Projects” means projects underway before the Effective Date within the central laboratories of Agilent’s Life Sciences and Diagnostics Group or Agilent’s Chemical Analysis Group, that, as of the Effective Date are expected to result in new products and services being brought to market before November 1, 2019, provided that such new products and services would not be reasonable extensions of 1) Agilent Products listed on Agilent’s published corporate price list as of the Effective Date; or of 2) Agilent Legacy Products.

 

“Agilent Legacy Products” means products which 1) are not on Agilent’s or Keysight’s published corporate price list as of the Effective Date; 2) were at one time sold by Agilent, or a predecessor-in-interest, and 3) will be supported by Agilent after the Effective Date, including, but not limited to, providing warranty support or meeting contractual support obligations.

 

“Agilent Patents” means every Patent other than design patents or the Transferred Patents, with a First Effective Filing Date prior to the first anniversary of the Distribution Date that is (i) owned by Agilent or any of its Affiliates as of or after the Distribution Date, or for which (ii) Agilent or any of its Affiliates has the right as of or after the Distribution Date under such Patent to grant licenses to Keysight of the scope granted by Agilent to Keysight in Section 3.1 of this Agreement without the payment of royalties or other consideration to any Third

 

A-1

 

Parties (excluding employees of Agilent or its Affiliates) provided, however, that no Patent shall be considered an Agilent Patent if it is an Agilent Restricted Patent.

 

“Agilent Primary Field” means: 1) products and services listed on Agilent’s published corporate price list as of the Effective Date;  2) Agilent Future Products and Services which are either actually sold by Agilent before November 1, 2017 or during a Development Extension, if granted by Keysight, or listed for sale on Agilent’s published corporate price list before November 1, 2017 or during a Development Extension, if granted by Keysight; 3) Agilent’s new products and services which are both: a) developed from an Agilent Labs Project, and b) either actually sold by Agilent before November 1, 2019 or during a Development Extension, if granted by Keysight, or listed for sale on Agilent’s published corporate price list before November 1, 2019 or during a Development Extension, if granted by Keysight;  4) Agilent Legacy Products; and 5) reasonable extensions of the all of the foregoing items within this definition.

 

“Agilent Products” means all products and services of the businesses in which Agilent or any of its Affiliates is now or hereafter engaged, including the business of making (but not having made) Third Party products for Third Parties when Agilent or any of its Affiliates is acting as a contract manufacturer or foundry for such Third Parties.  The term Agilent Products includes the Technology embodied in and/or used to manufacture or deliver the products and services referred to in the preceding sentence as well as marketing and other collateral materials related thereto.

 

“Agilent Restricted Patent” means any Patent under which Agilent is restricted from granting a license to Keysight pursuant to an agreement with a Third Party.

 

“Business Technology” means all Technology used in designing, developing, manufacturing, selling, providing or supporting products and services of the Keysight Business as they exist as of the Effective Date.

 

“Change of Control” means with respect to a Party, a transaction in which any of the following occurs, whether directly or indirectly:  (a) a Third Party acquires all or substantially all of such Party’s assets; or (b) a Third Party acquires greater than fifty percent (50%) ownership interest, direct or indirect, in the outstanding shares or stock entitled to vote for the election of directors of such Party, or (c) a Third Party otherwise acquires the ability to control or direct the management, policies, or affairs of such Party.

 

“CPL” means a Party’s published corporate price list as of the Effective Date.  Without limiting the foregoing, references to the Keysight CPL shall be deemed to include products listed in the Agilent CPL that the parties intend to transfer to Keysight as part of the Keysight Business, and references to the Agilent CPL shall be deemed to exclude any such products to the extent that such transfer is intended by the parties to be exclusive.

 

“Common Heritage Copyrights” means copyrights that are owned by Agilent or its Affiliates as of the Effective Date in works that relate to the common heritage of Agilent and Keysight including back to the formation of Hewlett-Packard Co. or to the common infrastructure of Agilent and the Keysight Business as of the Effective Date.

 

A-2

 

“Common Infrastructure Copyrights” means copyrights that relate to the common infrastructure of Agilent and the Keysight Business as of the Effective Date, including, for example, Agilent corporate policies, manuals, and employee training materials.

 

“Common Infrastructure Trade Secrets” means trade secrets that relate to the common infrastructure of Agilent and the Keysight Business as of the Effective Date.

 

“Development Extension” means an extension of the period related to the portion of a party’s Primary Field relating to the sale or listing on the corporate price list of future products and services.  A party seeking a Development Extension must make a request to the other party in writing.  Such request must be made before the expiration of the initial term and must provide a detailed description of the future product or service and the duration of the requested extension.  The party receiving a request for a Development Extension must review in good faith and reply within thirty (30) days of receiving the request.  Failure to reply will be deemed approval of the request.

 

“Distribution Date” means Distribution Date as defined in the Separation Agreement.

 

“First Effective Filing Date” means the earliest effective filing date in the particular country for any Patent or any Patent application.  By way of example, it is understood that the First Effective Filing Date for a United States Patent is the earlier of (a) the actual filing date of the application which issued into the Patent or (b) the priority date under 35 U.S.C. §119 or §120 for such Patent.

 

“Improvement” to any Intellectual Property Right or Technology means (a) with respect to Copyrights, any modifications, derivative works and translations of works of authorship in any medium, (b) with respect to Database Rights, any database that is created by extraction or re-utilization of another database, and (c) with respect to Technology, any improvement or modification to the Trade Secrets, Industrial Designs and Mask Works that cover or are otherwise incorporated into Technology.

 

“Intellectual Property Rights” or “IPR” means the rights associated with the following anywhere in the world:  (a) patents and utility models, and applications therefore (including any continuations, continuations-in-part, divisionals, reissues, renewals, extensions or modifications for any of the foregoing) (“Patents”); (b) trade secrets and all other rights in or to confidential business or technical information (“Trade Secrets”); (c) copyrights, copyright registrations and applications therefore, moral rights and all other rights corresponding to the foregoing (“Copyrights”); (d) uniform resource locators and registered internet domain names (“Internet Properties”); (e) industrial design rights and any registrations and applications therefore (“Industrial Designs”); (f) databases and data collections (including knowledge databases, customer lists and customer databases) under the laws of any jurisdiction, whether registered or unregistered, and any applications for registration therefor (“Database Rights”); (g) mask works, and mask work registrations and applications therefor (“Mask Work Rights”); (h) trademarks and service marks, whether registered or unregistered, and the goodwill appurtenant to each of the foregoing (“Trademarks”); and (i) any similar, corresponding or equivalent rights to any of the foregoing.  Intellectual Property Rights specifically excludes contractual rights (including license

 

A-3

 

grants from Third Parties) and also excludes the tangible embodiment of any of the foregoing in subsections (a) – (i).

 

“Keysight Business” has the meaning set forth in the Separation Agreement.

 

“Keysight Commercial Software” means software products commercially released by Keysight or its Affiliates and listed on a Keysight CPL as of the Effective Date, or (if applicable) that has been released by Keysight or any of its Affiliates to Third Parties for beta testing as of the Effective Date.

 

“Keysight Field” means the design, development, research, manufacture, supply, distribution, sale (directly or through third parties), support (including consulting, repair, upgrade, calibration and other services), and maintenance (including the supply of components (including integrated circuits, subassemblies, accessories, parts, or software (including firmware, programs and applications)) of any products that are: (a) within the Keysight Primary Field; or (b) within the Overlap Field; or (c) outside of the Agilent Primary Field.  For the avoidance of doubt, the Keysight Field excludes any products that are within the Agilent Primary Field unless those products are within the Keysight Primary Field or Overlap Field.

 

“Keysight Future Products and Services” mean new products and services that, as of the Effective Date, Keysight or a Keysight Affiliate has a business plan to bring to market before November 1, 2017, provided that such new products and services would not be a reasonable extension of 1) Keysight Products listed on Keysight’s published corporate price list as of the Effective Date; or of 2) Keysight Legacy Products.

 

“Keysight Legacy Products” means products which 1) are not on Keysight’s or Agilent’s published corporate price list as of the Effective Date; 2) were at one time sold by Agilent, or a predecessor-in-interest, and 3) will be supported by Keysight after the Effective Date including, but not limited to, providing warranty support or meeting contractual support obligations.

 

“Keysight Patents” means (a) the Transferred Patents, and (b) every other Patent other than design patents, with a First Effective Filing Date prior to the first anniversary of the Distribution Date which is (i) owned by Keysight or any Keysight Affiliate as of or after the Distribution Date, or for which (ii) Keysight or any Keysight Affiliate has the right as of or after the Distribution Date under such Patent to grant licenses to Agilent of the scope granted by Keysight to Agilent in Article IV of this Agreement without the payment of royalties or other consideration to any Third Parties (excluding employees of Keysight or its Affiliates); provided, however, that no Patent shall be considered a Keysight Patent if it is a Keysight Restricted Patent.

 

“Keysight Primary Field” means: 1) products and services listed on Keysight’s corporate price list as of the Effective Date; 2) Keysight Future Products and Services which are either actually sold by Keysight before November 1, 2017 or during a Development Extension, if granted by Agilent, or listed for sale on Keysight’s published corporate price list before November 1, 2017 or during a Development Extension, if granted by Agilent;  3) Keysight Legacy Products; and 4) reasonable extensions of the all of the foregoing items within this definition.

 

A-4

 

“Keysight Products” means all products and services of the businesses in which Keysight or any of its Affiliates is now or hereafter engaged, including the business of making (but not having made) Third Party products for Third Parties when Keysight or any Keysight Affiliates is acting as a contract manufacturer or foundry for such Third Parties.  The term Keysight Products includes the Technology embodied in and/or used to manufacture or deliver the products and services referred to in the preceding sentence as well as marketing and other collateral materials related thereto.

 

“Keysight Restricted Patent” means any Patent under which Keysight is restricted from granting a license to Agilent pursuant to an agreement with a Third Party.

 

“Licensed Agilent IPR” means (a) the Agilent Patents and (b) all Intellectual Property Rights other than Patents and Trademarks (i) which are owned by Agilent or an Agilent Affiliate as of the Distribution Date or (ii) for which Agilent or any Agilent Affiliate has as of the Distribution Date the right to grant licenses to Keysight of the scope granted by Agilent to Keysight in the corresponding sections of Article III without the payment of royalties or other consideration to any Third Parties (excluding employees of Agilent or its Affiliates); provided, however, that no Intellectual Property Right shall be considered Licensed Agilent IPR if Agilent is restricted from granting Keysight a license under any such Intellectual Property Right pursuant to an agreement with a Third Party.

 

“Licensed Agilent Source Code” means source code versions of Agilent software included in Licensed Agilent IPR.

 

“Licensed Keysight IPR” means Transferred Intellectual property rights, including: (a) the Keysight Patents and (b) all Intellectual Property Rights other than Patents and Trademarks (i) which are owned by Keysight or a Keysight Affiliate as of the Distribution Date or (ii) for which Keysight or any Keysight Affiliate has the right as of the Distribution Date to grant licenses to Agilent of the scope granted by Keysight to Agilent in the corresponding sections of Article IV without the payment of royalties or other consideration to any Third Parties (excluding employees of Keysight, or any Keysight Affiliates); provided, however, that no Intellectual Property Right shall be considered Licensed Keysight IPR if Keysight is restricted from granting Agilent a license under any such Intellectual Property Right pursuant to an agreement with a Third Party.

 

“Licensed Keysight Source Code” means source code versions of Keysight software included in Licensed Keysight IPR.

 

“Overlap Field” means products, components, or services relating to microscopy (including, but not limited to optical, scanning electron and Atomic Force).

 

“Party’s Primary Field” means the Agilent Primary Field or the Keysight Primary Field as the case may be.

 

“Subsidiary” shall have the meaning set forth in the Separation Agreement.

 

A-5

 

“Technology” means tangible embodiments, whether in electronic, written or other media, of copyrightable works, technology, including designs, design and manufacturing documentation (such as bill of materials, build instructions and test reports), sales documentation (such as marketing materials, installation manuals, service manuals, user manuals) schematics, algorithms, routines, software, databases, lab notebooks, development and lab equipment, processes, prototypes and devices.  Technology does not include Intellectual Property Rights, including any Intellectual Property Rights in any of the foregoing.

 

“Third Party” means any Person other than a Party.

 

“Transferred Copyrights” means copyright in and to the Business Technology, whether registered or unregistered, that are owned by Agilent or by an Agilent Affiliate as of the Effective Date and that are primarily used in the Keysight Business, specifically including the Copyrights (if any) listed in Exhibit D.  For the avoidance of doubt, Transferred copyrights do not include 1) copyrights in Agilent Commercial Software; 2) copyrights in works that are used exclusively in or relate exclusively to Agilent Products; or 3) Common Heritage Copyrights.

 

“Transferred Database Rights” means database right in and to the Business Technology that are owned by Agilent or by an Agilent Affiliate as of the Effective Date and that are primarily used in the Keysight Business including the Database Rights (if any) listed in Exhibit D.

 

“Transferred Industrial Designs” means industrial design right in and to the Business Technology that are owned by Agilent or by an Agilent Affiliate as of the Effective Date and that are primarily used in the Keysight Business including the Industrial Designs (if any) listed in Exhibit D.

 

“Transferred Intellectual Property Rights” means (a) the Transferred Patents, (b) the Transferred Copyrights, (c) the Transferred Internet Properties, (d) the Transferred Industrial Designs, (e) The Transferred Database Rights,(f) the Transferred Mask Work Rights, (g) the Transferred Trade Secrets, and (h) the Transferred Trademarks.

 

“Transferred Internet Properties” means internet properties (including domain names) that are owned by Agilent or by an Agilent Affiliate as of the Effective Date and that are listed in Exhibit D.

 

“Transferred Licenses” means the agreements between Agilent or its Affiliates and a Third Party that provide a license to Intellectual Property Rights and that are primarily used in the Keysight Business or license Transferred Intellectual Property Rights.

 

“Transferred Mask Work Rights” means mask work rights, whether registered or unregistered, in and to the Business Technology that are owned by Agilent or by an Agilent Affiliate as of the Effective Date and that are primarily used by the Keysight Business, specifically including the Mask Work Rights (if any) listed in Exhibit D.  For the avoidance of doubt, Transferred Mask Work Rights do not include any mask work rights that are used exclusively in or relate exclusively to Agilent Products.

 

A-6

 

“Transferred Patents” means the Patents identified on Exhibit C hereto which shall include any related Patent applications, continuations, continuations-in-part, divisionals, reissues, renewals, extensions or modifications for any of the foregoing.

 

“Transferred Trade Secrets” means the trade secrets known to the Parties that are owned by Agilent or by an Agilent Affiliate as of the Effective Date and that are primarily used by the Keysight Business, specifically including the Trade Secrets listed in Exhibit D.  For the avoidance of any doubt Transferred Trade Secrets do not include: 1) any trade secrets that are used exclusively in or relate exclusively to Agilent Products or 2) Common Infrastructure Trade Secrets.

 

“Transferred Trademarks” means all trademarks, registered or unregistered, including common law marks, trade names, business name, designs, logos, and trade dress, which prior to the Effective Date were used solely with regard to Keysight Products, specifically including but not limited to those trademarks identified on Exhibit D hereto, EXCEPT for trademarks containing “Agilent,” or “Agilent Technologies” or any transliteration or translation thereof; any version of the “Spark” logo; or the “Agilent Signature”; all of which are and shall remain own by Agilent.

 

A-7

 

EXHIBIT B

 

Composite Intellectual Property Assignment Agreements

 

 

EXHIBIT B1

 

Patent Assignment Agreement

 

This Patent Assignment is effective as of the 1st day of August, 2014 (“Effective Date”), between Agilent Technologies, Inc. a corporation incorporated under the laws of Delaware (“Assignor”), and Keysight Technologies, Inc., a corporation organized under the laws of Delaware (“Assignee”).

 

WHEREAS, pursuant to the Intellectual Property Matters Agreement dated as of August 1, 2014 between Assignor and Assignee (the “IP Matters Agreement”), Assignor agreed to assign or cause to be assigned to Assignee all of Assignor’s right, title and interest in and to certain patent rights.

 

NOW, THEREFORE, for good and valuable consideration, receipt and sufficiency of which are hereby acknowledged, it is hereby agreed by and between the parties as follows:

 

Capitalized terms used in this Patent Assignment Agreement which are not otherwise defined herein shall have the meanings set forth in the IP Matters Agreement.

 

1.                                Assignor hereby grants, conveys and assigns to Assignee, by execution hereof, the Patents listed on Schedule A hereto (the “Assigned Patents”).

 

2.                                Assignor further grants, conveys and assigns to Assignee all its right, title and interest in and to any and all proceeds, causes of action and rights of recovery for past and future infringement or misappropriation of any of the Assigned Patents.

 

3.                                Assignor further grants, conveys and assigns to Assignee all its right, title and interest in and to any and all rights of Assignor to obtain reissues, re-examinations, continuations, continuations-in-part, divisions, extensions or other legal protections arising solely from the Assigned Patents that are or may be secured in any relevant jurisdiction anywhere in the world, including but not limited to the United States, its territories and possessions, now or hereinafter in effect.

 

4.                                The Assigned Patents are conveyed subject to any and all licenses, permissions, consents or other rights that may have been granted by Assignor or its predecessors-in-interest with respect thereto prior to the Effective Date.

 

5.                                This Patent Assignment Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together constitute one and the same original.

 

[SIGNATURE PAGE FOLLOWS]

 

B1-1

 

IN WITNESS WHEREOF, the undersigned has caused this Patent Assignment Agreement to be duly executed and delivered as of the Effective Date.

 

	
 
    	
AGILENT   TECHNOLOGIES, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By:
    	
 
    
	
 
    	
 
    	
 
    	
Michael   Tang
    
	
 
    	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Date:
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
KEYSIGHT   TECHNOLOGIES, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By:
    	
 
    
	
 
    	
 
    	
 
    	
Jeffrey   K. Li
    
	
 
    	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
Date:
    	
 
    
						

 

B1-2

 

SCHEDULE A

Assigned Patents

 

The Assigned Patents, subject to the terms and conditions of this Agreement, are those assocated with the following Agilent patent families:

 

	
190579
    	
10010745
    	
10020825
    	
10030979
    	
10040644
    
	
190596
    	
10010816
    	
10020851
    	
10030985
    	
10040670
    
	
191257
    	
10010835
    	
10020880
    	
10031023
    	
10040678
    
	
191528
    	
10010869
    	
10020917
    	
10031048
    	
10040679
    
	
191610
    	
10010880
    	
10020981
    	
10031075
    	
10040748
    
	
490051
    	
10010980
    	
10021061
    	
10031166
    	
10040886
    
	
10001804
    	
10011095
    	
10021089
    	
10031220
    	
10040907
    
	
10001940
    	
10011122
    	
10021092
    	
10031229
    	
10040927
    
	
10002352
    	
10011125
    	
10021116
    	
10031230
    	
10040959
    
	
10003329
    	
10011162
    	
10021119
    	
10031276
    	
10041015
    
	
10003336
    	
10011201
    	
10021216
    	
10031298
    	
10041025
    
	
10003342
    	
10011219
    	
10021250
    	
10031301
    	
10041043
    
	
10003680
    	
10011269
    	
10021270
    	
10031315
    	
10041052
    
	
10003845
    	
10011298
    	
10030041
    	
10031355
    	
10041057
    
	
10003879
    	
10011300
    	
10030042
    	
10031555
    	
10041086
    
	
10003880
    	
10011302
    	
10030056
    	
10031556
    	
10041127
    
	
10003976
    	
10011338
    	
10030059
    	
10031564
    	
10041143
    
	
10004017
    	
10011355
    	
10030061
    	
10040010
    	
10041158
    
	
10004048
    	
10011387
    	
10030094
    	
10040025
    	
10041159
    
	
10004095
    	
10020043
    	
10030114
    	
10040032
    	
10041239
    
	
10004195
    	
10020076
    	
10030186
    	
10040033
    	
10041240
    
	
10004221
    	
10020111
    	
10030268
    	
10040054
    	
10041242
    
	
10004222
    	
10020154
    	
10030335
    	
10040055
    	
10041244
    
	
10004384
    	
10020205
    	
10030362
    	
10040070
    	
10041248
    
	
10004402
    	
10020206
    	
10030379
    	
10040101
    	
10041249
    
	
10010023
    	
10020245
    	
10030469
    	
10040152
    	
10041253
    
	
10010048
    	
10020278
    	
10030523
    	
10040173
    	
10041307
    
	
10010051
    	
10020340
    	
10030530
    	
10040181
    	
10041313
    
	
10010090
    	
10020389
    	
10030543
    	
10040210
    	
10041314
    
	
10010274
    	
10020417
    	
10030610
    	
10040292
    	
10041315
    
	
10010323
    	
10020454
    	
10030611
    	
10040321
    	
10041316
    
	
10010334
    	
10020524
    	
10030612
    	
10040352
    	
10041325
    
	
10010400
    	
10020532
    	
10030724
    	
10040476
    	
10041328
    
	
10010403
    	
10020610
    	
10030762
    	
10040481
    	
10041329
    
	
10010493
    	
10020611
    	
10030838
    	
10040492
    	
10041333
    
	
10010512
    	
10020668
    	
10030882
    	
10040511
    	
10041348
    
	
10010591
    	
10020681
    	
10030906
    	
10040536
    	
10041371
    
	
10010657
    	
10020693
    	
10030919
    	
10040569
    	
10041382
    
	
10010689
    	
10020725
    	
10030972
    	
10040580
    	
10041390
    
	
10010709
    	
10020819
    	
10030978
    	
10040581
    	
10041470
    

 

B1-3

 

	
10041504
    	
10051506
    	
10060349
    	
10070124
    	
1093738
    
	
10041556
    	
10051635
    	
10060353
    	
10070146
    	
1093804
    
	
10041568
    	
10051689
    	
10060354
    	
10070147
    	
1093811
    
	
10041598
    	
10051691
    	
10060356
    	
10070162
    	
1093854
    
	
10041666
    	
10051694
    	
10060358
    	
10070176
    	
1094280
    
	
10041675
    	
10051738
    	
10060360
    	
10070192
    	
1094336
    
	
10041676
    	
10051739
    	
10060365
    	
10070194
    	
1094401
    
	
10050020
    	
10051740
    	
10060366
    	
10070219
    	
1094470
    
	
10050034
    	
10051743
    	
10060368
    	
10070220
    	
1094576
    
	
10050041
    	
10060031
    	
10060374
    	
10070239
    	
1094643
    
	
10050124
    	
10060044
    	
10060412
    	
10070251
    	
1094669
    
	
10050125
    	
10060051
    	
10060426
    	
10070262
    	
1094725
    
	
10050132
    	
10060059
    	
10060448
    	
10070265
    	
1094750
    
	
10050137
    	
10060075
    	
10060449
    	
10070276
    	
1094752
    
	
10050156
    	
10060101
    	
10060459
    	
10070290
    	
1094769
    
	
10050196
    	
10060122
    	
10060463
    	
10070292
    	
1094855
    
	
10050203
    	
10060135
    	
10060491
    	
10070328
    	
1094862
    
	
10050204
    	
10060138
    	
10060493
    	
10070329
    	
1094892
    
	
10050214
    	
10060146
    	
10060501
    	
10070330
    	
1094956
    
	
10050216
    	
10060157
    	
10060521
    	
10070331
    	
1094957
    
	
10050388
    	
10060158
    	
10060545
    	
10070448
    	
1094958
    
	
10050450
    	
10060160
    	
10060577
    	
10070531
    	
1094961
    
	
10050515
    	
10060174
    	
10060637
    	
10070632
    	
10950612
    
	
10050516
    	
10060175
    	
10060640
    	
10070633
    	
10950679
    
	
10050517
    	
10060185
    	
10060642
    	
10070701
    	
10950745
    
	
10050518
    	
10060186
    	
10060644
    	
10070702
    	
10950804
    
	
10050557
    	
10060190
    	
10060653
    	
10070709
    	
10950818
    
	
10050572
    	
10060191
    	
10060660
    	
10070726
    	
10950855
    
	
10050573
    	
10060202
    	
10060666
    	
10070727
    	
10950881
    
	
10050827
    	
10060205
    	
10060669
    	
10070752
    	
10950983
    
	
10050859
    	
10060298
    	
10060688
    	
10070760
    	
10951149
    
	
10050866
    	
10060301
    	
10060699
    	
10070764
    	
10951180
    
	
10050942
    	
10060302
    	
10060700
    	
10080004
    	
10951224
    
	
10050995
    	
10060303
    	
10060701
    	
1092062
    	
10951228
    
	
10050997
    	
10060304
    	
10060717
    	
1092251
    	
10960204
    
	
10051012
    	
10060305
    	
10060762
    	
1092286
    	
10960205
    
	
10051175
    	
10060311
    	
10060767
    	
1092537
    	
10960463
    
	
10051278
    	
10060322
    	
10070027
    	
1092728
    	
10960472
    
	
10051348
    	
10060324
    	
10070036
    	
1093029
    	
10960572
    
	
10051349
    	
10060332
    	
10070050
    	
1093349
    	
10960581
    
	
10051358
    	
10060341
    	
10070076
    	
1093451
    	
10960700
    
	
10051390
    	
10060342
    	
10070091
    	
1093492
    	
10960967
    
	
10051391
    	
10060343
    	
10070097
    	
1093573
    	
10960975
    
	
10051400
    	
10060344
    	
10070107
    	
1093609
    	
10961057
    
	
10051435
    	
10060346
    	
10070112
    	
1093674
    	
10961060
    
	
10051439
    	
10060347
    	
10070115
    	
1093714
    	
10961061
    

 

B1-4

 

	
10961063
    	
10991077
    	
20080333
    	
20090227
    	
20100245
    
	
10961131
    	
10991088
    	
20080338
    	
20090242
    	
20100263
    
	
10961156
    	
10991315
    	
20080345
    	
20090293
    	
20104183
    
	
10961161
    	
10991384
    	
20080346
    	
20090299
    	
20104184
    
	
10961221
    	
10991497
    	
20080353
    	
20090300
    	
20110004
    
	
10961281
    	
10991652
    	
20080412
    	
20090301
    	
20110008
    
	
10961334
    	
10992455
    	
20080546
    	
20090316
    	
20110011
    
	
10961374
    	
10992580
    	
20080570
    	
20090348
    	
20110012
    
	
10961375
    	
10992632
    	
20080573
    	
20090376
    	
20110053
    
	
10961394
    	
10992787
    	
20080579
    	
20100023
    	
20110056
    
	
10970169
    	
20003003
    	
20080580
    	
20100037
    	
20110063
    
	
10970368
    	
20010438
    	
20080589
    	
20100038
    	
20110074
    
	
10970623
    	
20010440
    	
20080590
    	
20100039
    	
20110084
    
	
10970629
    	
20010490
    	
20080594
    	
20100040
    	
20110094
    
	
10970754
    	
20010575
    	
20080599
    	
20100041
    	
20110095
    
	
10970859
    	
20010577
    	
20080600
    	
20100043
    	
20110119
    
	
10971126
    	
20010625
    	
20080605
    	
20100047
    	
20110140
    
	
10971436
    	
20010698
    	
20081033
    	
20100048
    	
20110147
    
	
10971781
    	
20011286
    	
20081159
    	
20100056
    	
20110158
    
	
10971961
    	
20011450
    	
20081160
    	
20100057
    	
20110178
    
	
10971963
    	
20020366
    	
20081163
    	
20100058
    	
20110180
    
	
10971974
    	
20020480
    	
20081169
    	
20100059
    	
20110189
    
	
10980009
    	
20020534
    	
20081171
    	
20100063
    	
20110192
    
	
10980010
    	
20020565
    	
20081200
    	
20100064
    	
20110193
    
	
10980085
    	
20020728
    	
20081215
    	
20100065
    	
20110199
    
	
10980102
    	
20031035
    	
20081238
    	
20100093
    	
20110200
    
	
10980244
    	
20040623
    	
20081252
    	
20100117
    	
20110214
    
	
10980262
    	
20050068
    	
20081260
    	
20100118
    	
20110221
    
	
10980306
    	
20051342
    	
20081275
    	
20100136
    	
20110228
    
	
10980345
    	
20060292
    	
20081283
    	
20100138
    	
20110255
    
	
10980630
    	
20060707
    	
20081302
    	
20100141
    	
20110258
    
	
10980908
    	
20070059
    	
20081322
    	
20100159
    	
20110281
    
	
10981286
    	
20070751
    	
20081330
    	
20100160
    	
20110299
    
	
10981397
    	
20080011
    	
20081346
    	
20100175
    	
20110304
    
	
10981436
    	
20080012
    	
20081350
    	
20100180
    	
20110308
    
	
10981471
    	
20080123
    	
20090009
    	
20100181
    	
20110319
    
	
10982159
    	
20080139
    	
20090011
    	
20100185
    	
20110337
    
	
10982344
    	
20080142
    	
20090044
    	
20100186
    	
20110339
    
	
10990135
    	
20080144
    	
20090096
    	
20100191
    	
20110351
    
	
10990287
    	
20080181
    	
20090144
    	
20100207
    	
20110361
    
	
10990370
    	
20080222
    	
20090173
    	
20100209
    	
20110362
    
	
10990531
    	
20080253
    	
20090191
    	
20100218
    	
20110363
    
	
10990545
    	
20080255
    	
20090204
    	
20100220
    	
20110370
    
	
10990602
    	
20080294
    	
20090211
    	
20100221
    	
20110371
    
	
10991074
    	
20080297
    	
20090219
    	
20100228
    	
20120018
    
	
10991075
    	
20080312
    	
20090222
    	
20100235
    	
20120024
    

 

B1-5

 

	
20120026
    	
20130019
    	
20140069
    	
30070305
    	
40070043
    
	
20120028
    	
20130025
    	
20140070
    	
3093027
    	
4093018
    
	
20120036
    	
20130037
    	
20140076
    	
3093066
    	
4093022
    
	
20120040
    	
20130048
    	
20140093
    	
30960012
    	
4094001
    
	
20120062
    	
20130054
    	
20140096
    	
30960031
    	
4094005
    
	
20120067
    	
20130055
    	
20140097
    	
30960075
    	
4094008
    
	
20120085
    	
20130056
    	
20140102
    	
30960138
    	
4094009
    
	
20120090
    	
20130069
    	
20140115
    	
30980096
    	
40950005
    
	
20120091
    	
20130070
    	
20140121
    	
31011113
    	
40950006
    
	
20120100
    	
20130071
    	
20140124
    	
31020091
    	
40950011
    
	
20120101
    	
20130073
    	
20140125
    	
31021290
    	
40960001
    
	
20120105
    	
20130075
    	
20140129
    	
31030445
    	
40990004
    
	
20120108
    	
20130084
    	
20140141
    	
31030614
    	
70060212
    
	
20120125
    	
20130085
    	
20140142
    	
31031360
    	
70060246
    
	
20120130
    	
20130086
    	
20140152
    	
31051560
    	
70060269
    
	
20120139
    	
20130087
    	
20140161
    	
31060195
    	
70060677
    
	
20120157
    	
20130119
    	
20140167
    	
31060367
    	
70060838
    
	
20120161
    	
20130131
    	
20140170
    	
31060558
    	
70070065
    
	
20120162
    	
20130134
    	
20140172
    	
31060559
    	
70070067
    
	
20120167
    	
20130139
    	
20140199
    	
31060560
    	
70070221
    
	
20120168
    	
20130153
    	
20140209
    	
31070733
    	
70070692
    
	
20120198
    	
20130159
    	
20140221
    	
32070164
    	
70070693
    
	
20120199
    	
20130161
    	
20140225
    	
32070168
    	
70070761
    
	
20120249
    	
20130168
    	
20140239
    	
32070169
    	
9094004
    
	
20120260
    	
20130171
    	
2094021
    	
40011316
    	
 
    
	
20120262
    	
20130187
    	
2094029
    	
40011444
    	
 
    
	
20120264
    	
20130194
    	
20960013
    	
40030494
    	
 
    
	
20120284
    	
20130210
    	
20970001
    	
40031201
    	
 
    
	
20120290
    	
20130211
    	
20980026
    	
40031253
    	
 
    
	
20120291
    	
20130213
    	
20990037
    	
40040376
    	
 
    
	
20120292
    	
20130235
    	
30003829
    	
40040469
    	
 
    
	
20120303
    	
20130247
    	
30004025
    	
40040487
    	
 
    
	
20120310
    	
20130301
    	
30004036
    	
40040570
    	
 
    
	
20120312
    	
20130315
    	
30004066
    	
40040572
    	
 
    
	
20120317
    	
20130322
    	
30010535
    	
40041090
    	
 
    
	
20120318
    	
20130329
    	
30020258
    	
40050538
    	
 
    
	
20120319
    	
20130359
    	
30020382
    	
40050565
    	
 
    
	
20120331
    	
20130360
    	
30020533
    	
40050918
    	
 
    
	
20120351
    	
20140022
    	
30020913
    	
40051089
    	
 
    
	
20120354
    	
20140033
    	
30021158
    	
40060170
    	
 
    
	
20120356
    	
20140034
    	
30031118
    	
40060196
    	
 
    
	
20120359
    	
20140038
    	
30041688
    	
40060228
    	
 
    
	
20120360
    	
20140045
    	
30050710
    	
40060229
    	
 
    
	
20120393
    	
20140058
    	
30050715
    	
40060252
    	
 
    
	
20120398
    	
20140059
    	
30050988
    	
40060339
    	
 
    
	
20120402
    	
20140068
    	
30051152
    	
40060535
    	
 
    

 

B1-6

 

EXHIBIT B2

 

Trademark Assignment Agreement

 

This Agreement is made between Agilent Technologies, Inc., a Delaware corporation whose address is 5301 Stevens Creek Blvd, Santa Clara, CA 95051 (“Assignor”), and Keysight Technologies, Inc., a Delaware corporation whose address is 1400 Fountaingrove Pkwy, Santa Rosa, CA 95403 (“Assignee”).  These parties are also parties to an Intellectual Property Matters Agreement (“IPMA”).

 

The Trademarks are: (a) the trademarks listed in Exhibit A to this Assignment, including those that are registered and those that are pending registration, and (b) certain common law marks, trade names, business names, designs, logos, and trade dress that are used exclusively by Keysight or relate exclusively to the Keysight Primary Field as defined in the IPMA.

 

For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Assignor hereby assigns, transfers, and conveys to Assignee, on a worldwide basis, all of its right, title and interest in and to the Trademarks together with the associated goodwill in the Trademarks and in the business, products, and services symbolized by the Trademarks, including any and all rights, priorities, and privileges of Assignor under the laws of the United States and any of its states, the laws of any other jurisdiction, multinational law, and any compact, treaty, protocol, convention, or organization, subject to such currently outstanding license or use rights to the Trademarks as currently exist, if any.

 

Assignor also assigns to Assignee (a) all of its right, title, and interest in and to all proceeds or damages past, present, or future, (b) the right to bring suit and recover damages for past claims or causes of action arising from or relating to the Trademarks, including infringement, and misappropriation, and (c) all applications and registrations for the Trademarks that Assignor holds or controls, including the right to file trademark additional applications and to all resulting registrations.

 

Assignor will sign such additional documents as may be necessary to perfect or record the assignment and to carry out the intent of the parties as reflected in this Assignment.

 

This assignment is effective as of August 1, 2014.

 

[SIGNATURE PAGE FOLLOWS]

 

B2-1

 

IN WITNESS WHEREOF, the undersigned has caused this Trademark Assignment Agreement to be duly executed and delivered as of the Effective Date.

 

 

	
 
    	
AGILENT   TECHNOLOGIES, INC. (Assignor)
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Michael   Tang
    
	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Date:
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
KEYSIGHT   TECHNOLOGIES, INC. (Assignee)
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Jeffrey   K. Li
    
	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
Date:
    	
 
    

 

B2-2

 

Exhibit A

 

Keysight / EMG registered marks

 

	
ACQIRIS
    	
NANOSUITE
    
	
ANTICIPATE       ACCELERATE     ACHIEVE
    	
PARBERT
    
	
ASSUREME
    	
PICOCAFÉ
    
	
BASEBAND   STUDIO
    	
PXA
    
	
BENCHLINK
    	
PXB
    
	
BENCHVUE
    	
PXT
    
	
BITE   QUALIFICATION TESTER (and Design)
    	
REAL   EDGE
    
	
CERTIPRIME
    	
REALEDGE
    
	
CODEONE
    	
RIDER   Radiofrequency IDentification testER (and Design)
    
	
COMMAND   EXPERT
    	
SEQUENCE   STUDIO
    
	
CXA
    	
SIGNAL   INTEGRITY STUDIO
    
	
EASYEXPERT
    	
SIGNAL   STUDIO
    
	
EESOF
    	
SMART   TEST
    
	
ENA
    	
SPECTRAL   ENGINE
    
	
EPM
    	
SYSTEMVUE
    
	
ESA
    	
TESTEXEC
    
	
ESG
    	
TESTJET
    
	
E-TRAK
    	
TESTMOBILE
    
	
EXA
    	
TESTTRACS
    
	
EXG
    	
TRUEFORM
    
	
EXT
    	
TRUEIR
    
	
FASTUNE
    	
TRUEVOLT
    
	
FAULT   DETECTIVE
    	
VEE   PRO
    
	
FIELDFOX
    	
VEE   PRO (and Design)
    
	
FIGURE   EIGHT
    	
VEE   PRO (Stylized and w/Design)
    
	
FIGURE8
    	
VERSAPOWER
    
	
FRAMESCOPE
    	
VXA
    
	
INFINIIMAX
    	
WIRESCOPE
    
	
INFINIISCAN
    	
X-PARAMETERS
    
	
INFINIIUM
    	
 
    
	
INFINIIVIEW
    	
 
    
	
INFINIIVISION
    	
 
    
	
INFINISCAN
    	
 
    
	
INTUILINK
    	
 
    
	
J-BERT
    	
 
    
	
LIBRA
    	
 
    
	
MAC   MODE
    	
 
    
	
MEDALIST
    	
 
    
	
MEGAZOOM
    	
 
    
	
MEGAZOOM   (and Design)
    	
 
    
	
miNT   Mobile Communications INtegrated Tester (and Design)
    	
 
    
	
MXA
    	
 
    
	
MXE
    	
 
    
	
MXG
    	
 
    
	
NANO   INDENTER
    	
 
    

 

B2-3

 

EXHIBIT B3

 

Copyright and Mask Work Assignment Agreement

 

This Agreement is made between Agilent Technologies, Inc., a Delaware corporation whose address is 5301 Stevens Creek Blvd, Santa Clara, CA 95051 (“Assignor”), and Keysight Technologies, Inc., a Delaware corporation whose address is 1400 Fountaingrove Pkwy, Santa Rosa, CA 95403 (“Assignee”).  These parties are also parties to an Intellectual Property Matters Agreement (“IPMA”).

 

The Works are the registered works listed in Exhibit A attached, together with the unregistered works that are used primarily by Keysight or relate primarily to the Keysight Primary Field as defined in the IPMA, and excluding both the Common Heritage Copyrights and the Common Infrastructure Copyrights, as defined in the IPMA.

 

For valuable consideration, receipt and sufficiency of which are hereby acknowledged, Assignor does hereby sell, assign, and transfer to Assignee, its successors and assigns, the entire right, title and interest in and to: the copyrights in the Works in all versions, forms, and formats (including source code and object code formats) and in all languages, together with all prior versions and all derivations, modifications, changes, translations, revisions, elaborations, adaptations or transformations of any of these; all works incorporating any of these whether in whole or in part; all copyright registrations and copyright registration applications relating to any of these and any renewals and extensions thereof; and in and to all income, royalties, damages, claims and payments now or hereafter due or payable with respect thereto, as well as in and to all causes of action, either in law or in equity for past, present, or future infringement based on the copyrights; and in and to all rights corresponding to the foregoing throughout the world.

 

The parties understand and intend that this COPYRIGHT AND MASK WORK ASSIGNMENT is to be recorded in the United States Copyright Office of the Library of Congress and elsewhere as appropriate.

 

In witness whereof, the parties have executed this Assignment of Copyrights, effective as of the 1st day of August, 2014.

 

[SIGNATURE PAGE FOLLOWS]

 

B3-1

 

IN WITNESS WHEREOF, the undersigned has caused this Copyright and Mask Work Assignment Agreement to be duly executed and delivered as of the Effective Date.

 

 

	
 
    	
AGILENT   TECHNOLOGIES, INC. (Assignor)
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Michael   Tang
    
	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Date:
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
KEYSIGHT   TECHNOLOGIES, INC. (Assignee)
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Jeffrey   K. Li
    
	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Date:
    	
 
    

 

B3-2

 

Exhibit A

 

Copyrights registered with US Copyright Office plus those registered in China are those associated with the following Agilent file numbers:

 

	
05.11.001
    	
12.08.009
    	
12.11.017
    
	
05.11.002
    	
12.08.010
    	
12.11.018
    
	
06.08.001
    	
12.08.011
    	
12.11.019
    
	
06.08.002
    	
12.08.012
    	
12.11.020
    
	
06.08.003
    	
12.08.013
    	
12.11.021
    
	
07.11.001
    	
12.08.014
    	
12.11.022
    
	
08.04.001
    	
12.08.015
    	
12.11.023
    
	
08.04.002
    	
12.08.016
    	
12.11.024
    
	
08.04.003
    	
12.09.001
    	
13.04.001
    
	
08.04.004
    	
12.09.002
    	
13.07.001
    
	
08.04.005
    	
12.09.003
    	
13.07.002
    
	
08.04.006
    	
12.09.004
    	
13.07.003
    
	
08.09.001
    	
12.09.005
    	
13.07.004
    
	
08.11.001
    	
12.09.006
    	
13.07.005
    
	
09.01.001
    	
12.09.007
    	
13.10.006
    
	
09.01.002
    	
12.09.008
    	
13.10.007
    
	
09.02.003
    	
12.09.009
    	
13.10.008
    
	
09.06.001
    	
12.10.001
    	
13.11.001
    
	
09.07.001
    	
12.10.002
    	
14.01.001
    
	
10.03.001
    	
12.10.003
    	
14.02.001
    
	
10.07.001
    	
12.10.004
    	
14.03.001
    
	
10.07.002
    	
12.10.005
    	
14.04.001
    
	
10.11.001
    	
12.10.006
    	
14.05.001
    
	
12.03.001
    	
12.10.007
    	
14.05.002
    
	
12.03.002
    	
12.10.008
    	
14.06.001
    
	
12.03.003
    	
12.11.001
    	
14.06.002
    
	
12.03.004
    	
12.11.002
    	
14.06.003
    
	
12.04.001
    	
12.11.003
    	
14.06.004
    
	
12.04.002
    	
12.11.004
    	
 
    
	
12.04.003
    	
12.11.005
    	
 
    
	
12.04.004
    	
12.11.006
    	
 
    
	
12.04.005
    	
12.11.007
    	
 
    
	
12.05.001
    	
12.11.008
    	
 
    
	
12.08.001
    	
12.11.009
    	
 
    
	
12.08.002
    	
12.11.010
    	
 
    
	
12.08.003
    	
12.11.011
    	
 
    
	
12.08.004
    	
12.11.012
    	
 
    
	
12.08.005
    	
12.11.013
    	
 
    
	
12.08.006
    	
12.11.014
    	
 
    
	
12.08.007
    	
12.11.015
    	
 
    
	
12.08.008
    	
12.11.016
    	
 
    

 

B3-3

 

EXHIBIT B4

 

Trade Secret Assignment Agreement

 

This Trade Secret Assignment is effective as of the 1st day of August, 2014 (“Effective Date”), between Agilent Technologies, Inc. a corporation incorporated under the laws of Delaware (“Assignor”), and Keysight Technologies, Inc., a corporation organized under the laws of Delaware (“Assignee”).

 

WHEREAS, pursuant to the Intellectual Property Matters Agreement dated as of August 1, 2014 between Assignor and Assignee (the “IP Matters Agreement”), Assignor agreed to assign or cause to be assigned to Assignee all of Assignor’s right, title and interest in and to certain trade secrets.

 

NOW, THEREFORE, for good and valuable consideration, receipt and sufficiency of which are hereby acknowledged, it is hereby agreed by and between the parties as follows:

 

Capitalized terms used in this Trade Secret Assignment Agreement which are not otherwise defined herein shall have the meanings set forth in the IP Matters Agreement.

 

1.                                Assignor hereby grants, conveys and assigns to Assignee, by execution hereof, the Transferred Trade Secrets including the Trade Secrets listed on Schedule A hereto (the “Assigned Trade Secrets”).

 

2.                                Assignor further grants, conveys and assigns to Assignee all its right, title and interest in and to any and all proceeds, causes of action and rights of recovery for past and future infringement or misappropriation of any of the Assigned Trade Secrets.

 

3.                                Assignor further grants, conveys and assigns to Assignee all its right, title and interest in and to any and all rights of Assignor to obtain reissues, re-examinations, continuations, continuations-in-part, divisions, extensions or other legal protections arising solely from the Assigned Trade Secrets that are or may be secured in any relevant jurisdiction anywhere in the world, including but not limited to the United States, its territories and possessions, now or hereinafter in effect.

 

4.                                The Assigned Trade Secrets are conveyed subject to any and all licenses, permissions, consents or other rights that may have been granted by Assignor or its predecessors-in-interest with respect thereto prior to the Effective Date.

 

5.                                This Trade Secret Assignment Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together constitute one and the same original.

 

[SIGNATURE PAGE FOLLOWS]

 

B4-1

 

IN WITNESS WHEREOF, the undersigned has caused this Trade Secret Assignment Agreement to be duly executed and delivered as of the Effective Date.

 

 

	
 
    	
AGILENT   TECHNOLOGIES, INC. (Assignor)
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Michael   Tang
    
	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Date:
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
KEYSIGHT   TECHNOLOGIES, INC. (Assignee)
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Jeffrey   K. Li
    
	
 
    	
 
    	
Vice   President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
Date:
    	
 
    

 

B4-2

 

Schedule A

 

Trade Secrets associated with the following Agilent file numbers:

 

	
189528
    	
10060726
    	
20140238
    
	
190136
    	
10060781
    	
20140250
    
	
190495
    	
10070270
    	
20140251
    
	
190525
    	
10070707
    	
20140254
    
	
190526
    	
10070723
    	
20140257
    
	
191083
    	
10070766
    	
20140258
    
	
191477
    	
10961072
    	
50060234
    
	
191626
    	
10961226
    	
70980010
    
	
1092221
    	
10961294
    	
 
    
	
1092222
    	
10961305
    	
 
    
	
1092430
    	
10970954
    	
 
    
	
1092516
    	
10980140
    	
 
    
	
1092520
    	
10980141
    	
 
    
	
1093456
    	
10980153
    	
 
    
	
1094090
    	
10981314
    	
 
    
	
1094095
    	
10981662
    	
 
    
	
1094096
    	
10990066
    	
 
    
	
1094281
    	
10990167
    	
 
    
	
10002451
    	
10990621
    	
 
    
	
10003740
    	
10990637
    	
 
    
	
10004076
    	
10992593
    	
 
    
	
10011485
    	
10992735
    	
 
    
	
10020129
    	
10992819
    	
 
    
	
10020287
    	
20080518
    	
 
    
	
10020418
    	
20081183
    	
 
    
	
10020598
    	
20081184
    	
 
    
	
10020901
    	
20081285
    	
 
    
	
10020918
    	
20081328
    	
 
    
	
10030125
    	
20090102
    	
 
    
	
10040586
    	
20090289
    	
 
    
	
10040762
    	
20110198
    	
 
    
	
10040763
    	
20120159
    	
 
    
	
10040764
    	
20130089
    	
 
    
	
10051113
    	
20130229
    	
 
    
	
10060049
    	
20130272
    	
 
    
	
10060129
    	
20130361
    	
 
    
	
10060130
    	
20140019
    	
 
    
	
10060259
    	
20140089
    	
 
    
	
10060429
    	
20140212
    	
 
    
	
10060634
    	
20140221
    	
 
    
	
10060635
    	
20140230
    	
 
    
	
10060685
    	
20140237
    	
 
    

 

B4-3

 

EXHIBIT C

 

Schedule of Transferred Patents

 

The Transferred Patents, subject to the terms and conditions of this Agreement, are those associated with the following Agilent patent families:

 

	
190579
    	
10010745
    	
10020825
    	
10030979
    	
10040644
    
	
190596
    	
10010816
    	
10020851
    	
10030985
    	
10040670
    
	
191257
    	
10010835
    	
10020880
    	
10031023
    	
10040678
    
	
191528
    	
10010869
    	
10020917
    	
10031048
    	
10040679
    
	
191610
    	
10010880
    	
10020981
    	
10031075
    	
10040748
    
	
490051
    	
10010980
    	
10021061
    	
10031166
    	
10040886
    
	
10001804
    	
10011095
    	
10021089
    	
10031220
    	
10040907
    
	
10001940
    	
10011122
    	
10021092
    	
10031229
    	
10040927
    
	
10002352
    	
10011125
    	
10021116
    	
10031230
    	
10040959
    
	
10003329
    	
10011162
    	
10021119
    	
10031276
    	
10041015
    
	
10003336
    	
10011201
    	
10021216
    	
10031298
    	
10041025
    
	
10003342
    	
10011219
    	
10021250
    	
10031301
    	
10041043
    
	
10003680
    	
10011269
    	
10021270
    	
10031315
    	
10041052
    
	
10003845
    	
10011298
    	
10030041
    	
10031355
    	
10041057
    
	
10003879
    	
10011300
    	
10030042
    	
10031555
    	
10041086
    
	
10003880
    	
10011302
    	
10030056
    	
10031556
    	
10041127
    
	
10003976
    	
10011338
    	
10030059
    	
10031564
    	
10041143
    
	
10004017
    	
10011355
    	
10030061
    	
10040010
    	
10041158
    
	
10004048
    	
10011387
    	
10030094
    	
10040025
    	
10041159
    
	
10004095
    	
10020043
    	
10030114
    	
10040032
    	
10041239
    
	
10004195
    	
10020076
    	
10030186
    	
10040033
    	
10041240
    
	
10004221
    	
10020111
    	
10030268
    	
10040054
    	
10041242
    
	
10004222
    	
10020154
    	
10030335
    	
10040055
    	
10041244
    
	
10004384
    	
10020205
    	
10030362
    	
10040070
    	
10041248
    
	
10004402
    	
10020206
    	
10030379
    	
10040101
    	
10041249
    
	
10010023
    	
10020245
    	
10030469
    	
10040152
    	
10041253
    
	
10010048
    	
10020278
    	
10030523
    	
10040173
    	
10041307
    
	
10010051
    	
10020340
    	
10030530
    	
10040181
    	
10041313
    
	
10010090
    	
10020389
    	
10030543
    	
10040210
    	
10041314
    
	
10010274
    	
10020417
    	
10030610
    	
10040292
    	
10041315
    
	
10010323
    	
10020454
    	
10030611
    	
10040321
    	
10041316
    
	
10010334
    	
10020524
    	
10030612
    	
10040352
    	
10041325
    
	
10010400
    	
10020532
    	
10030724
    	
10040476
    	
10041328
    
	
10010403
    	
10020610
    	
10030762
    	
10040481
    	
10041329
    
	
10010493
    	
10020611
    	
10030838
    	
10040492
    	
10041333
    
	
10010512
    	
10020668
    	
10030882
    	
10040511
    	
10041348
    
	
10010591
    	
10020681
    	
10030906
    	
10040536
    	
10041371
    
	
10010657
    	
10020693
    	
10030919
    	
10040569
    	
10041382
    
	
10010689
    	
10020725
    	
10030972
    	
10040580
    	
10041390
    
	
10010709
    	
10020819
    	
10030978
    	
10040581
    	
10041470
    

 

C-1

 

	
10041504
    	
10051506
    	
10060349
    	
10070124
    	
1093738
    
	
10041556
    	
10051635
    	
10060353
    	
10070146
    	
1093804
    
	
10041568
    	
10051689
    	
10060354
    	
10070147
    	
1093811
    
	
10041598
    	
10051691
    	
10060356
    	
10070162
    	
1093854
    
	
10041666
    	
10051694
    	
10060358
    	
10070176
    	
1094280
    
	
10041675
    	
10051738
    	
10060360
    	
10070192
    	
1094336
    
	
10041676
    	
10051739
    	
10060365
    	
10070194
    	
1094401
    
	
10050020
    	
10051740
    	
10060366
    	
10070219
    	
1094470
    
	
10050034
    	
10051743
    	
10060368
    	
10070220
    	
1094576
    
	
10050041
    	
10060031
    	
10060374
    	
10070239
    	
1094643
    
	
10050124
    	
10060044
    	
10060412
    	
10070251
    	
1094669
    
	
10050125
    	
10060051
    	
10060426
    	
10070262
    	
1094725
    
	
10050132
    	
10060059
    	
10060448
    	
10070265
    	
1094750
    
	
10050137
    	
10060075
    	
10060449
    	
10070276
    	
1094752
    
	
10050156
    	
10060101
    	
10060459
    	
10070290
    	
1094769
    
	
10050196
    	
10060122
    	
10060463
    	
10070292
    	
1094855
    
	
10050203
    	
10060135
    	
10060491
    	
10070328
    	
1094862
    
	
10050204
    	
10060138
    	
10060493
    	
10070329
    	
1094892
    
	
10050214
    	
10060146
    	
10060501
    	
10070330
    	
1094956
    
	
10050216
    	
10060157
    	
10060521
    	
10070331
    	
1094957
    
	
10050388
    	
10060158
    	
10060545
    	
10070448
    	
1094958
    
	
10050450
    	
10060160
    	
10060577
    	
10070531
    	
1094961
    
	
10050515
    	
10060174
    	
10060637
    	
10070632
    	
10950612
    
	
10050516
    	
10060175
    	
10060640
    	
10070633
    	
10950679
    
	
10050517
    	
10060185
    	
10060642
    	
10070701
    	
10950745
    
	
10050518
    	
10060186
    	
10060644
    	
10070702
    	
10950804
    
	
10050557
    	
10060190
    	
10060653
    	
10070709
    	
10950818
    
	
10050572
    	
10060191
    	
10060660
    	
10070726
    	
10950855
    
	
10050573
    	
10060202
    	
10060666
    	
10070727
    	
10950881
    
	
10050827
    	
10060205
    	
10060669
    	
10070752
    	
10950983
    
	
10050859
    	
10060298
    	
10060688
    	
10070760
    	
10951149
    
	
10050866
    	
10060301
    	
10060699
    	
10070764
    	
10951180
    
	
10050942
    	
10060302
    	
10060700
    	
10080004
    	
10951224
    
	
10050995
    	
10060303
    	
10060701
    	
1092062
    	
10951228
    
	
10050997
    	
10060304
    	
10060717
    	
1092251
    	
10960204
    
	
10051012
    	
10060305
    	
10060762
    	
1092286
    	
10960205
    
	
10051175
    	
10060311
    	
10060767
    	
1092537
    	
10960463
    
	
10051278
    	
10060322
    	
10070027
    	
1092728
    	
10960472
    
	
10051348
    	
10060324
    	
10070036
    	
1093029
    	
10960572
    
	
10051349
    	
10060332
    	
10070050
    	
1093349
    	
10960581
    
	
10051358
    	
10060341
    	
10070076
    	
1093451
    	
10960700
    
	
10051390
    	
10060342
    	
10070091
    	
1093492
    	
10960967
    
	
10051391
    	
10060343
    	
10070097
    	
1093573
    	
10960975
    
	
10051400
    	
10060344
    	
10070107
    	
1093609
    	
10961057
    
	
10051435
    	
10060346
    	
10070112
    	
1093674
    	
10961060
    
	
10051439
    	
10060347
    	
10070115
    	
1093714
    	
10961061
    

 

C-2

 

	
10961063
    	
10991077
    	
20080333
    	
20090227
    	
20100245
    
	
10961131
    	
10991088
    	
20080338
    	
20090242
    	
20100263
    
	
10961156
    	
10991315
    	
20080345
    	
20090293
    	
20104183
    
	
10961161
    	
10991384
    	
20080346
    	
20090299
    	
20104184
    
	
10961221
    	
10991497
    	
20080353
    	
20090300
    	
20110004
    
	
10961281
    	
10991652
    	
20080412
    	
20090301
    	
20110008
    
	
10961334
    	
10992455
    	
20080546
    	
20090316
    	
20110011
    
	
10961374
    	
10992580
    	
20080570
    	
20090348
    	
20110012
    
	
10961375
    	
10992632
    	
20080573
    	
20090376
    	
20110053
    
	
10961394
    	
10992787
    	
20080579
    	
20100023
    	
20110056
    
	
10970169
    	
20003003
    	
20080580
    	
20100037
    	
20110063
    
	
10970368
    	
20010438
    	
20080589
    	
20100038
    	
20110074
    
	
10970623
    	
20010440
    	
20080590
    	
20100039
    	
20110084
    
	
10970629
    	
20010490
    	
20080594
    	
20100040
    	
20110094
    
	
10970754
    	
20010575
    	
20080599
    	
20100041
    	
20110095
    
	
10970859
    	
20010577
    	
20080600
    	
20100043
    	
20110119
    
	
10971126
    	
20010625
    	
20080605
    	
20100047
    	
20110140
    
	
10971436
    	
20010698
    	
20081033
    	
20100048
    	
20110147
    
	
10971781
    	
20011286
    	
20081159
    	
20100056
    	
20110158
    
	
10971961
    	
20011450
    	
20081160
    	
20100057
    	
20110178
    
	
10971963
    	
20020366
    	
20081163
    	
20100058
    	
20110180
    
	
10971974
    	
20020480
    	
20081169
    	
20100059
    	
20110189
    
	
10980009
    	
20020534
    	
20081171
    	
20100063
    	
20110192
    
	
10980010
    	
20020565
    	
20081200
    	
20100064
    	
20110193
    
	
10980085
    	
20020728
    	
20081215
    	
20100065
    	
20110199
    
	
10980102
    	
20031035
    	
20081238
    	
20100093
    	
20110200
    
	
10980244
    	
20040623
    	
20081252
    	
20100117
    	
20110214
    
	
10980262
    	
20050068
    	
20081260
    	
20100118
    	
20110221
    
	
10980306
    	
20051342
    	
20081275
    	
20100136
    	
20110228
    
	
10980345
    	
20060292
    	
20081283
    	
20100138
    	
20110255
    
	
10980630
    	
20060707
    	
20081302
    	
20100141
    	
20110258
    
	
10980908
    	
20070059
    	
20081322
    	
20100159
    	
20110281
    
	
10981286
    	
20070751
    	
20081330
    	
20100160
    	
20110299
    
	
10981397
    	
20080011
    	
20081346
    	
20100175
    	
20110304
    
	
10981436
    	
20080012
    	
20081350
    	
20100180
    	
20110308
    
	
10981471
    	
20080123
    	
20090009
    	
20100181
    	
20110319
    
	
10982159
    	
20080139
    	
20090011
    	
20100185
    	
20110337
    
	
10982344
    	
20080142
    	
20090044
    	
20100186
    	
20110339
    
	
10990135
    	
20080144
    	
20090096
    	
20100191
    	
20110351
    
	
10990287
    	
20080181
    	
20090144
    	
20100207
    	
20110361
    
	
10990370
    	
20080222
    	
20090173
    	
20100209
    	
20110362
    
	
10990531
    	
20080253
    	
20090191
    	
20100218
    	
20110363
    
	
10990545
    	
20080255
    	
20090204
    	
20100220
    	
20110370
    
	
10990602
    	
20080294
    	
20090211
    	
20100221
    	
20110371
    
	
10991074
    	
20080297
    	
20090219
    	
20100228
    	
20120018
    
	
10991075
    	
20080312
    	
20090222
    	
20100235
    	
20120024
    

 

C-3

 

	
20120026
    	
20120360
    	
20140022
    	
30010535
    	
40040469
    
	
20120028
    	
20120393
    	
20140033
    	
30020258
    	
40040487
    
	
20120036
    	
20120398
    	
20140034
    	
30020382
    	
40040570
    
	
20120040
    	
20120402
    	
20140038
    	
30020533
    	
40040572
    
	
20120062
    	
20130019
    	
20140045
    	
30020913
    	
40041090
    
	
20120067
    	
20130025
    	
20140058
    	
30021158
    	
40050538
    
	
20120085
    	
20130037
    	
20140059
    	
30031118
    	
40050565
    
	
20120090
    	
20130048
    	
20140068
    	
30041688
    	
40050918
    
	
20120091
    	
20130054
    	
20140069
    	
30050710
    	
40051089
    
	
20120100
    	
20130055
    	
20140070
    	
30050715
    	
40060170
    
	
20120101
    	
20130056
    	
20140076
    	
30050988
    	
40060196
    
	
20120105
    	
20130069
    	
20140093
    	
30051152
    	
40060228
    
	
20120108
    	
20130070
    	
20140096
    	
30070305
    	
40060229
    
	
20120125
    	
20130071
    	
20140097
    	
3093027
    	
40060252
    
	
20120130
    	
20130073
    	
20140102
    	
3093066
    	
40060339
    
	
20120139
    	
20130075
    	
20140115
    	
30960012
    	
40060535
    
	
20120157
    	
20130084
    	
20140121
    	
30960031
    	
40070043
    
	
20120161
    	
20130085
    	
20140124
    	
30960075
    	
4093018
    
	
20120162
    	
20130086
    	
20140125
    	
30960138
    	
4093022
    
	
20120167
    	
20130087
    	
20140129
    	
30980096
    	
4094001
    
	
20120168
    	
20130119
    	
20140141
    	
31011113
    	
4094005
    
	
20120198
    	
20130131
    	
20140142
    	
31020091
    	
4094008
    
	
20120199
    	
20130134
    	
20140152
    	
31021290
    	
4094009
    
	
20120249
    	
20130139
    	
20140161
    	
31030445
    	
40950005
    
	
20120260
    	
20130153
    	
20140167
    	
31030614
    	
40950006
    
	
20120262
    	
20130159
    	
20140170
    	
31031360
    	
40950011
    
	
20120264
    	
20130161
    	
20140172
    	
31051560
    	
40960001
    
	
20120284
    	
20130168
    	
20140199
    	
31060195
    	
40990004
    
	
20120290
    	
20130171
    	
20140209
    	
31060367
    	
70060212
    
	
20120291
    	
20130187
    	
20140221
    	
31060558
    	
70060246
    
	
20120292
    	
20130194
    	
20140225
    	
31060559
    	
70060269
    
	
20120303
    	
20130210
    	
20140239
    	
31060560
    	
70060677
    
	
20120310
    	
20130211
    	
2094021
    	
31070733
    	
70060838
    
	
20120312
    	
20130213
    	
2094029
    	
32070164
    	
70070065
    
	
20120317
    	
20130235
    	
20960013
    	
32070168
    	
70070067
    
	
20120318
    	
20130247
    	
20970001
    	
32070169
    	
70070221
    
	
20120319
    	
20130301
    	
20980026
    	
40011316
    	
70070692
    
	
20120331
    	
20130315
    	
20990037
    	
40011444
    	
70070693
    
	
20120351
    	
20130322
    	
30003829
    	
40030494
    	
70070761
    
	
20120354
    	
20130329
    	
30004025
    	
40031201
    	
9094004
    
	
20120356
    	
20130359
    	
30004036
    	
40031253
    	
 
    
	
20120359
    	
20130360
    	
30004066
    	
40040376
    	
 
    

 

C-4

 

EXHIBIT D

 

Schedule of Transferred Intellectual Property Rights

 

The Transferred Intellectual Property Rights, subject to the terms and conditions of this Agreement, include:

 

1.             Copyrights:  The copyrights associated with the following Agilent file numbers:

 

	
05.11.001
    	
10.11.001
    	
12.08.012
    	
12.11.001
    	
12.11.023
    
	
05.11.002
    	
12.03.001
    	
12.08.013
    	
12.11.002
    	
12.11.024
    
	
06.08.001
    	
12.03.002
    	
12.08.014
    	
12.11.003
    	
13.04.001
    
	
06.08.002
    	
12.03.003
    	
12.08.015
    	
12.11.004
    	
13.07.001
    
	
06.08.003
    	
12.03.004
    	
12.08.016
    	
12.11.005
    	
13.07.002
    
	
07.11.001
    	
12.04.001
    	
12.09.001
    	
12.11.006
    	
13.07.003
    
	
08.04.001
    	
12.04.002
    	
12.09.002
    	
12.11.007
    	
13.07.004
    
	
08.04.002
    	
12.04.003
    	
12.09.003
    	
12.11.008
    	
13.07.005
    
	
08.04.003
    	
12.04.004
    	
12.09.004
    	
12.11.009
    	
13.10.006
    
	
08.04.004
    	
12.04.005
    	
12.09.005
    	
12.11.010
    	
13.10.007
    
	
08.04.005
    	
12.05.001
    	
12.09.006
    	
12.11.011
    	
13.10.008
    
	
08.04.006
    	
12.08.001
    	
12.09.007
    	
12.11.012
    	
13.11.001
    
	
08.09.001
    	
12.08.002
    	
12.09.008
    	
12.11.013
    	
14.01.001
    
	
08.11.001
    	
12.08.003
    	
12.09.009
    	
12.11.014
    	
14.02.001
    
	
09.01.001
    	
12.08.004
    	
12.10.001
    	
12.11.015
    	
14.03.001
    
	
09.01.002
    	
12.08.005
    	
12.10.002
    	
12.11.016
    	
14.04.001
    
	
09.02.003
    	
12.08.006
    	
12.10.003
    	
12.11.017
    	
14.05.001
    
	
09.06.001
    	
12.08.007
    	
12.10.004
    	
12.11.018
    	
14.05.002
    
	
09.07.001
    	
12.08.008
    	
12.10.005
    	
12.11.019
    	
14.06.001
    
	
10.03.001
    	
12.08.009
    	
12.10.006
    	
12.11.020
    	
14.06.002
    
	
10.07.001
    	
12.08.010
    	
12.10.007
    	
12.11.021
    	
14.06.003
    
	
10.07.002
    	
12.08.011
    	
12.10.008
    	
12.11.022
    	
14.06.004
    

 

2.             Mask Work Rights:

 

[Intentionally Left Blank]

 

3.             Database Rights:

 

ASIC Database, Keysight Team Foundation Database, Enovia Database

 

D-1

 

4.             Trade Secrets:

 

Trade Secrets associated with the following Agilent file numbers:

 

	
189528
    	
10003740
    	
10060429
    	
10981662
    	
20130272
    
	
190136
    	
10004076
    	
10060634
    	
10990066
    	
20130361
    
	
190495
    	
10011485
    	
10060635
    	
10990167
    	
20140019
    
	
190525
    	
10020129
    	
10060685
    	
10990621
    	
20140089
    
	
190526
    	
10020287
    	
10060726
    	
10990637
    	
20140212
    
	
191083
    	
10020418
    	
10060781
    	
10992593
    	
20140221
    
	
191477
    	
10020598
    	
10070270
    	
10992735
    	
20140230
    
	
191626
    	
10020901
    	
10070707
    	
10992819
    	
20140237
    
	
1092221
    	
10020918
    	
10070723
    	
20080518
    	
20140238
    
	
1092222
    	
10030125
    	
10070766
    	
20081183
    	
20140250
    
	
1092430
    	
10040586
    	
10961072
    	
20081184
    	
20140251
    
	
1092516
    	
10040762
    	
10961226
    	
20081285
    	
20140254
    
	
1092520
    	
10040763
    	
10961294
    	
20081328
    	
20140257
    
	
1093456
    	
10040764
    	
10961305
    	
20090102
    	
20140258
    
	
1094090
    	
10051113
    	
10970954
    	
20090289
    	
50060234
    
	
1094095
    	
10060049
    	
10980140
    	
20110198
    	
70980010
    
	
1094096
    	
10060129
    	
10980141
    	
20120159
    	
 
    
	
1094281
    	
10060130
    	
10980153
    	
20130089
    	
 
    
	
10002451
    	
10060259
    	
10981314
    	
20130229
    	
 
    

 

5.             Industrial Designs.

 

[Intentionally Left Blank]

 

6.  Trademarks:

 

	
ACQIRIS
    	
EASYEXPERT
    
	
ANTICIPATE   ACCELERATE ACHEIVE
    	
EESOF
    
	
ASSUREME
    	
ENA
    
	
BASEBAND   STUDIO
    	
EPM
    
	
BENCHLINK
    	
ESA
    
	
BENCHVUE
    	
ESG
    
	
BITE   QUALIFICATION TESTER (and Design)
    	
E-TRAK
    
	
CERTIPRIME
    	
EXA
    
	
CODEONE
    	
EXG
    
	
COMMAND   EXPERT
    	
EXT
    
	
CXA
    	
FASTUNE
    
	
 
    	
FAULT   DETECTIVE
    
	
 
    	
FIELDFOX
    

 

D-2

 

	
FIGURE   EIGHT
    	
PXB
    
	
FIGURE8
    	
PXT
    
	
FRAMESCOPE
    	
REAL   EDGE
    
	
INFINIIMAX
    	
REALEDGE
    
	
INFINIISCAN
    	
RIDER   Radiofrequency IDentification testER (and Design)
    
	
INFINIIUM
    	
SEQUENCE   STUDIO
    
	
INFINIIVIEW
    	
SIGNAL   INTEGRITY STUDIO
    
	
INFINIIVISION
    	
SIGNAL   STUDIO
    
	
INFINISCAN
    	
SMART   TEST
    
	
INTUILINK
    	
SPECTRAL   ENGINE
    
	
J-BERT
    	
SYSTEMVUE
    
	
LIBRA
    	
TESTEXEC
    
	
MAC   MODE
    	
TESTJET
    
	
MEDALIST
    	
TESTMOBILE
    
	
MEGAZOOM
    	
TESTTRACS
    
	
MEGAZOOM   (and Design)
    	
TRUEFORM
    
	
miNT   Mobile Communications INtegrated Tester (and Design)
    	
TRUEIR
    
	
MXA
    	
TRUEVOLT
    
	
MXE
    	
VEE   PRO
    
	
MXG
    	
VEE   PRO (and Design)
    
	
MYSEM   (Stylized)
    	
VEE   PRO (Stylized and w/Design)
    
	
NANO   INDENTER
    	
VERSAPOWER
    
	
NANOSUITE
    	
VXA
    
	
PARBERT
    	
WIRESCOPE
    
	
PICOCAFÉ
    	
X-PARAMETERS
    
	
PXA
    	
 
    

 

D-3

 

7.  Internet Properties:

 

	
4g-radio.com
    	
eesof.tv
    
	
accelicon-da.com
    	
eesofeda.com
    
	
accelicon.com
    	
elanix.com
    
	
acqiris.biz
    	
expedion.com
    
	
acqiris.ca
    	
fast-digitizer.com
    
	
acqiris.ch
    	
framescope.com
    
	
acqiris.cn
    	
fuckkey-sight.com
    
	
acqiris.com
    	
fuckkey-sight.net
    
	
acquiris.com
    	
fuckkey-sight.org
    
	
benchlink.com
    	
fuckkeysight-tech.com
    
	
boycotkeysight.com
    	
fuckkeysight-tech.net
    
	
boycotkeysight.net
    	
fuckkeysight-tech.org
    
	
boycotkeysight.org
    	
fuckkeysight.com
    
	
boycottkey-sight.com
    	
fuckkeysight.net
    
	
boycottkey-sight.net
    	
fuckkeysight.org
    
	
boycottkey-sight.org
    	
fuckkeysightech.com
    
	
boycottkeysight-tech.com
    	
fuckkeysightech.net
    
	
boycottkeysight-tech.net
    	
fuckkeysightech.org
    
	
boycottkeysight-tech.org
    	
fuckkeysightechnologies.com
    
	
boycottkeysight.com
    	
fuckkeysightechnologies.net
    
	
boycottkeysight.net
    	
fuckkeysightechnologies.org
    
	
boycottkeysight.org
    	
fuckkeysighttech.com
    
	
boycottkeysightech.com
    	
fuckkeysighttech.net
    
	
boycottkeysightech.net
    	
fuckkeysighttech.org
    
	
boycottkeysightech.org
    	
fuckkeysighttechnologies.com
    
	
boycottkeysightechnologies.com
    	
fuckkeysighttechnologies.net
    
	
boycottkeysightechnologies.net
    	
fuckkeysighttechnologies.org
    
	
boycottkeysightechnologies.org
    	
ihatekey-sight.com
    
	
boycottkeysighttech.com
    	
ihatekey-sight.net
    
	
boycottkeysighttech.net
    	
ihatekey-sight.org
    
	
boycottkeysighttech.org
    	
ihatekeysight-tech.com
    
	
boycottkeysighttechnologies.com
    	
ihatekeysight-tech.net
    
	
boycottkeysighttechnologies.net
    	
ihatekeysight-tech.org
    
	
boycottkeysighttechnologies.org
    	
ihatekeysight.com
    
	
btinfo.com
    	
ihatekeysight.net
    
	
buykeysight.com
    	
ihatekeysight.org
    
	
cadbucks.com
    	
ihatekeysightech.com
    
	
eagleware.com
    	
ihatekeysightech.net
    
	
educatorscorner.com
    	
ihatekeysightech.org
    
	
eesof-eda.com
    	
ihatekeysightechnologies.com
    
	
eesof.com
    	
ihatekeysightechnologies.net
    
	
eesof.net
    	
ihatekeysightechnologies.org
    
	
eesof.org
    	
ihatekeysighttech.com
    

 

D-4

 

	
ihatekeysighttech.net
    	
keysight.co.kr
    
	
ihatekeysighttech.org
    	
keysight.co.uk
    
	
ihatekeysighttechnologies.com
    	
keysight.co.za
    
	
ihatekeysighttechnologies.net
    	
keysight.com
    
	
ihatekeysighttechnologies.org
    	
keysight.com.ar
    
	
ip-telephony-testing.com
    	
keysight.com.au
    
	
key-sight-email.com
    	
keysight.com.bo
    
	
key-sight.com
    	
keysight.com.br
    
	
key-sight.net
    	
keysight.com.cn
    
	
key-sight.org
    	
keysight.com.ec
    
	
key-sight.xxx
    	
keysight.com.es
    
	
key-sightcompanystore.com
    	
keysight.com.hk
    
	
key-sightfail.com
    	
keysight.com.hr
    
	
key-sightfail.net
    	
keysight.com.mx
    
	
key-sightfail.org
    	
keysight.com.my
    
	
key-sightonline.com
    	
keysight.com.pe
    
	
key-sightonsite.com
    	
keysight.com.ph
    
	
key-sightsucks.com
    	
keysight.com.py
    
	
key-sightsucks.net
    	
keysight.com.ru
    
	
key-sightsucks.org
    	
keysight.com.sg
    
	
keysight-email.com
    	
keysight.com.tw
    
	
keysight-tech-email.com
    	
keysight.com.ua
    
	
keysight-tech.com
    	
keysight.com.uy
    
	
keysight-tech.net
    	
keysight.cr
    
	
keysight-tech.org
    	
keysight.cz
    
	
keysight-tech.xxx
    	
keysight.de
    
	
keysight-techcompanystore.com
    	
keysight.dk
    
	
keysight-techfail.com
    	
keysight.do
    
	
keysight-techfail.net
    	
keysight.es
    
	
keysight-techfail.org
    	
keysight.eu
    
	
keysight-techonline.com
    	
keysight.fi
    
	
keysight-techonsite.com
    	
keysight.fr
    
	
keysight-techsucks.com
    	
keysight.gr
    
	
keysight-techsucks.net
    	
keysight.hk
    
	
keysight-techsucks.org
    	
keysight.in
    
	
keysight.ae
    	
keysight.it
    
	
keysight.asia
    	
keysight.jp
    
	
keysight.at
    	
keysight.kr
    
	
keysight.be
    	
keysight.lt
    
	
keysight.ch
    	
keysight.ly
    
	
keysight.cl
    	
keysight.ma
    
	
keysight.cn
    	
keysight.mk
    
	
keysight.co
    	
keysight.mx
    
	
keysight.co.il
    	
keysight.my
    
	
keysight.co.in
    	
keysight.nl
    
	
keysight.co.jp
    	
keysight.org
    

 

D-5

 

	
keysight.ph
    	
keysightek.com
    
	
keysight.pl
    	
keysightfail.com
    
	
keysight.pr
    	
keysightfail.net
    
	
keysight.pt
    	
keysightfail.org
    
	
keysight.qa
    	
keysightmarketingresearch.com
    
	
keysight.ro
    	
keysightonline.com
    
	
keysight.ru
    	
keysightonsite.com
    
	
keysight.se
    	
keysightsucks.com
    
	
keysight.sg
    	
keysightsucks.net
    
	
keysight.si
    	
keysightsucks.org
    
	
keysight.sv
    	
keysighttec.com
    
	
keysight.tn
    	
keysighttech-email.com
    
	
keysight.tw
    	
keysighttech.com
    
	
keysight.us
    	
keysighttech.net
    
	
keysight.vn
    	
keysighttech.org
    
	
keysight.xxx
    	
keysighttech.xxx
    
	
keysightcompanystore.com
    	
keysighttechcompanystore.com
    
	
keysightec.com
    	
keysighttechfail.com
    
	
keysightech-email.com
    	
keysighttechfail.net
    
	
keysightech.com
    	
keysighttechfail.org
    
	
keysightech.net
    	
keysighttechnologies-email.com
    
	
keysightech.org
    	
keysighttechnologies.com
    
	
keysightech.xxx
    	
keysighttechnologies.net
    
	
keysightechcompanystore.com
    	
keysighttechnologies.org
    
	
keysightechfail.com
    	
keysighttechnologies.xxx
    
	
keysightechfail.net
    	
keysighttechnologiescompanystore.com
    
	
keysightechfail.org
    	
keysighttechnologiesfail.com
    
	
keysightechnologies-email.com
    	
keysighttechnologiesfail.net
    
	
keysightechnologies.com
    	
keysighttechnologiesfail.org
    
	
keysightechnologies.net
    	
keysighttechnologiesonline.com
    
	
keysightechnologies.org
    	
keysighttechnologiesonsite.com
    
	
keysightechnologies.xxx
    	
keysighttechnologiessucks.com
    
	
keysightechnologiescompanystore.com
    	
keysighttechnologiessucks.net
    
	
keysightechnologiesfail.com
    	
keysighttechnologiessucks.org
    
	
keysightechnologiesfail.net
    	
keysighttechonline.com
    
	
keysightechnologiesfail.org
    	
keysighttechonsite.com
    
	
keysightechnologiesonline.com
    	
keysighttechsucks.com
    
	
keysightechnologiesonsite.com
    	
keysighttechsucks.net
    
	
keysightechnologiessucks.com
    	
keysighttechsucks.org
    
	
keysightechnologiessucks.net
    	
keysighttek.com
    
	
keysightechnologiessucks.org
    	
keysite.com
    
	
keysightechonline.com
    	
kysght.co
    
	
keysightechonsite.com
    	
kysig.ht
    
	
keysightechsucks.com
    	
lightscatter.com
    
	
keysightechsucks.net
    	
metrologyforum.com
    
	
keysightechsucks.org
    	
mini-otdr.com
    

 

D-6

 

	
miniotdr.com
    	
signal-integrity-tips.com
    
	
mtsnano.com
    	
afmuniversity.org
    
	
mykey-sight.com
    	
keysighttechnologies.ca
    
	
mykeysight-tech.com
    	
 
    
	
mykeysight.com
    	
 
    
	
mykeysightech.com
    	
 
    
	
mykeysightechnologies.com
    	
 
    
	
mykeysighttech.com
    	
 
    
	
mykeysighttechnologies.com
    	
 
    
	
network-analyzer.com
    	
 
    
	
network-troubleshooting.com
    	
 
    
	
networkfab.com
    	
 
    
	
onenetworks.com
    	
 
    
	
otdr.com
    	
 
    
	
probestore.com
    	
 
    
	
pxit.com
    	
 
    
	
rf-alliance.com
    	
 
    
	
routertester.com
    	
 
    
	
scope.com
    	
 
    
	
sigintcom.com
    	
 
    
	
sigintcomm.com
    	
 
    
	
sigintcommunications.com
    	
 
    
	
testjet.com
    	
 
    
	
theshopatkeysight.com
    	
 
    
	
tunablelaserupgrades.com
    	
 
    
	
voice-over-ip-test.com
    	
 
    
	
wirescope.com
    	
 
    
	
wwwkey-sight.com
    	
 
    
	
wwwkeysight-tech.com
    	
 
    
	
wwwkeysight.com
    	
 
    
	
wwwkeysightech.com
    	
 
    
	
wwwkeysightechnologies.com
    	
 
    
	
wwwkeysighttech.com
    	
 
    
	
wwwkeysighttechnologies.com
    	
 
    
	
xn--80apeb0bi.xn--p1ai
    	
 
    
	
xn--eckry1f3m.jp
    	
 
    
	
xn--kpry7y67erxl.tw
    	
 
    
	
xn--p5tw7l.tw
    	
 
    
	
xn--p5tx5d19dp81a.tw
    	
 
    
	
xn--vf4b27jtri46b.com
    	
 
    
	
xn--vf4b27jtri46b.kr
    	
 
    
	
xn--vf4b27jtri46b.xn--3e0b707e
    	
 
    
	
xpedion.com
    	
 
    
	
caddatastore.com
    	
 
    
	
picocafe.com
    	
 
    
	
pico-cafe.com
    	
 
    

 

D-7

 

EXHIBIT E

 

 

FORM OF

 

TRADEMARK
 LICENSE AGREEMENT

 

between

 

AGILENT TECHNOLOGIES, INC.

 

and

 

KEYSIGHT TECHNOLOGIES, INC.

 

Effective as of August 1, 2014

 

E-1

 

TRADEMARK LICENSE AGREEMENT

 

This Trademark License Agreement (this “License”) is effective as of August 1, 2014, (the “Effective Date”) between Agilent Technologies, Inc., a Delaware corporation (“Agilent”), and Keysight Technologies, Inc., a Delaware corporation (“Keysight”).

 

WHEREAS, pursuant to the Separation and Distribution Agreement entered into by and between Keysight and Agilent (the “Separation Agreement”), the parties have agreed to separate the Keysight Business (as defined below) from Agilent;

 

WHEREAS, it is the intent of the parties, in accordance with the Separation Agreement and the other agreements and instruments provided for therein, that Agilent convey, and cause its Affiliates to convey, to Keysight and its Affiliates substantially all of the Keysight Business and assets of the Keysight Business and that Keysight and its Affiliates assume certain of the liabilities related to the Keysight Business;

 

WHEREAS, Agilent and Keysight have also entered into an Intellectual Property Matters Agreement, of even date herewith (the “IPMA”), which provides among other things, for the assignment and transfer of certain intellectual property rights; and

 

WHEREAS, the parties agree that Agilent will license the Licensed Marks (as defined below) to Keysight.

 

NOW, THEREFORE, in consideration of the mutual promises of the parties, and of good and valuable consideration, it is agreed by and between the parties as follows:

 

ARTICLE I
 DEFINITIONS

 

For the purpose of this License, unless specifically defined otherwise in this License, all defined terms will have the meanings set forth in the Separation Agreement and/or the IPMA, as applicable:

 

1.1       “Affiliate” means Affiliate as defined in the Separation Agreement.

 

1.2       “Agilent Blue” means the shade of blue color used in the Spark Licensed Mark and elsewhere which is both an unregistered common-law mark as well as Agilent trade dress element.

 

1.3       “Agilent Enterprise Quality Director” means the contact specified in Exhibit E.

 

1.4       “Agilent Lime Green” means the shade of lime green color used in the Eco-Label Symbol and elsewhere, which is both an unregistered common-law mark as well as Agilent trade dress element.

 

1.5       “Authorized Dealer” means any distributor, dealer, OEM customer, VAR customer, VAD customer, systems integrator or other agent that on or after the Effective Date is

 

E-2

 

authorized by Keysight or any of its Affiliates to market, advertise, sell, lease, rent, service, distribute or otherwise offer a Licensed Product.

 

1.6       “Collateral Materials” means all packaging, tags, labels, instructions, warranties and other materials of any similar type associated with the Licensed Products that are marked with at least one of the Licensed Marks and distributed to the customer in connection with the Sale and Service of the Licensed Product as well as end user license agreements and other agreements or licenses relating to a Licensed Product.

 

1.7       “Contract Manufacturer” means any Third Party who manufactures Licensed Products for Keysight or its Affiliates under written agreements and sells such Licensed Products only to Keysight or its Affiliates.

 

1.8       “Corporate Identity Materials” means materials that are not Keysight Products or Keysight Product-related and that Keysight may now or hereafter use to communicate its identity, including, by way of example and without limitation, business cards, letterhead, stationery, paper stock and other supplies, signage on real property, buildings, fleet and uniforms.

 

1.9       “Dispute” means the term defined in Section 13.3.

 

1.10   “Distribution Date” means Distribution Date as defined in the Separation Agreement.

 

1.11   “Eco-Label Symbol” means the Agilent created symbol shown in the figure, below, which serves as a visual cue used in association with an eco-friendly message.  Although it is not currently a registered trademark in any jurisdiction, Agilent owns the copyright in this symbol, as well as such common law trademark rights and trade dress rights as may have accrued through Agilent’s usage in commerce.

 

 

1.12   “Guideline Initial Cure Period” means the term defined in    Section 6.1.

 

1.13   “Internal Parts” means the subset of Licensed Products that are parts and components inside a Keysight instrument and which are not visible to the end user during normal operation of that instrument.   For the avoidance of doubt “normal operation” for purposes of this definition does not include inspection, calibration, maintenance, and service, or any other activity which would involve the removal or opening of a fastener or panel to gain access to the interior of the Keysight instrument.

 

E-3

 

1.14   “Initial Cure Period” means the term defined in Section 8.1.

 

1.15   “Keysight Business” means Keysight Business as defined in the Separation Agreement.

 

1.16   “Keysight Director of Quality” means the contact specified in Exhibit E.

 

1.17   “Keysight Overlap Field” means Keysight Overlap Field as defined in the IPMA.

 

1.18   “Keysight Primary Field” means Keysight Primary Field as defined in the IPMA.

 

1.19   “Keysight Quality Reports” means the term defined in Section 7.3(a).

 

1.20   “Keysight Product” means Keysight Product as defined in the IPMA.

 

1.21   “Law” means Law as defined in the Separation Agreement.

 

1.22   “Legacy Products” means products which are not on Agilent’s published corporate price list as of one day prior to the Effective Date, but which once were on Agilent’s, or its predecessors-in-interest corporate price list and which relate to the Keysight Primary Field or Keysight Overlap Field.

 

1.23   “Licensed Marks” means the Agilent Marks listed on Exhibit A of this License.

 

1.24   “Licensed Products” means any of the following:  (1) Keysight Products on Agilent’s published corporate price list as of one day prior to the Effective Date; (2) Keysight Products available for purchase from Agilent or an Affiliate as a special order as of July 31, 2014; (3) parts, components or software for Keysight Products or Legacy Products which are sold by Agilent as of one day prior to the Effective Date; (4) any new versions of items (1), (2) or (3), above, that have merely minor incremental differences, (5) software containing a Mark Displaying Software Code Block; and (6) services including maintenance (whether diagnostic, preventive, remedial, warranty or non-warranty), parts replacement, components (including software) support, and similar services associated with Licensed Products or Legacy Products, pursuant to Maintenance Contracts or otherwise.

 

1.25   “Maintenance Contracts” means agreements pursuant to which Keysight, its Affiliates or their Authorized Dealers or their designees provide repair and maintenance services (whether preventive, diagnostic, remedial, warranty or non-warranty) in connection with Licensed Products or Legacy Products, including without limitation, agreements entered into by Agilent or its predecessors-in-interest prior to August 1 and assigned to Keysight.

 

1.26   “Mark” means any trademark, service mark, trade name, domain name, URL or other electronic identifier, and the like or other word, name, symbol or device or any combination thereof, used or intended to be used by a Person to identify and distinguish the products or services of that Person from the products or services of others and to indicate the

 

E-4

 

source of such products or services, including without limitation all registrations and applications therefor throughout the world and all common law and other rights therein throughout the world.

 

1.27   “Mark Displaying Software Code Block” means software code segments written before the Distribution Date and included in software that is either a Keysight Product, or designed to run on, a Keysight Product or Legacy Product, and which result in a Licensed Mark being displayed to a user.  Examples of screens where such displays often appear include: installation instructions, splash screens, license information, and help information.

 

1.28   “Marketing Materials” means advertising, promotions, display fixtures or similar type literature or things, in any medium, for the marketing, promotion or advertising of the Sale or Service of the Licensed Products or parts therefor that are marked with at least one of the Licensed Marks.

 

1.29   “Non-Customer-Facing Parts” means tangible parts which contain or bear Licensed Marks that are not visible to end customers in the ordinary course of use.  For the avoidance of doubt, “ordinary course of use” for purposes of this definition includes normal inspection, use, calibration, maintenance, and service.  Examples of Non-Customer-Facing Parts include a semiconductor die which bears a Licensed Mark but which is sold in an encapsulated form (where the encapsulation does not bear a Licensed Mark) and software whose source code includes a Licensed Mark, but whose user accessible interfaces do not bear Licensed Marks.  It also includes tangible parts where the Licensed Mark has been obscured and is thus not visible, perhaps because a label has been affixed over the Licensed Mark.

 

1.30   “Person” means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof.

 

1.31   “Quality Standards” means written standards of quality applicable to the Licensed Products, as in use immediately prior to the Effective Date, unless otherwise modified in writing by Keysight from time to time during the Term of this License and communicated to Agilent for review/approval.

 

1.32              “Second Cure Period” means the term defined in Section 8.2.

 

1.33              “Second Guideline Cure Period” means the term defined in Section 6.2.

 

1.34   “Sell” means to sell, transfer, lease or otherwise dispose of a product. “Sale” and “Sold” have the corollary meanings ascribed thereto.

 

1.35   “Service” means to repair, refurbish, fix, perform any maintenance or otherwise review a Sold Licensed Product, so that such product continues to operate in normal, working conditions, or to diagnose any existing operational issues with such Licensed Product.

 

1.36   “Subsidiary” means Subsidiary as defined in the Separation Agreement.

 

1.37   “Term” means the term defined in Section 3.2 of this License.

 

E-5

 

1.38     “Third Party” means a Person other than Agilent and its Affiliates or Keysight and its Affiliates.

 

1.39     “Trademark Usage Guidelines” means the written guidelines for proper usage of the Licensed Mark that are in use immediately prior to the Effective Date and located at:  http://www.agilent.com/secure/agilentbrand/.

 

User Name:  brandid
 Password:  spark.

 

For literature, packaging, exhibit standards, emarketing, learning products, web and Third Party Marks use standards located at:  http://www.agilent.com/secure/trademark.

 

User Name:  trademark
 Password:  ez4u.

 

For product labeling, use the product labeling standards attached hereto as Exhibit B.

 

Agilent shall notify Keysight in writing of any change to the above URLs, user names, or passwords.   All such standards and guidelines may be revised and updated by Agilent from time to time during the Term in writing at the sites listed above or by written communication to Keysight, at Agilent’s sole discretion with regard to the product labeling standards.  With regard to product labeling embedded into the manufacturing process, any such labeling that was created by Agilent and used on Licensed Products as of the Effective Date will be deemed to be in compliance with any product labeling standards, provided the embedded product labeling has not been altered by Keysight or its Affiliates.

 

1.40     “Unencapsulated Integrated Circuits” means the Licensed Products listed in Exhibit C.

 

ARTICLE II
 LICENSES

 

2.1            LICENSE GRANT.  Agilent grants to Keysight a personal, non-exclusive, worldwide and non-transferable (except as set forth in Section 11.3 hereof) license to the Licensed Marks, Agilent Blue, Agilent Lime Green, and the Eco-Label Symbol commencing on the day prior to the Effective Date and continuing for their respective stated license terms as set out in Article III below, to use for the respective license term the Licensed Marks on or in connection with:

 

(a)                                 Corporate Identity Materials;

 

(b)                                 Licensed Products,

 

(c)                                  Collateral Materials, and

 

E-6

 

(d)                                 Marketing Materials,

 

all in connection with the Sale, offer for Sale, support, and Service of such Licensed Products (or in the case of Licensed Products in the form of software, in connection with the licensing of such Licensed Products).

 

2.2            LICENSE RESTRICTIONS.

 

(a)               Keysight may not make any use whatsoever, in whole or in part, of the Licensed Marks or Agilent Blue, as any part of or otherwise in direct connection with Keysight’s corporate name, trade name, “doing business as” name, fictitious name or Internet domain name, or on any Corporate Identity Materials, without the prior written consent of Agilent, except as expressly set forth in Section 3.3 (a)-(c) below.  Nothing herein shall prevent or restrict Keysight from making informational use of the Licensed Marks as stated in Section 2.8 herein.

 

(b)               Except for those combined marks expressly listed in this 2.2(b), Keysight may not use any Licensed Mark in direct association with another Mark such that the two Marks appear to be a single Mark or in any other composite manner with any Marks of Keysight or any Third Party.  Keysight shall cease use of the listed combined marks within five (5) years of the Distribution Date.

 

(i)                                     Agilent Advantage

(ii)                                  Agilent Assured

(iii)                               Agilent Assureme

(iv)                              Agilent Certiprime (and Design)

(v)                                 Agilent CXA

(vi)                              Agilent Direct

(vii)                           Agilent Easyexpert

(viii)                        Agilent Fault Detective

(ix)                              Agilent Instapin

(x)                                 Agilent N2X

(xi)                              Agilent Open

(xii)                           Agilent Open (and Design)

(xiii)                        Agilent Vee

(xiv)                       MyAgilent

 

(c)                                  In all respects, Keysight’s usage of the Licensed Marks during the Term pursuant to the license granted hereunder shall be in a manner consistent with the high standards, reputation and prestige of Agilent as represented by its use of the Licensed Marks, and any usage by Keysight that is inconsistent with the foregoing shall be deemed to be outside the scope of the license granted hereunder.

 

E-7

 

2.3            LICENSEE UNDERTAKINGS.  As a condition to the licenses granted hereunder, Keysight undertakes to Agilent that:

 

(a)                                 Keysight shall not use the Licensed Marks (or any other Mark of Agilent) in any manner contrary to public morals, in any manner which is deceptive or misleading, which ridicules or is derogatory to the Licensed Marks, or which compromises or reflects unfavorably upon the goodwill, good name, reputation or image of Agilent or the Licensed Marks, or which might jeopardize or limit Agilent’s proprietary interest therein.

 

(b)                                 Keysight shall not use the Licensed Marks or any other Agilent Mark in connection with any products other than the Licensed Products, including without limitation any other products sold and/or manufactured by Keysight.

 

(c)                                  Keysight shall not:  (i) misrepresent to any Person the scope of its authority under this License, (ii) incur or authorize any expenses or liabilities chargeable to Agilent or (iii) take any actions that would impose upon Agilent any obligation or liability to a Third Party other than obligations under this License or other obligations which Agilent expressly approves in writing for Keysight to incur on its behalf.

 

(d)                                 All press releases and corporate advertising and promotions that embody the Licensed Marks and messages conveyed thereby shall be consistent with the high standards and prestige represented by the Licensed Marks.

 

2.4            RESERVATION OF RIGHTS.  Except as otherwise expressly provided in this License, Agilent shall retain all rights in and to the Licensed Marks and all other Agilent Marks, including without limitation:

 

(a)                                 all rights of ownership in and to the Licensed Marks;

 

(b)                                 the right to use (including the right of Agilent’s Affiliates to use) the Licensed Marks, either alone or in combination with other Marks, in connection with the marketing, offer or provision of any products or services, except for the Licensed Products; and

 

(c)                                  the right to license Third Parties to use the Licensed Marks, except on the Licensed Products.

 

2.5            SEARCH ENGINE AUTHORITY.  Agilent hereby authorizes Keysight to utilize the Licensed Marks as keywords in pay-for-placement online advertising, such as through search engines for a period ending on November 1, 2019, provided that such use is limited to Keysight Products, e.g., “Agilent Oscilloscope,” and does not overlap with any Agilent retained products, e.g., “Agilent Lab Software” or “Agilent Analyzer.”

 

2.6            THIRD-PARTY LICENSES.  Nothing in this License shall be construed to prevent Agilent from granting any licenses for the use of the Licensed Marks or from utilizing the Licensed Marks in any manner whatsoever, except in relation to the Licensed Products following the Distribution Date.

 

E-8

 

2.7            NOTIFICATION.  Except as would be a violation of Law, Keysight agrees to notify all customers receiving parts and materials bearing the Licensed Marks that Keysight is the source of and is the proper contact for such products, parts and materials.

 

2.8            REFERENCES TO AGILENT.  It is understood and agreed that it shall not be a violation of this License for Keysight, its Affiliates or its Authorized Dealers, at any time during or after the Term, to make accurate references to the fact that Keysight has succeeded to the business of Agilent with respect to the Licensed Products, or to advertise or promote its or their provision of maintenance services or supply of spare parts for Licensed Products or Legacy Products previously sold under any of the Licensed Marks, provided that Keysight, its Affiliates and its Authorized Dealers do not in connection therewith claim to be authorized by Agilent in any manner with respect to such activities and do not brand any products, Marketing Materials, Collateral Materials or parts Sold after the Term with any of the Licensed Marks in a manner that is inconsistent with this Article II.  Notwithstanding the foregoing, it shall not be a violation of this License, either during or after the Term of this License, for Keysight to refer to Agilent in a nominative or non-trademark use, such as a statement that Keysight’s parts and components are compatible with Licensed Products previously sold by Agilent, as long as such use is not misleading or would otherwise cause consumer confusion.  For the avoidance of doubt, Keysight may make accurate references to the fact that Keysight has succeeded to the business of Agilent with respect to the Licensed Products within its Corporate Identity Materials.  In addition, it shall not be a violation of this License, either during or after the Term of this License for Keysight products, in response to a software identification command, including but not limited to a SCPI command, to identify themselves in a way that may include “Agilent” or “Agilent Technologies.”  Further, it shall not be a violation of this License, either during or after the Term of this License, for Keysight products to utilize the USB Vendor ID associated with Agilent.

 

2.9            EXISTING INVENTORY OF PARTS AND COMPONENTS.  It is understood and agreed that it shall not be a violation of this License, either during or after the Term of this License, for Keysight to sell as spare parts or components, or to utilize in maintenance (whether diagnostic, preventive, remedial, warranty or non-warranty) or refurbishment of any Licensed Products or Legacy Products any Licensed Products that were any of the following, and such sale or use is not misleading or would otherwise cause consumer confusion:

 

(a)                                 Made under license;

(b)                                 In Keysight inventory as of the Distribution Date;

(c)                                  Part of lifetime buy initiated prior to the Distribution Date; or

(d)                                 Software substantially unmodified after the Distribution Date.

 

2.10     NON-CUSTOMER-FACING PARTS. It is understood and agreed that it shall not be a violation of this License, either during or after the Term of this License, for Keysight to sell or distribute Non-Customer-Facing Parts provided such is not misleading or would otherwise cause consumer confusion.

 

2.11     UNMODIFIED COPYRIGHTED WORKS.  It is understood and agreed that it shall not be a violation of this License, either during or after the Term of this License, for Keysight to exercise their rights in copyrighted works (including but not limited to software,

 

E-9

 

documents, presentation materials, learning products, application notes, and videos), including the right to distribute and publically display such works, where the copyright has been assigned by Agilent to Keysight as of the Distribution Date even if such works bear a Licensed Mark, as long as such remain substantially unmodified from the Distribution Date, and such exercise of copyright rights is not misleading or would otherwise cause consumer confusion.

 

2.12     REPAIR AND REFURBISHMENT.  It is understood and agreed that it shall not be a violation of this License, either during or after the Term of this License, for Keysight to repair or refurbish any Licensed Product or Legacy Product bearing a Licensed Mark, or to sell or distribute any such refurbished or repaired Licensed Product or Legacy Product, as long as such activity is not misleading or would otherwise cause consumer confusion.

 

2.13     INDEMNIFICATION.  Keysight and its Affiliates shall indemnify Agilent and its Affiliates and hold them harmless from all Third Party claims arising out of or relating to their use or sale of any products, parts or materials using or containing any of the Licensed Marks from and after the Distribution Date and any sales activities relating thereto.

 

ARTICLE III
 TERM OF LICENSE

 

3.1            The term of each of the licenses granted pursuant to Section 2.1 above shall begin on the Effective Date and, unless terminated sooner pursuant to the provisions of Articles VIII or XI hereof, shall last for the periods set forth in Section 3.3 below.

 

3.2            “Term” means the period of time Keysight is permitted to use the Licensed Marks.

 

3.3            Except as provided for in Sections 2.9 through 2.13, above, Keysight agrees to discontinue all use of the Licensed Marks no later than the expiration of the Terms shown below:

 

(a)              Corporate Identity Materials:  six (6) months from the Distribution Date;

 

(b)              Licensed Products and associated Collateral Materials and Marketing Materials: except as provided in Sections 3.3 (c), (d) or (e) below, five (5) years from the Distribution Date;

 

(c)               Internal Parts:  twenty (20) years from the Distribution Date;

 

(d)              Licensed Products listed in Exhibit D:  twenty (20) years from the Distribution Date; and

 

(e)               Unencapsulated Integrated Circuits:  Until removed from the Keysight corporate price list.

 

3.4            Keysight agrees to timely notify Agilent when all of the Unencapsulated Integrated Circuits have been removed from the Keysight corporate price list.

 

E-10

 

ARTICLE IV
 PERMITTED SUBLICENSES

 

4.1            SUBLICENSES.

 

(a)                                 SUBLICENSES TO AFFILIATES AND CONTRACT MANUFACTURERS.  Subject to the terms and conditions of this License, including all applicable Quality Standards, Quality Control Monitoring, and Trademark Usage Guidelines and other restrictions in this License, Keysight may grant sublicenses to its Affiliates and to Contract Manufacturers entering into Contract Manufacturer agreements with Keysight (collectively “sublicensees”) to use the Licensed Marks in accordance with the license grant in Section 2.1 above; provided that:  (i) Keysight enters into a written sublicense agreement with each such sublicensee and (ii) such agreement does not include the right to grant further sublicenses other than sublicenses between Affiliates of Keysight.  Keysight shall provide copies of such written sublicense agreements to Agilent upon request.  If Keysight grants any sublicense rights pursuant to this Section 4.1(a) and any such sublicensee ceases to be an Affiliate or Contract Manufacturer, then the sublicense granted to such Affiliate or Contract Manufacturer pursuant to this Section 4.1(a) shall terminate immediately upon cessation.

 

(b)                                 SUBLICENSES TO TRANSFEREES.  If Keysight transfers a going business (but not all or substantially all of its business or assets), and such transfer includes at least one marketable product and tangible assets having a net value of at least twenty-five million U.S. dollars ($25,000,000) then, subject to the terms and conditions of this License, including all applicable Quality Standards, Quality Control Monitoring, and Trademark Usage Guidelines and other restrictions in this License, Keysight may grant sublicenses to the transferee of such business to use the Licensed Marks on the Keysight Products that are in the transferred business as of the effective date of the transfer in accordance with the license grant set forth in Section 2.1 above; provided, that:  (i) Keysight enters into a written sublicense agreement with the sublicensee, (ii) such agreement does not include the right to grant further sublicenses and (iii) in any event, such sublicense shall terminate ninety (90) days after the effective date of the transfer.  Keysight shall provide copies of such written sublicense agreements to Agilent upon request.  Keysight shall remain responsible and liable to Agilent for all acts or omissions of such permitted sublicensees with respect to the Licensed Marks or this License if such acts or omissions were made by Keysight.

 

4.2            AUTHORIZED DEALERS’ USE OF MARKS.  Subject to the terms and conditions of this License, including all applicable Quality Standards and Trademark Usage Guidelines and other restrictions in this License, Keysight (and those Affiliates sublicensed to use the Licensed Marks pursuant to Section 4.1) may allow Authorized Dealers to:  (a) Sell, otherwise distribute or Service Collateral Materials and Licensed Products bearing the Licensed Marks, (b) create and use Marketing Materials and (c) allow other Authorized Dealers to do any or all of these things, provided that such Authorized Dealers agree to full compliance with all relevant provisions of this License.  Keysight shall remain responsible and liable to Agilent for all acts or omissions of Authorized Dealers with respect to the Licensed Marks or this License if such acts or omissions were made by Keysight.

 

E-11

 

4.3            ENFORCEMENT OF AGREEMENTS.  Keysight shall take all reasonably appropriate measures at Keysight’s expense to promptly and diligently enforce the terms of any sublicense agreement or other agreement with any sublicensee or Authorized Dealer and shall restrain any such sublicensee or Authorized Dealer from violating such terms, including without limitation:  (a) monitoring the sublicensees’ and Authorized Dealers’ compliance with the relevant Quality Standards and Trademark Usage Guidelines and causing any non-complying sublicensee or Authorized Dealer promptly to remedy any failure; (b) if need be, terminating such agreement; and/or (c) if need be, commencing legal action, in each case using a standard of care consistent with Agilent’s practices as of one day prior to the Effective Date, but in no case using a standard of care less than what is reasonable in the industry.  In the event that Agilent determines that Keysight has failed to promptly and diligently enforce the terms of any such agreement using such standard of care, Agilent reserves the right to enforce such terms, only after providing Keysight with written notice and time to cure such failure to enforce consistent with the procedures set forth in Articles VI and VIII.  If Keysight fails to cause sublicensees to cure any defects, and Agilent elects to enforce its rights in accordance with this paragraph,  Keysight shall reimburse Agilent for its reasonable litigation costs, attorneys’ fees, and expenses incurred in enforcing the agreement, including out-of-pocket costs, attorneys’ fees, and expenses incurred from litigation.

 

ARTICLE V
 TRADEMARK USAGE GUIDELINES

 

5.1            TRADEMARK USAGE GUIDELINES.  Keysight, its Affiliates and Authorized Dealers shall use the Licensed Marks during the Term only in a manner that is consistent with the Trademark Usage Guidelines.  To the extent that Keysight’s use of the Licensed Marks is unchanged from how the Licensed Marks were used in a product Sold by Agilent’s Electronic Measurement Group prior to the Effective Date, such use in the counterpart Keysight product shall be deemed to be consistent with the Trademark Usage Guidelines.

 

5.2            TRADEMARK REVIEWS.  At Agilent’s reasonable request, Keysight agrees to furnish or make available for inspection to Agilent one (1) sample of Corporate Identity Materials, Licensed Products, Collateral Materials and Marketing Materials of Keysight and its Affiliates that are marked with one or more of the Licensed Marks.  Keysight further agrees to take reasonably appropriate measures to require its Authorized Dealers to furnish or make available for inspection to Keysight samples of Marketing Materials and Collateral Materials of its Authorized Dealers.  If Keysight is notified or reasonably determines that it or any of its Affiliates or Authorized Dealers is not complying with any Trademark Usage Guidelines, it shall notify Agilent and the provisions of Section 4.3 and Article VI hereof shall apply to such noncompliance.

 

ARTICLE VI
 TRADEMARK USAGE GUIDELINES ENFORCEMENT

 

6.1            INITIAL CURE PERIOD.  If Agilent becomes aware that Keysight or any of its Affiliates is not complying with any Trademark Usage Guidelines, Agilent shall notify

 

E-12

 

Keysight in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance.  Keysight shall then have forty-five (45) calendar days after receipt of such notice (“Guideline Initial Cure Period”) to correct such noncompliance or submit to Agilent a written plan to correct such noncompliance, which written plan shall be reasonably acceptable to Agilent, unless Agilent previously affirmatively concurs in writing, in its sole discretion, that Keysight or its Affiliate is in compliance.  If Agilent or Keysight becomes aware that an Authorized Dealer is not complying with any Trademark Usage Guidelines, Keysight (but not Agilent) shall promptly notify such Authorized Dealer in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance.  Such Authorized Dealer shall then have the Guideline Initial Cure Period to correct such noncompliance or submit to Keysight a written plan to correct such noncompliance, which written plan shall be reasonably acceptable to Keysight and Agilent.

 

6.2            SECOND CURE PERIOD.  If the noncompliance with the Trademark Usage Guidelines continues beyond the Guideline Initial Cure Period, Keysight and Agilent shall each promptly appoint a representative to negotiate in good faith actions that may be necessary to correct such noncompliance.  The parties shall have thirty (30) calendar days following the expiration of the Guideline Initial Cure Period to agree on corrective actions, and Keysight shall have thirty (30) calendar days from the date of an agreement of corrective actions to implement such corrective actions and cure or cause the cure of such noncompliance (“Second Guideline Cure Period”).

 

6.3            ENFORCEMENT UPON FAILURE TO CURE.  If the noncompliance with the Trademark Usage Guidelines by Keysight or any Affiliate (as the case may be) remains uncured after the expiration of the Second Guideline Cure Period, then at Agilent’s election, Keysight or the non-complying Affiliate (as the case may be) promptly shall cease using the non-complying Corporate Identity Materials, Licensed Product, Collateral Materials and/or Marketing Materials until Agilent reasonably determines that Keysight or the non-complying Affiliate (as the case may be) has reasonably demonstrated its ability and commitment to comply with the Trademark Usage Guidelines.  If the noncompliance with the Trademark Usage Guidelines by an Authorized Dealer remains uncured after the expiration of the Second Guideline Cure Period, then at Keysight’s election, such Authorized Dealer promptly shall cease using the non-complying Collateral Materials and/or Marketing Materials until Keysight determines that such Authorized Dealer has demonstrated its ability and commitment to comply with the Trademark Usage Guidelines.  Nothing in this Article VI shall be deemed to limit Keysight’s obligations under Section 4.3 above or to preclude Agilent from exercising any rights or remedies under Section 4.3 above.

 

ARTICLE VII
 QUALITY STANDARDS

 

7.1            GENERAL.  Keysight acknowledges that the Licensed Products permitted by this License to be marked with one or more of the Licensed Marks must continue to be of sufficiently high quality as to provide protection of the Licensed Marks and the goodwill they symbolize, and at least consistent and in compliance with the applicable Agilent Quality Standards in effect as of the day prior to the Effective Date.  Prior to making any material change

 

E-13

 

in any applicable Quality Standard, Keysight shall first advise Agilent of the anticipated change, and obtain Agilent’s consent before implementing it.

 

7.2            QUALITY STANDARDS.  Keysight and its Affiliates shall use the Licensed Marks only on and in connection with Licensed Products that meet or exceed in all respects the applicable Quality Standards in effect on the Distribution Date, or as otherwise mutually agreed between the parties.

 

7.3            QUALITY CONTROL MONITORING.

 

(a)                                 REPORTS:  Keysight will provide Agilent with the quality reports in the form and at the frequency used by Agilent’s Electronic Measurement Group as of July 31, 2014 (“Keysight Quality Reports”) unless otherwise agreed in writing between the parties.  Keysight Quality Reports should be sent electronically to Agilent Enterprise Quality Director or a delegate using the contact information provided in Exhibit E.  If a Keysight Quality Report is not submitted within fourteen (14) days of its respective due date, Keysight shall be considered in violation of this provision and subject to the provisions of Artilce VIII (including Section 8.4), below, except when the parties have otherwise agreed in writing.

 

(b)                                 ADDITIONAL INFORMATION.  Any Agilent concerns about the reports or their contents should be directed the Keysight Director of Quality or authorized delegate using the contact information provided in Exhibit E.  If Agilent determines that further information or other action is needed, appropriate requests will be made via email to the Keysight Director of Quality or authorized delegate, using the contact information provided in Exhibit E, who will acknowledge such request within fifteen (15) days of receipt.  The parties will then confer to exchange relevant information and determine needed actions and applicable deadlines.

 

(c)                                  SAMPLES.  In addition, at Agilent’s reasonable request, Keysight shall furnish or make available to Agilent for inspection one (1) sample of each requested Licensed Product marked with one or more of the Licensed Marks.

 

(d)                                 UPDATING CONTACT INFORMATION. Contact information may be updated consistent with Section 8.6 of the Separation Agreement, below, with a copy to Agilent Enterprise Quality Director and the Keysight Director of Quality.

 

ARTICLE VIII
 QUALITY STANDARD ENFORCEMENT

 

8.1            INITIAL CURE PERIOD.  If Agilent becomes aware that Keysight or any Affiliate is not complying with any Quality Standard or transmitting the reports identified in Section 7.3(b), above, Agilent shall notify Keysight in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance.  Following receipt of such notice, Keysight shall make an inquiry promptly and in good faith concerning each instance of noncompliance described in the notice.  Keysight shall then have thirty (30) calendar days after receipt of such notice (“Initial Cure Period”) to correct such noncompliance or submit to Agilent a written plan to correct such noncompliance, which

 

E-14

 

written plan shall be reasonably acceptable to Agilent, unless Agilent previously affirmatively concurs in writing, in its sole discretion, that Keysight or its Affiliates is in compliance.

 

8.2            SECOND CURE PERIOD.  If the noncompliance with the Quality Standards continues beyond the Initial Cure Period, Keysight and Agilent shall each promptly appoint a representative to negotiate in good faith actions that may be necessary to correct such noncompliance.  The parties shall have fifteen (15) calendar days following the expiration of the Initial Cure Period to agree on corrective actions, and Keysight shall have fifteen (15) calendar days from the date of an agreement of corrective actions to implement such corrective actions and cure or cause the cure of such noncompliance (“Second Cure Period”).

 

8.3            ENFORCEMENT UPON FAILURE TO CURE.  If the said noncompliance with the Quality Standards by Keysight or any Affiliate (as the case may be) remains uncured after the expiration of the Second Cure Period, then at Agilent’s election, Keysight or the non-complying Affiliate (as the case may be) promptly shall cease offering the non-complying Licensed Products under the Licensed Marks until Agilent reasonably determines that Keysight or the non-complying Affiliate (as the case may be) has reasonably demonstrated its ability and commitment to comply with the Quality Standards.  Nothing in this Article VIII shall be deemed to limit Keysight’s obligations under Section 4.3 above or to preclude Agilent from exercising any rights or remedies under Section 4.3 above.

 

8.4            REPEATED VIOLATIONS OF REPORT REQUIREMENT.   If Keysight violates Section 7.3(a), above, in any three (3) months during any consecutive twelve (12)—month period, Keysight’s license rights to use the Licensed Marks under this agreement shall be deemed automatically terminated with respect to all Licensed Products, regardless of whether or not Agilent has provided Keysight any notices of noncompliance.

 

8.5            LICENSE RE-GRANT FOLLOWING LICENSE TERMINATION.  In the event of an automatic license termination under Section 8.4 above, Keysight may, at any time, request in writing that Agilent re-grant Keysight a license having identical terms to apply from the new grant date forward and potentially also apply retroactively as to certain products.  The written request shall include: (1) current Keysight Quality Reports;(2) all of the relevant Keysight Quality Reports covering the periods of unlicensed use; and (3) two thousand U.S. dollars ($2,000) per month for each month of unlicensed use of the Licensed Marks, to compensate Agilent for the costs and risks associated with Keysight’s unlicensed use of the Licensed Marks.  Effective upon receipt of such request from Keysight, the license shall be deemed granted effective from the receipt date forward.  If Keysight has also requested the license apply retroactively, Agilent shall evaluate the request in light of the written application.  Within thirty (30) days of receipt, Agilent shall review the back Keysight Quality Reports and respond to the request with any concerns raised in the current Keysight Quality Reports being addressed using the processes of Section 7.3 and Sections 8.1, 8.2 and 8.3, above.  If supported by the data submitted, Agilent shall grant the request for retroactive application of the license by making the re-granted license applicable to the relevant Licensed Products, as if the license had not been terminated.

 

E-15

 

ARTICLE IX
 PROTECTION OF LICENSED MARKS

 

9.1            GOODWILL OF LICENSED MARKS.  Any increase in the goodwill associated with Keysight’s use of the Licensed Marks shall inure exclusively to the benefit of Agilent and Keysight shall not acquire or assert any rights therein.  Keysight recognizes the value of the goodwill associated with the Licensed Marks, and that the Licensed Marks may have acquired secondary meaning in the minds of the public.

 

9.2            PROTECTION OF LICENSED MARKS.  During the term of this License, Keysight shall assist Agilent, at Agilent’s request and expense, in the procurement and maintenance of Agilent’s intellectual property rights in the Licensed Marks.  Keysight will not grant or attempt to grant a security interest in the Licensed Marks or record any such security interest in the United States Patent and Trademark Office or elsewhere against any Mark application or registration belonging to Agilent.  Keysight agrees to, and shall cause its Affiliates to, execute all documents reasonably requested by Agilent to affect further registration of, maintenance and renewal of the Licensed Marks, recordation of the license relationship between Agilent and Keysight and recordation of Keysight as a registered user.  Agilent makes no warranty or representation that Mark registrations have been or will be applied for, secured or maintained in the Licensed Marks throughout, or anywhere within the world.  Keysight shall cause to appear on all Licensed Products, all Marketing Materials and all Collateral Materials, such legends, markings and notices as may be required by applicable law or as otherwise agreed by Agilent and Keysight.

 

9.3            SIMILAR MARKS.  Keysight agrees not to use or register in any country any Mark that is or may be confusingly similar to or otherwise infringe Licensed Marks, or any element thereof.  Keysight agrees not to adopt any Marks incorporating the root “Agil” or any other Mark confusingly similar to the Licensed Marks.  Keysight shall not challenge Agilent’s ownership of or the validity of the Licensed Marks or any application for registration thereof throughout the world.  Keysight shall not use or register in any country or jurisdiction, or permit others to use or register on its behalf in any country or jurisdiction, any copyright, telephone number or any other intellectual property right, whether recognized currently or in the future, or any other designation which would affect the ownership or rights of Agilent in and to the Licensed Marks, or otherwise take any action which would adversely affect any of such ownership rights, or assist anyone else in doing so.  Keysight shall cause its Affiliates and direct its Authorized Dealers to comply with the provisions of this Section 9.3.

 

9.4            INFRINGEMENT PROCEEDINGS.

 

(a)                                 NOTICE TO AGILENT.  If Keysight learns, during the Term of this License, of any infringement or threatened infringement of the Licensed Marks, or any unfair competition, passing-off or dilution with respect to the Licensed Marks, Keysight shall provide timely notice to Agilent or its authorized representative giving particulars thereof and indicating whether Keysight requests Agilent take action to enforce its rights in such matter.   Notwithstanding the foregoing, Keysight is not obligated to monitor or police use of the Licensed Marks by Third Parties other than as specifically set forth in Section 4.3 hereof.

 

E-16

 

(b)              DECISION TO ENFORCE.  Except for those actions initiated by Keysight pursuant to Section 4.3 hereof to enforce any sublicense or other agreement with any Affiliate or Authorized Dealer, Agilent shall have exclusive control of any litigation, opposition, cancellation or related legal proceedings.  The decision whether to bring, maintain or settle any such proceedings shall be at the exclusive option of Agilent; provided, however, that in cases where Keysight is bearing the costs of such action, Agilent agrees to consult with Keysight prior to making such decisions.  Keysight can revoke its request that Agilent take action at any time upon written notice.  If the revocation is received by Agilent before an action is initiated, the revocation will be effective upon receipt.  However, if the revocation is received by Agilent after an action is initiated, Keysight’s revocation will become effective only upon the action being successfully terminated or concluded.  If, during the pendency of an action for which Keysight is bearing the costs, a settlement opportunity is presented that Keysight elects to accept, Agilent may alone reject the settlement and continue the litigation on the condition that Agilent bear the costs from that time forward.  Keysight shall not and shall have no right to initiate any litigation, opposition, cancellation or related legal proceedings with respect to the Licensed Marks in its own name (except for those actions initiated by Keysight pursuant to Section 4.3 hereof).  Other than disbursement of monetary recoveries in accordance with Section 9.4(d), below, Agilent shall incur no liability to Keysight or any other Person under any legal theory by reason of Agilent’s failure or refusal to prosecute, nor by reason of any settlement to which Agilent may agree.

 

(c)               KEYSIGHT ASSISTANCE.   Keysight shall provide necessary information and assistance to Agilent or its authorized representatives in the event that Agilent decides that proceedings should be commenced.  Keysight agrees to cooperate with Agilent to enforce its rights in the Licensed Marks, including to join or be joined as a party in any action taken by Agilent against a Third Party for infringement or threatened infringement of the Licensed Marks, to the extent such joinder is required under mandatory local law for the prosecution of such an action.

 

(d)              COST OF ENFORCEMENT.  Unless Keysight has indicated its desire that Agilent take action to enforce its rights in a matter, Agilent shall be responsible for all costs associated with Agilent’s enforcement, including the costs of Keysight assistance provided in accordance with Section 9.4(c), above, and all monetary recoveries shall belong exclusively to Agilent.  Where Keysight has requested Agilent take action, Keysight shall be responsible for all costs associated with Agilent’s enforcement.  If Keysight is responsible for costs, all monetary recoveries up to the full cost of enforcement shall be paid to Keysight with any amounts above and beyond the cost of enforcement split equally between Agilent and Keysight.  If Keysight revokes its request that Agilent take action in a particular matter, Keysight shall remain liable for any costs incurred through the date the revocation became effective, and all monetary recoveries shall belong exclusively to Agilent.

 

(e)               PENDING ACTIONS.  As to actions pending on as of the day prior to the Effective Date, Agilent shall continue to bear the costs, and Keysight shall provide assistance in accordance with Section 9.4(c) above, unless the parties otherwise agree in writing as to a specific action.

 

E-17

 

9.5            TECHNICAL ASSISTANCE.  Except as otherwise set forth herein, in the Agreement or any other mutually executed agreement between the parties, no party shall be required to provide the other party with any technical assistance or to furnish any other party with, or obtain on their behalf, any documents, materials or other information (including copies of registrations of the Licensed Marks).

 

9.6            NO CHALLENGE TO TITLE.  The party receiving the license hereunder acknowledges and agrees that the party (or its applicable Affiliate) granting the license is the sole and exclusive owner of the Licensed Mark so licensed.  Keysight agrees that it shall not (and shall cause its Affiliates not to), for any reason, whether during or after the termination of this License, do or authorize any Third Party to do, any of the following with respect to any Licensed Mark licensed to Keysight or its Affiliates hereunder:  (a) represent to any Third Party in any manner that it owns or has any ownership rights in the Licensed Marks; (b) apply for federal, state, or national registration of the Licensed Marks; or (c) impair, dispute or contest the validity of the Agilent (or any of its Affiliates) right, title and interest in and to the Licensed Marks.

 

ARTICLE X
 CONFIDENTIALITY

 

The provisions set forth in Section 6.2 of the Separation Agreement are hereby expressly incorporated into this License and made a part thereof, and all information, whether written or oral, furnished by either party to the other party or any Affiliate of such other party pursuant to this License shall also be “Confidential Information,” as that term is defined in the Separation Agreement.

 

ARTICLE XI
 TERMINATION

 

11.1     VOLUNTARY TERMINATION.  By written notice to Agilent, Keysight may voluntarily terminate all or a specified portion of the licenses granted to it hereunder by Agilent.  Such notice shall specify the effective date of such termination and shall clearly specify any affected Licensed Marks and Licensed Products.

 

11.2     EFFECT OF TERMINATION; SURVIVAL.  Any voluntary termination of licenses and rights of Keysight under Section 11.1 hereof shall not affect Keysight’s licenses and rights with respect to any Licensed Products made or furnished by Keysight prior to such termination or Keysight’s licenses and rights with respect to any Licensed Marks not so terminated.  Notwithstanding anything in this License to the contrary, Section 2.4 (Reservation of Rights), Section 2.13 (Indemnification), Article X (Confidentiality), this Section 11.2 (Effect of Termination; Survival), Article XII (Limitation of Liability and Warranty Disclaimer) and Article XIII (Miscellaneous Provisions) shall survive any expiration or termination of this License in whole or in part.

 

11.3     CHANGE OF CONTROL.

 

(a)                                 Notwithstanding any other provisions of this License, Change of Control, as defined in the IPMA applies to this License and all licenses granted to Keysight by this

 

E-18

 

License.   For example, if the licenses granted by Agilent to Keysight pursuant to the IPMA are deemed not assignable pursuant to Section 8.2 of the IPMA, then this License and all licenses granted under this License are not assignable.

 

(b)              Further, upon any Change of Control of Keysight, the term specified in each of Sections 2.2(b), 3.3(b), 3.3(c), 3.3(d) and 3.3(e) shall change to “three (3) years from the Distribution Date,” unless Agilent, in its sole and absolute discretion, agrees otherwise in writing.  For example, in the absence of Agilent’s written agreement to the contrary: (1) if the Change of Control event were to occur on the second anniversary of the Distribution Date, then all licenses granted under this Agreement would be deemed to terminate on the third anniversary of the Distribution Date (i.e. in one (“1”) year); and (2) if the Change of Control event were to occur after the third anniversary of the Distribution Date, then all licenses granted under this agreement would be deemed terminated immediately upon the occurrence of the Change of Control.

 

ARTICLE XII
 LIMITATION OF LIABILITY AND WARRANTY DISCLAIMER

 

12.1     IN NO EVENT SHALL ANY PARTY BE LIABLE TO THE OTHER PARTY FOR ANY SPECIAL, CONSEQUENTIAL, INDIRECT, INCIDENTAL OR PUNITIVE DAMAGES OR LOST PROFITS, HOWEVER CAUSED AND BASED ON ANY THEORY OF LIABILITY (INCLUDING NEGLIGENCE) ARISING IN ANY WAY OUT OF THIS LICENSE, WHETHER OR NOT SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.  THE FOREGOING SHALL NOT, HOWEVER, LIMIT THE DAMAGES AVAILABLE TO AGILENT FOR (A) INFRINGEMENT OR MISAPPROPRIATION OF ANY LICENSED MARKS OR (B) BREACHES OF ARTICLE X.

 

12.2     WARRANTIES DISCLAIMER.  EXCEPT AS OTHERWISE SET FORTH HEREIN, EACH PARTY ACKNOWLEDGES AND AGREES THAT ALL LICENSED MARKS AND ANY OTHER INFORMATION OR MATERIALS LICENSED OR FURNISHED HEREUNDER ARE LICENSED OR FURNISHED WITHOUT ANY WARRANTIES WHATSOEVER, WHETHER EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT THERETO, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF TITLE, FITNESS FOR A PARTICULAR PURPOSE, TITLE, ENFORCEABILITY OR NON-INFRINGEMENT.

 

12.3     Except as otherwise set forth herein, neither Agilent nor any of its Affiliates makes any warranty or representation as to the validity of any Licensed Mark or any warranty or representation that any use of any Licensed Mark with respect to any product or service will be free from infringement of any rights of any Third Party.

 

E-19

 

ARTICLE XIII
  MISCELLANEOUS PROVISIONS

 

13.1     ENTIRE AGREEMENT.  This License, together with the Separation Agreement and the IPMA constitute the entire understanding between the parties with respect to the subject matter hereof and shall supersede all prior written and oral and all contemporaneous oral agreements and understandings with respect to the subject matter hereof.  To the extent that there is a conflict between this License and such other agreements, this License shall govern.

 

13.2     INCORPORATION OF MISCELLANEOUS TERMS.  Article VIII of the Separation Agreement is hereby incorporated into this Agreement by this reference.

 

13.3     DISPUTE RESOLUTION.  In the event of any controversy, dispute or claim (a “Dispute”) arising out of or relating to any party’s rights or obligations under this License (whether arising in contract, tort or otherwise) (including the interpretation or validity of this License), such Dispute shall be resolved in accordance with the dispute resolution process referred to in Article VII of the Separation Agreement.

 

13.4     SPECIFIC PERFORMANCE.  Subject to Section 13.3, in the event of any actual or threatened default in, or breach of, any of the terms, conditions and provisions of this License, the party or parties who are or are to be thereby aggrieved shall have the right to specific performance and injunctive or other equitable relief (on an interim or permanent basis) of its rights under this License, in addition to any and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative.  The parties agree that the remedies at law for any breach or threatened breach, including monetary damages, may be inadequate compensation for any loss and that any defense in any action for specific performance that a remedy at law would be adequate is waived.  Any requirements for the securing or posting of any bond with such remedy are waived by each of the parties.

 

[SIGNATURE PAGE FOLLOWS]

 

E-20

 

IN WITNESSS WHEREOF, the parties have caused this Trademark License Agreement to be duly executed.

 

	
 
    	
AGILENT   TECHNOLOGIES, INC.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
 
    
	
 
    	
 
    	
 
    	
Sheila   Barr Robertson
    
	
 
    	
 
    	
 
    	
Senior   Vice President, Corporate Development and Strategy
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
Date:
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
KEYSIGHT   TECHNOLOGIES, INC.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
 
    
	
 
    	
 
    	
 
    	
Ronald   S. Nersesian
    
	
 
    	
 
    	
 
    	
President   and Chief Executive Officer
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
Date:
    	
 
    

 

[Signature Page to the Trademark License Agreement]

 

 

Exhibit A

 

Licensed Marks

 

1.              “Agilent” — word mark

 

2.              “Agilent Technologies” — word mark

 

3.              “Spark (4-dot)” - graphic

 

4.              “Spark (3-dot)” - graphic

 

5.              “Agilent Signature” — composite word mark and graphic, and trade dress element

 

E-22

 

Exhibit B

 

Agilent Identity System:
  Product Labeling Standards

 

 

Click above graphic to open PDF.

 

E-23

 

Exhibit C

 

Unencapsulated Integrated Circuits

 

	
Part Number
    	
 
    	
Description
    
	
1NB4-5057
    	
 
    	
IC-ASIC   1NB4-5057 256-TBGA, Agilent Trade Restricted
    
	
 
    	
 
    	
 
    
	
1NB7-8453
    	
 
    	
Rattler   PRE AMP, Agilent Trade Restricted
    
	
 
    	
 
    	
 
    
	
1NB7-8477
    	
 
    	
Rattler   Preamp 50 OHM, Agilent Trade Restricted
    
	
 
    	
 
    	
 
    
	
1NG9-8201
    	
 
    	
Sperlin   - External
    
	
 
    	
 
    	
 
    
	
1NG9-8202
    	
 
    	
Berlin   - External
    
	
 
    	
 
    	
 
    
	
2AT9-8201
    	
 
    	
IC   ASIC preamplifier 40-QFN - external
    

 

E-24

 

Exhibit D

 

Licensed Products subject to Long Term Exception

 

	
Part Number
    	
 
    	
Description
    
	
M9101A,   M9102A, M9103A, M9120A, M9121A, M9122A, M9128A, M9130A, M9131A, M9132A,   M9133A, M9135A, M9146A, M9147A, M9148A, M9149A, M9150A, M9151A, M9152A,   M9153A, M9187A
    	
 
    	
Software/Firmware   used in the “Pipeline” family of switch products.
    
	
 
    	
 
    	
 
    
	
M9330A,   M9331A
    	
 
    	
Software/Firmware   used in the Arbitrary Wafeform Generator
    
	
 
    	
 
    	
 
    
	
34921A,   34922A, 34923A, 34924A, 34925A, 34931A, 34932A, 34933A, 34934A, 34934C,   34937A, 34938A, 34939A, 34941A, 34942A, 34945A, 34945EXT, 34946A, 34947A,   34950A, 34951A, 34952A 34959A, 34980A, L4421A, L4433A, L4437A, L4445A,   L4450A, L4451A, L4452A, L4490A, L4491A, L4532A, L4534A
    	
 
    	
Software/Firmware   used in the “Abe” family of switch products
    
	
 
    	
 
    	
 
    
	
Agilent   Measurement Manager Software as distributed with USB modular products
    	
 
    	
This   is a software module that runs the background and interfaces with embedded   code on every USB modular product made by Agilent prior to Keysight spin.   Changing the name may break functionality with legacy products.
    
	
 
    	
 
    	
 
    
	
Parametric   Measurement Manager (PMM) as used with U2722/23A USB Modular Source   Measurement unit and its parametric test fixture accessory, U2941A
    	
 
    	
PMM   is an optional, free software that allows users to program the U2722/23A and   the U2941A
    
	
 
    	
 
    	
 
    
	
W400d
    	
 
    	
VEE   software
    

 

E-25

 

Exhibit E

 

Quality Contacts

 

Keysight Contact:

 

Keysight Director of Quality

keysightquality.reporting@keysight.com and

bill_lycette@keysight.com

707.577.6571

 

1400 Fountaingrove Pkwy

Santa Rosa, CA 95403

 

 

Agilent Contact:

 

Agilent Enterprise Quality Director

agilentquality.reporting@agilent.com

408.345.8117

 

5301 Stevens Creek Blvd

Santa Clara, CA 9505

 

E-26

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}]]